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Summary  
 
This thesis dissertation involves two projects. The first project focuses on the interactions of 
bacterial lipopolysaccharide(LPS) with different types of polymyxins studied by NMR spectroscopy. The 
second project involves NMR structural studies of the N-terminal domains of the Y-receptors and the 
recombinant production of larger transmembrane domains from the neuropeptide Y4 receptor, as well as its 
structural and functional exploration using multi-dimensional NMR techniques. Lipopolysaccharide(LPS) 
forms the main constituent of the outer membrane of gram-negative bacteria. As a potent stimulator of the 
immune system, LPS is an important pathogenic factor for infection and inflammation playing a key role 
during the septic shock. The septic shock syndrome caused by the endotoxin still has an unacceptably high 
mortality rate and, owing to increasing numbers of antibiotic resistant strains, remains an ongoing threat 
throughout the world.  
 
An understanding of the structural aspects of binding of LPS to its ligands in a membrane-
mimicking environment would be very useful for the rational development of compounds with anti-
endotoxin activity. We have focused for our study on two systems:  1. Binding of sCD14(1-152) to LPS and 
2.Binding of different types of polymyxins to LPS. CD14 is a myelomonocytic differentiation antigen in 
mammals. It occurs in two forms a 50–55-kDa glycosylphosphatidyl-inositol (GPI)-anchored membrane 
protein (mCD14) and a monocyte or liver-derived soluble serum protein (sCD14) that lacks the membrane 
anchor. Both mCD14 and sCD14 are critical for LPS-dependent signal transduction, and sCD14 confers LPS 
sensitivity to cells which lacks mCD14. Mutant sCD14 containing only the N-terminal 152 amino acid 
residues were found to have and displays activity equivalent to the full length sCD14. Polymyxins are a 
group of cyclic polycationic polypeptides with a long hydrophobic tail isolated from various strains of 
Bacillus polymyxa and related species. They are selectively toxic for Gram-negative bacteria due to their 
specificity for lipopolysaccharide.  
 
    In the first stage, we started with the expression of sCD14(1-152)  in E.coli and in the yeast Pichia 
pastoris expression system. Expression and purification of sCD14 was reported before, but the protein was 
highly aggregated precluding detailed structural studies by NMR. To increase solubility and retard 
aggregation we tested several fusion strategies and refolding trials to obtain properly folded sCD14(1-152). 
However, although some of the tested constructs were expressed at reasonable yields NMR experiments 
quickly revealed that they were either unfolded or highly aggregated. Since a crystal structure of the full-
length protein was published during the studies we decided to not longer pursue that project. 
 
    Next, we investigated the structural properties of the LPS-Polymyxin (PMX) complex. NMR studies 
of polymyxins bound to LPS were published but no experimental data on the complex nor on the LPS-
interacting residues were known. We present a study of interactions of PMX-B, -E and -M with LPS from the 
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deep rough mutant strain of E.coli in membrane-mimetic dodecylphosphocholine (DPC) micelles. This 
mutant of LPS is a so-called heptose-less mutants, in which the core, lipid-A, is only decorated by 2 Kdo (2-
Keto-3-deoxyoctonate) moieties. First a method for efficient purification of biosynthetically produced LPS 
using RP-HPLC in a ternary solvent mixture was developed. Polymyxin-M(PMX-M) was biosynthetically 
produced from the B.polymyxa strain. The bacteria were grown on isotopically labeled medium, from which 
polymyxin-M was secreted into the medium and purified by chromatography. LPS was incorporated into a 
phospholipid micelles and its interaction with polymyxins was studied by heteronuclear NMR spectroscopy. 
The data enabled us to localize the interaction sites between LPS and polymyxins. Using simulated annealing 
protocol and restraints derived from intermolecular NOEs a model of the LPS–PMX-B complex was 
established, which was also in accordance with the chemical shift mapping data. The model was further 
refined by MD calculations, which included DPC micelles and explicit water. In the modelled complex the 
macrocycle of PMX-B is centered around the phosphate group at GlcN-B (N-acetylglucosamine-B) and 
additional contacts from polar side chains are formed to GlcN-A and Kdo-C, while hydrophobic side chains 
target the acyl region. In this study, we have synthesized and characterized all the constituents of the complex 
and the nature of the interacting moieties.   
 
My second project involves structural studies of fragments of a human G-protein coupled receptor, 
in particular the Y4-receptor. Y-receptors are members of the rhodopsin-like G-protein coupled receptor 
(GPCR) family 1b. The Y-receptors are activated by neuropeptide Y, pancreatic polypeptide, and peptide 
YY, which belong to the family of neuroendocrine hormones. These receptors play an important role in the 
regulation of blood pressure, memory retention, food uptake and seizure. In this work, we focussed initially 
on structural studies of the extracellular N-terminal domains of the Y-receptors, and report on structural 
properties of the N-terminal domains of the human Y1-, Y2-, Y4-, and Y5- receptors. Synthetic routes for 
recombinant production of the polypeptides in isotopically-labeled form are described and compared to each 
other. The N-terminal domains from these Y receptors are fully unstructured in aqueous solution, as shown 
by measurements of the internal backbone dynamics. In contrast, in the presence of phospholipid micelles the 
N-terminal domain of the Y4 receptor (N-Y4) adopts a short !-helix in a segment mainly comprised of 
hydrophobic residues. N-Y1 is largely helical although remaining flexibility precludes a detailed structural 
analysis. N-Y5 is segregated into more structured and rather flexible regions, similarly to N-Y4. However, 
measurements of internal backbone dynamics revealed secondary structure to be less stable than in N-Y4. N-
Y2 does not interact with the micelles and remains unstructured also in that environment. 
 
In the second stage, on basis of structure and functional studies of N-Y4, we have extended our 
studies to longer transmembrane fragments, which contain two or more helices from the membrane domain, 
thus better mimicking the native properties of the receptor. In this study we describe about the expression and 
purification strategy for the production of double transmembrane fragments containing helices 4 and 5 (TM4-
TM5 [I2(147)TM4-E2-TM5-I3(259)]) and helices 6 and 7 (TM6-TM7-C [I3(260)TM6-E3-TM7-C])  of the 
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Y4 receptor in isotopically enriched form in E. coli. Both the double transmembrane constructs were 
successfully expressed as Trp leader (Trp!LE) fusion proteins, from which they were liberated by either 
cyanogen bromide (CNBr) cleavage (TM4-TM5) or by enzymatic cleavage(TM6-TM7-C) in the presence of 
detergents using C3 protease and purified by a combination of affinity chromatography and RP-HPLC. The 
cleavage strategy is an  important point of concern because for  many membrane proteins to be soluble at 
useful concentrations they require more acidic or more basic pH levels, high or low salt levels, or the 
presence of detergents or chaotropes. We tested using the N-terminus of Y4 receptor as a small fusion tag to 
favour the expression of double-transmembrane constructs. Accordingly, a N(Y4)-TM4-TM5 construct 
[(158)TM4-E2-TM5-I3(259)]  was designed with a CNBr cleavage site to remove the N-terminal domain 
fusion if needed. This fusion strategy takes advantage of the small size of the N-terminal domain (41 
aminoacids), which may allow direct NMR analysis without the need of removing the fusion protein. Two 
constructs were made, one, in which the I2 loop region before the TM4 region was included and one, in 
which this loop sequence was absent. [
15
N,
1
H]-HSQC spectra in detergent micelles revealed that the TM4-
TM5 fragments in absence of the intracellular-2 (I2) loops form larger aggregates thus revealing the 
additional importance of loop residues for structural studies of the transmembrane segments. 
 
Expression yields were optimized using different strains and growth temperatures as well as various 
induction parameters. The yield was found to be approximately 3-4 mg/L for TM4-TM5 fusion constructs 
and for TM6-TM7-C fusion protein 4-5 mg/L was obtained. The CNBr cleavage conditions were optimized, 
and cleavage efficency was found to be approximately 75-80%. The C3 protease cleavage, carried out in 
CHAPS or LDAO, still requires optimization of other buffer ingredients to maximize cleavage efficiency. In 
case of the TM4-TM5 construct, an extensive detergent screening using 15N-labelled protein that resulted in 
spectra of reasonable quality. Structures of these constructs in addition to the N4-TM1-TM2 fragment, 
previously studied in our group, will be an important step towards an structural understanding of the enitre 
receptor in detergent micelles. 
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Zusammenfassung 
 
Diese Dissertation beinhaltet zwei Projekte. Das erste untersucht mittels NMR Spektroskopie die 
Wechselwirkung von bakteriellem Lipopolysaccharid (LPS) mit verschiedenen Arten von Polymyxinen. 
Das zweite widmet sich - ebenfalls durch Anwendung von mehrdimensionalen NMR-spektroskopischen 
Methoden - strukturellen und funktionellen Aspekten rekombinant hergestellter N-terminaler Domänen der 
Y-Rezeptoren und grösserer Transmembrandomänen des Y4-Rezeptors. LPS ist der Hauptbestandteil der 
äusseren Membran gram-negativer Bakterien. Als potenter Stimulator des Immunsystems stellt LPS einen 
wichtigen Faktor in der Infektion und Entzündung dar und spielt zudem eine wichtige Rolle beim 
septischen Schock. Die während des septischen Schocks durch das Endotoxin LPS hervorgerufenen 
Symptome haben immer noch eine inakzeptabel hohe Mortalitätsrate weltweit, insbesondere auch aufgrund 
einer wachsenden Anzahl antibiotikaresistenter Stämme. 
 
Ein Verständnis der strukturellen Aspekte der Bindung von LPS an seine Liganden in einer 
membranmimetischen Umgebung wäre sehr nützlich für die rationale Entwicklung von Verbindungen mit 
anti-endotoxischer Aktivität. Für unsere Studien haben wir uns auf zwei Systeme konzentriert: 1. Bindung 
von sCD14(1-152) an LPS und 2. Bindung verschiedener Arten von Polymyxinen an LPS. CD14 ist ein 
myelomonozytisches Differentiationsantigen in Säugetieren. Es liegt sowohl in Form eines 50-55 kDa, via 
Glycosylphosphatidylinositol (GPI) verankerten Membranproteins (mCD14), als auch eines 
monozytischen, aus der Leber stammenden, löslichen Serumproteins (sCD14), welches keine 
Membranverankerung aufweist, vor. Sowohl mCD14 als auch sCD14 sind notwendig für LPS-abhängige 
Signalleitung. sCD14 ist dabei in der Lage Zellen, welchen mCD14 fehlt, sensitiv gegenüber LPS zu 
machen. Ein sCD14 Abkömmling, welcher nur aus den N-terminalen 152 Aminosäuren besteht, zeigt 
diesbezüglich die gleiche Aktivität wie vollständiges sCD14. Polymyxine sind eine Gruppe zyklischer, 
polykationischer Polypeptide mit einem grossen hydrophoben Teil und wurden aus verschiedenen Stämmen 
der Familie Bacillus polymyxa und artverwandter Spezies isoliert. Sie sind selektiv toxisch für gram-
negative Bakterien aufgrund ihrer Spezifität gegenüber LPS. 
 
In einer ersten Phase begannen wir mit der Expression von sCD14(1-152) in E. coli und in der Hefe 
Pichia pastoris. Über die Herstellung und Aufreinigung von sCD14 wurde bereits berichtet, aber das 
Protein lag in aggregierter Form vor, was strukturelle Untersuchungen mittels NMR verunmöglichte. Um 
die Löslichkeit zu erhöhen und die Aggregation zu verhindern und so korrekt gefaltetes sCD14(1-152) zu 
erhalten, haben wir mehrere Fusions- und Rückfaltungsstrategien ausprobiert. Aber obwohl einige der 
untersuchten Konstrukte mit guten Ausbeuten exprimiert werden konnten, zeigten NMR Experimente 
schnell, dass die so hergestellten Proteine entweder entfaltet oder aggregiert waren. Da zudem während 
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dieser Studien eine Kristallstruktur von sCD14 veröffentlicht wurde, haben wir uns entschlossen dieses 
Projekt nicht weiter zu verfolgen. 
 
Als Nächstes haben wir die strukturellen Eigenschaften des LPS-Polymyxin Komplexes untersucht. 
NMR Studien zu diesem Thema wurden bereits andernorts durchgeführt, jedoch konnten keine Daten, 
welche die Komplexbildung erklärten, erhalten werden. Wir präsentieren eine Studie der 
Wechselwirkungen von Polymyxin-B, -E und -M (PMX-B, -E und -M) mit LPS der "deep rough" Mutante 
von E. coli in einer membranmimetischen Umgebung aus Dodecylphosphocholin (DPC) Mizellen. Diese 
Mutante produziert ein LPS, das heptoselos ist, und in welchem der Kern, genannt Lipid A, nur mit 2 
Resten des Zuckers 2-Keto-3-desoxy-octonat (Kdo) versehen ist. Zuerst wurde eine Methode für die 
effiziente Reinigung von biosynthetisch hergestelltem LPS mittels RP-HPLC in einem ternären 
Lösungsmittelgemisch entwickelt. Polymyxin-M wurde im B. polymyxa Stamm - ebenfalls biosynthetisch - 
hergestellt. Die Bakterien wurden in isotopenmarkiertem Medium vermehrt. Polymyxin-M wurde dabei ins 
Medium sekretiert und konnte daraus chromatographisch gereinigt werden. LPS wurde in 
Phospholipidmizellen integriert und seine Interaktion mit den Polymyxinen mittels heteronuklearer NMR 
Spektroskopie untersucht. Die gewonnen Daten ermöglichten uns die Interaktionsstellen zwischen LPS und 
den Polymyxinen zu bestimmen. Durch Verwendung eines "simulated annealing" Protokolls und 
Distanzeinschränkungen aus intermolekularen NOEs konnte ein Modell des LPS-PMX-B Komplexes 
erstellt werden, welches in Einklang war mit anderen NMR Daten. Das Modell wurde durch 
molekulardynamische Simulationen, welche auch DPC Mizellen und Wassermolküle enthielten, weiter 
verfeinert. Im modellierten Komplex ist der PMX-B Makrozyklus um die Phosphatgruppen an N-
Acetylglucosamin-B (GlcN-B) zentriert. Zusätzlich gehen polare Seitenketten weitere Interaktionen mit 
GlcN-A und Kdo-C ein, während sich hydrophobe Seitenketten an die Acylreste von LPS anlagern. 
 
Das zweite Projekt war strukturellen Untersuchungen an Fragmenten von menschlichen G-Protein 
gekoppelten Rezeptoren (GPCRs) gewidmet, insbesondere dem Y4-Rezeptor. Y-Rezeptoren sind 
Mitglieder der rhodopsinähnlichen GPCR Familie 1b. Sie werden durch Neuropeptid Y, pankreatisches 
Polypeptid und Peptid YY aktiviert, welche alle zur Familie der neuroendokrinen Hormone gehören. Diese 
spielen wichtige Rollen in der Regulation des Blutdrucks, des Gedächtnisses, der Nahrungsaufnahme und 
im Entstehen von Schlaganfällen. In der vorliegenden Arbeit haben wir uns erst auf die N-terminalen 
Domänen der menschlichen Y1-, Y2-, Y4-, und Y5-Rezeptoren (N-Y1, N-Y2, N-Y4 und N-Y5) 
konzentriert. Synthetische Strategien für die rekombinante Produktion in isotopenmarkierter Form werden 
beschrieben und miteinander verglichen. Diese N-terminalen Domänen sind in wässriger Lösung komplett 
unstrukturiert wie Dynamikmessungen des Peptidrückgrats ergeben haben. In Anwesenheit von 
Phospholipidmizellen jedoch bildet sich in N-Y4 eine kurze !-Helix in einem Segment, welches 
hauptsächlich aus hydrophoben Aminosäuren besteht. N-Y1 ist unter diesen Bedingungen grösstenteils 
helikal. Eine hohe Flexibilität verunmöglicht jedoch eine detaillierte strukturelle Charakterisierung. N-Y5 
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kann in eine strukturierte und eine ziemlich flexible Region unterteilt werden, ähnlich N-Y4.  
Dynamikmessungen des Peptidrückgrats haben aber ergeben, dass die Sekundärstruktur in N-Y5 weniger 
stabil ist als in N-Y4. N-Y2 zeigt keine Interaktion mit Mizellen und bleibt auch in dieser Umgebung 
unstrukturiert. 
 
Basierend auf den strukturellen und funktionellen Studien von N-Y4 haben wir unsere 
Bemühungen auf längere, transmembranäre Fragmente, welche zwei oder mehr Helices enthalten, 
ausgedehnt. Diese Fragmente kommen dem natürlichen Rezeptor aufgrund ihrer grösseren Länge näher. 
Wir beschreiben hier die Expression und Aufreinigung von Fragmenten aus Helices 4 und 5 (TM4-TM5 
oder [I2(147)TM4-E2-TM5-I3(259)]) und Helices 6 und 7 (TM6-TM7-C oder [I3(260)TM6-E3-TM7-C]) 
des Y4-Rezeptors in isotopenmarkierter Form aus E. coli Bakterien. Beide Konstrukte wurden erfolgreich 
als Fusionsproteine mit der "Trp-leader" Sequenz (Trp"LE) exprimiert, von welcher sie entweder mittels 
Cyanogenbromid (CNBr) Spaltung oder durch enzymatische Spaltung mittels der C3 Protease in 
Anwesenheit von Detergentien freigesetzt wurden. Gereinigt wurden die Fragmente mit einer Kombination 
aus Affinitätschromatographie und RP-HPLC. Die Wahl einer geeigneten Spaltungsstrategie ist ein 
kritischer Punkt, weil viele Membranproteinfragmente nur unter sehr harschen Bedingungen löslich sind. 
Wir haben unter anderem auch N-Y4 als einen kleinen Fusionspartner ausprobiert, welcher die Expression 
der Doppel-TM Konstrukte erhöhen sollte. So haben wir ein N(Y4)-TM4-TM5 Konstrukt ([(158)TM4-E2-
TM5-I3(259)]) mit einer CNBr Spaltungsstelle, welche - falls gewünscht - die nachträgliche Abspaltung 
von N-Y4 erlaubt, erstellt. Diese Strategie nützt die geringe Grösse von N-Y4 (41 Aminosäuren) aus, 
welche auch eine direkte NMR Untersuchung ohne die vorherige Abspaltung des Fusionspartners 
ermöglicht. Zwei solcher Konstrukte wurden hergestellt: Eines, in welchem der I2-loop vor der TM4 
Region enthalten war, und ein Anderes, in welchem diese Sequenz nicht enthalten war. [15N,1H]-HSQC 
Spektren in Mizellen zeigten, dass die TM4-TM5 Fragmente in Abwesenheit des I2-loops aggregierten. Die 
Anwesenheit dieses Loops war darum unerlässlich für NMR Studien. 
 
Expressionsausbeuten wurden mittels verschiedener Stämme, Wachstumstemperaturen und 
Induktionsstrategien auf 3-4 mg/L (TM4-TM5) und 4-5 mg/L (TM6-TM7-C) optimiert. Die Effizienz der 
CNBr Spaltung konnte auf 75-80% optimiert werden. Die Spaltung mit der C3 Protease wurde in CHAPS 
oder LDAO Detergens durchgeführt und lässt noch Raum für Optimierung der Bedingungen. Für das TM4-
TM5 Konstrukt wurde eine grosse Menge an Detergentien auf ihre Fähigkeit gute NMR Spektren 
herzugeben getestet. Strukturen von diesen Konstrukten werden einen wichtigen Schritt in die Richtung des 
Verständnisses des ganzen Rezeptors in Detergensmizellen darstellen. 
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Chapter 1 
  
1.0 Introduction 
Proteins and enzymes that bind carbohydrates are present in large numbers in all 
living cells and are involved in a myriad of important biological functions. This 
abundance is primarily due to the fact that carbohydrates derived from carbon dioxide 
fixation constitute the bulk of the organic matter on earth, and together with their 
various derivatives and polymeric forms, are utilized for many essential purposes in the 
cell. Sugars are the central energy source for mechanical work and chemical reactions 
in living cells. Phosphate derivatives of monosaccharides are important in these energy 
transformations, and several sugar derivatives, particularly adenosine triphosphate, 
serve key roles in the storage and transfer of energy. The uptake of sugars into the cell 
and their subsequent utilization require transport proteins and a whole assemblage of 
enzymes. In addition, carbohydrates in the form of polysaccharides are used for fuel 
storage and as structural elements[1]. 
 
Protein–carbohydrate interactions are the basis of numerous biological 
processes, both normal and pathological ones. They play crucial roles in many  
biological mechanisms, including enzymatic synthesis and degradation of oligo- and 
polysaccharides, intracellular sorting of glycoconjugates, transport of carbohydrates 
into living cells and of their derivatives into subcellular organelles, the immunological 
response to carbohydrate antigens, and migration of leukocytes to sites of inflammation 
(so-called homing). These interactions also play a key role in a variety of cell adhesion 
phenomena, among them are the attachment of parasites, fungi, bacteria, and viruses to 
host cells, the first step in the initiation of infection. In these processes, they essentially 
depend on the molecular recognition of specific carbohydrates by proteins[2]. In this 
context, the determination of the structural and conformational factors, which govern 
the molecular recognition of these biomolecules, as well as the knowledge of the 
physicochemical features of these processes, is of paramount importance. Specificity of 
these interactions is mediated by various tissue dependent receptors. Although 
extensive biochemical work has been done in that field to determine which units of the 
oligosaccharides are important for the recognition process, little structural data on the 
orientation of these with respect to the membrane surface and about the steric  
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requirements for their interaction with ligands is available. Importantly, in the vicinity 
of the water–membrane interfacial area certain properties are dramatically different 
when compared to them in bulk aqueous solution. It will be therefore interesting to 
investigate, whether membrane–coupled carbohydrates adopt specific conformations 
that improve binding their targets in comparison to the non-coupled species.  
 
             A deeper understanding of these interactions at the molecular level will enable 
the development of novel, effective and highly selective therapeutics. Binding and 
recognition phenomena are essential processes by which the body exerts control over 
complex biological functions. Important targets for therapeutic intervention are the 
binding processes mediated through multivalent protein-carbohydrate interactions, such 
as the interactions of bacterial toxins with cell-surface receptors. Evidently, the 
structure and dynamics of the interacting entities are crucial for recognition. In this 
context, NMR has become a major tool for scrutinizing the conformational behavior 
and interaction properties of oligosaccharides. The development of new NMR 
techniques and access to stronger magnetic fields and to new technologies (e.g. 
cryoprobes and better electronics) are expanding the field in ways that were difficult to 
foresee a few years ago. 
 
1.1 Chemistry of protein–carbohydrate interactions 
A well-known characteristic of protein–carbohydrate interactions is the low 
affinity of binding, with dissociation constants usually in the millimolar range. Stronger 
binding or enhanced inhibition is often achieved by the use of multiple interactions by 
multivalent carbohydrates by a phenomenon called cluster effect[3]. These interactions 
are driven by a favorable enthalpy (heat is released). However, the favorable enthalpy is 
counteracted by an unfavorable entropy (degree of order) term that might stem from 
restricted carbohydrate flexibility. Enthalpy–entropy compensations are a characteristic 
of weak chemical interactions of many biological processes[4]. They comprise 
primarily a network of hydrogen bonds and hydrophobic interactions; in some cases 
electrostatic interactions (or ion pairing) and coordination with metal ions also play a 
role[5, 6]. 
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1.1.1 Hydrogen bonds 
Hydrogen bonds that are directional confer specificity to protein–carbohydrate 
interactions, as well as contributing to their affinity[7]. The hydrogen bonds are formed 
between carbohydrate hydroxyl groups and NH groups, hydroxyls, and oxygen atoms 
of the protein most frequently of aspartic acid, aparagine, glutamic acid, glutamine, 
arginine and serine residues. When each of two adjacent hydroxyls of a 
monosaccharide interacts with a different atom of the same amino acid (e.g., the two 
oxygens of the carboxylate of glutamic or aspartic acid), they form bidentate hydrogen 
bonds[7]. Such bonds are quite common in protein-carbohydrate complexes. A 
different kind of hydrogen-bond characteristic for such complexes is the cooperative 
bond, in which the hydroxyl group acts simultaneously as donor and acceptor. Polar–
polar interactions are actually stronger than in the corresponding protein–protein 
interactions. Three major factors responsible for this are (1) higher surface density of 
hydrogen bonds; (2) better hydrogen-bonding geometry; (3) larger proportion of 
hydrogen bonds involving charged groups. 
 
1.1.2 Hydrophobic interactions 
Even though carbohydrates are highly polar molecules, the steric disposition of 
hydroxyl groups creates hydrophobic patches on sugar surfaces that can form contacts 
with hydrophobic regions in the protein molecules[8]. One widely occurring interaction 
of this kind is the stacking of a monosaccharide on a side chain of an aromatic amino 
acid, which is due to the presence of partial positive charges on the aliphatic protons on 
one face of a hexopyranose ring and a partial negative charge from the ! electrons of 
the aromatic system[9]. 
 
1.1.3 Electrostatic interactions 
Most saccharides are uncharged, and therefore ionic, i.e., charge–charge 
interactions are less common however these interactions occur between negatively 
charged lipopolysaccharide (LPS) and cationic antimicrobial peptides like 
polymyxin[10]. The importance of electrostatic interactions for polymyxin-LPS binding 
also is evident from its inhibition by divalent cations and high ionic strength[11]. 
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1.1.4 Role of water 
As the human body has a water content of 70%, it is not surprising that water 
plays an essential role in both protein–protein and protein–carbohydrate 
interactions[12]. Due to its small size and ability to serve as both a hydrogen bond 
donor and acceptor it can act as a bridge in protein ligand interactions. Generally, 
complementary surfaces with well-matched polar interactions cause the escape of 
receptor/ligand-bound water molecules to the bulk, a reaction that favors the binding. In 
contrast, poorly matched surfaces result in incomplete desolvation of the molecules 
involved, and a low affinity binding[13]. Thus the individual changes in enthalpy and 
entropy might be substantial, yet the change in free energy of binding (!G°) between a 
receptor and different ligands is relatively small. Consequently, increasing the affinity 
(i.e. increasing !G°) of specific protein–carbohydrate interactions remains a 
complicated task. 
 
1.2 Tools for analyzing carbohydrate protein interactions 
            To understand the protein ligand interactions, we should know in detail the 
relationship between function and molecular recognition. Structure, kinetics, energetics, 
dynamics, stoichiometry and dissociation or association equilibrium constants have to 
be defined as accurately as possible. Here I will discuss in detail the NMR 
methodologies used and very briefly the other major techniques like X-Ray 
crystallography, molecular dynamic simulations, fluorescence spectroscopy, surface 
plasmon resonance, isothermal titration calorimetry and differential scanning 
calorimetry. There are many factors, which have to be taken into account, when 
applying a technique for the analysis of protein-ligand interactions.  
 
1.2.1 NMR approaches to study carbohydrate–protein interactions 
  High resolution NMR spectroscopy has proved to be a very useful technique for 
studying interactions between proteins and other molecules, which are of crucial 
importance in many molecular recognition processes in biology. It directly yields 
valuable experimental data on biologically important protein–ligand complexes. 
1. Qualitative and quantitative binding affinity: Changes in NMR parameters allow 
us to detect and quantitatively determine binding affinities of potential ligands. 
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2. Determination of binding site(s): Based on changes in the assigned NMR signals of 
a protein upon ligand addition, a ligand binding site on the protein can be mapped. 
3. Conformational information: The conformation of the protein and/or ligand in the 
complex can be determined and compared to their free states. 
4. Dynamic information: In addition to the static structure, local dynamics can be 
measured for the complex and the free components to yield a more accurate picture of 
the intermolecular interactions.  
 
NMR investigations allow us to deduce (a) structural information on the protein 
residues involved in the interaction; (b) information on the bound carbohydrate; and (c) 
information on the entire protein–carbohydrate complex. The first method observes the 
changes in chemical shift of the target resonances upon ligand binding through shift 
mapping. It requires milligram quantities of 15N- or 13C-labeled target, and resolved, 
heteronuclear, two-dimensional NMR correlations (e.g., HSQC, heteronuclear single-
quantum coherence) for monitoring chemical shift changes. If the target is large (>30 
kDa), extensive resonance overlap might prevent the complete and unambiguous 
interpretation of the spectra. A distinct disadvantage of the method is the necessity of a 
complete resonance assignment of the target or at least of the binding site of interest. 
The second methodology, which relies on the observation of the ligand resonances, is 
exclusively applicable to ligands in the low-affinity range (high micromolar to 
millimolar range). It is commonly used when either the target is too large to be 
observed by NMR (>50 kDa), or it is not available with the desired 15N- or 13C- 
labeling pattern from in vitro production, or it aggregates in solution at higher 
concentrations. All these scenarios prevent the collection of highly resolved spectra of 
the target.  
 
A number of NMR variables can be monitored in this screening assay: (a) line 
broadening, (b) change of the NOE (nuclear Overhauser effect) from positive to 
negative (transferred NOE), (c) intermolecular magnetization transfer, (d) restricted 
ligand diffusion, and (e) change in the relaxation properties of the ligand due to 
interaction with spin labels[14]. From a kinetic point of view, it could also be possible 
to say something about the ligand exchange timescale and the size of the complex 
(relaxation measurements)[15]. Thus a wide variety of NMR methods can be exploited 
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to characterize macromolecular complexes (in particular, protein-protein, -DNA, -
RNA, -sugar, -lipid, -drug, etc).  
 
The technique of choice will depend upon several factors[16], which  are as 
follows   
• size and type of molecules. 
• equilibrium binding constant (strong vs. weak). 
• kinetics of binding (fast vs. slow exchange). 
• stoichiometry and symmetry. 
• available nuclei (1H, 13C, 15N, 19F, 31P, 113Cd, ...) 
 
1.2.2 NMR parameters that yield information on protein ligand 
interactions  
1.2.2.1 Chemical shift  
Chemical shifts are exquisitely sensitive markers of the ligand charge state 
environment at the bound site. A qualitative interpretation of changes in chemical shifts 
on binding provide significant insight into the nature of the binding site even though it 
is not possible to construct an accurate model of the binding site using this knowledge. 
1H and 13C have been the nuclei most widely studied, and the dependence of these 
shifts in proteins on secondary structure is well established[17, 18]. Nitrogen chemical 
shifts of backbone amides are sensitive to many factors like hydrogen bonding of 
corresponding protons, which makes them difficult to interpret. They are used only to 
increase the dimensionality of the spectra to allow assigning the individual amino acids. 
 
1.2.2.2 Relaxation parameters 
 Transverse and longitudinal relaxation of proton spins is mainly prompted by 
dipolar interactions between proximate spins. The relaxation efficiency depends on the 
distance separation of the interactions and on the reorientation time of the internuclear 
vector. Thus the spin-lattice relaxation time T1 and the spin-spin relaxation time T2 are 
dependent on overall and internal molecular mobility and hence provide sensitive 
probes of binding. Binding of the ligand to the target leads to dramatic changes in 
overall tumbling for the bound fraction of ligand. T2 values traditionally have been 
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more often utilized in the study of macromolecule-ligand interactions than T1 values. 
Binding of ligand leads to significant changes in linewidth of the ligand signals. 
 
1.2.2.3 NOEs 
The nuclear Overhauser effect (NOE) is defined as the change in intensity of a 
certain resonance after perturbation of the population of a spin in close spatial 
proximity (by saturation or inversion). The interaction through space of the dipoles of 
neighboring nuclei, or cross-relaxation, gives rise to the NOE. The cross relaxation rate 
", which depends on the rate of molecular tumbling, governs the magnitude and sign of 
the NOE[19]. Low- or medium-molecular-weight molecules (MW<1-2 kDa) have a 
short correlation time #c and, as a consequence, such molecules exhibit positive NOEs, 
no NOEs, or very small negative NOEs depending on their molecular weight, shape, 
and the field strength. Large molecules, however, exhibit strongly negative NOEs. 
  
NOEs are the most useful NMR parameter for the analysis of protein-ligand 
complexes. By establishing the proximity in space of two nuclei (via NOEs), it is 
possible to deduce conformational information (in the case of intramolecular NOEs) or 
locate a binding site (via intermolecular NOEs). Although NOEs have been used widely 
for the former application in the past, for conformational and structural studies of both 
small molecules[20] and proteins[21], it has been only in the last few years that major 
advances have been made in the latter application. The detection of significant number 
of intermolecular NOEs for tightly bound protein-ligand complexes has been driven by 
the development of isotope editing techniques that have rendered the assignment of 
such NOEs possible.  
 
When a small molecule (ligand) is bound to a large-molecular weight protein 
(the protein receptor molecule) it behaves as a part of the large molecule and adopts the 
corresponding NOE behavior, that is, it shows strong negative NOEs, so-called trNOEs. 
These trNOEs reflect the conformation of the bound ligand. Binding of a ligand to a 
receptor protein can thus easily be distinguished by looking at the sign and size of the 
observed NOEs. 
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1.2.2.4 Magnetization transfer rates 
Information about exchange processes can be provided by monitoring the 
changes in peak intensity in a NMR spectrum. In particular, the use of saturation 
transfer or inversion transfer techniques allows information about the kinetics of 
exchanging systems to be deduced. The rate of loss of NH signal intensity following 
dissolution of the sample in D2O provides a measure of the degree of protection of the 
proton from solvent revealing its involvement in hydrogen bonding underlying 
secondary structure stabilization. 
 
1.2.2.5 Aspects of binding affinity and timescale for detection of NMR 
parameters  
  The type of experiment most appropriate for the system is dependent on the 
exchange rates between the ligand and protein relative to the NMR time scale[22]. The 
thermodynamic and kinetic properties (dissociation constant and on/off rates) of the 
protein-ligand interactions influence the outcome of the NMR parameters such as the 
chemical shift, the relaxation rates of the ligand, and the Nuclear Overhauser effect 
(NOEs). On the NMR time scale, exchange regimes are broadly classified as slow, 
intermediate and fast with the regime being related to the equilibrium dissociation 
constant, KD. The binding of a ligand L to an enzyme E can be considered a two site 
second-order exchange. 
  E +L   !    EL  
The above equilibrium is described by the dissociation constant, KD = koff /kon, 
where koff is the rate of dissociation (off–rate) of the ligand from the protein and kon is 
the rate constant for association (on–rate) of the ligand with the protein. The off- and 
on-rate define the lifetime # of the particular state. The lifetime of a NMR nucleus in 
the ligand molecule in state EL is given by #EL = 1/koff , and the lifetime in the state L 
by #L  = 1/ (kon [E]). For a nucleus in the protein the lifetime in the state EL is given by 
# EL= 1/koff and the lifetime in the state E by # E = 1 /(kon [L]). E and L are respectively, 
the concentration of the free enzyme and the ligand and [EL] the concentration of the 
complex. A single lifetime is used to characterize the process defined by the equation. 
For ligand  
   1/# = 1 /# EL + 1/#L = koff (1+ PEL /PL) 
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where PEL = [EL]/[ L tot] and PL = [L] / [Ltot ], respectively, the fraction of the ligand in 
the bound and free states, and Ltot = [EL] + [L]. It is important to note that the # and 
hence the actual appearance of the spectrum depends on the ligand concentration. 
 
For a typical millimolar protein concentration, depending on the type of 
interaction we have 1) strong binding with dissociation constants KD in the sub 
micromolar range 2) moderate binding with micromolar KD values and 3) weak 
interactions with millimolar dissociation constants. For strongly binding ligands, both 
the protein and ligand exist almost exclusively (>95%) in the bound state and the 
complex behaves as a single stable molecule. The spectra will not show any signs of the 
free species or of exchange between free and bound species. In the moderately binding 
case, under stoichiometric conditions both protein and ligand will exist as bound and 
free species in significant percentages. Depending on the kinetic stability, exchange 
between the free and bound species might also affect the NMR spectra. However this 
can be driven to a completely complexed state by adding 10 to 100 fold excess of the 
ligand. A lot of information about the complex can be gained from NMR measurements 
(usually involving isotope filtering) e.g. indications of conformational changes upon 
complexation and molecular regions involved in binding. Assuming that the on–rate kon 
is diffusion limited, one can estimate the range of complex lifetimes for different 
affinities (Table1). 
                    
 
                           
 :  
   
 
 
 
                           Table 1:  Lifetime of protein-ligand complexes with different affinities  
 
 
 
 
 
 
KD koff Life time of the complex  
1 nM 0.1 s-1 10 s 
1 uM 100 s-1 10 ms 
1 mM 105 s-1 0.1 ms 
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        Table 2: Exchange time scale for NMR parameters 
 
In order to measure NMR parameters (represented by a frequency or rate) 
separately for each state, its lifetime has to be significantly longer than the inverse of 
the differences of this parameter in the two states (slow exchange). If it is much shorter 
than the intermediate exchange regime then only a single set of signals will be 
observed, reflecting an average over both the free and the complexed species, weighted 
by their relative concentration (fast exchange). 
 
 Slow exchange     1/# <<   2!| $L - $EL |  
 Intermediate exchange   1/#  %    2!| $L - $EL |  
 Fast exchange       1/# >>   2!| $L - $EL |  
 
The fast and slow exchange regimes are not fixed, but depend on the NMR 
parameters under consideration and also on their specific differences in the two species. 
Except for high affinity ligands with nanomolar KD values, lifetimes usually range in 
the millisecond range for most complexes. From the Table 2, it can be seen that the 
parameters least sensitive to averaging are the chemical shifts and to a lesser degree, T2 
relaxation rates. NMR parameters which serve as measure of binding and can be 
obtained easily with high sensitivity are chemical-shift changes, changes in relaxation 
times, changes of diffusion constants, changes of NOEs, or exchange of saturation. A 
number of criteria have to be considered to choose the right method to identify and 
characterize protein-ligand interactions by NMR spectroscopy. 
 
Parameters Typical range 
 (Hz) 
Typical difference 
 between free and 
bound states (Hz) 
Lifetime at 
intermediate 
exchange 
Chemical shift 0 - 10000 100 - 1000 1 - 10 ms 
Scalar couplings 0 - 200 1 - 10 0.1 – 1s 
NOE (build–up rates) 0 - 5 0.1 - 5 0.2 – 10 s 
Relaxation times T1 
                           T2 
0.1 – 10 
1 - 100 
0.1 – 10 
1 - 50 
0.1 – 10 s 
0.02 – 1s 
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1.2.3 Experiments based on chemical shift perturbation 
NMR spectroscopy provides detailed information on the chemical surroundings 
of a given nucleus through chemical shifts and therefore, NMR titration experiments 
may provide an adequate means to analyze sugar-induced perturbations of proteins and 
vice versa. For the protein, nuclei located in the protein-binding pocket usually show 
the largest effects. Because of the signal overlap in the 1D spectra of proteins changes 
in chemical shift are most conveniently monitored by heteronuclear correlation 
experiments. This method is referred to as chemical shift mapping[23]. The HSQC 
based methods are presently limited to macromolecular complexes with a molecular 
weight below 30 or 100 kDa, depending on whether complete deuteration of the protein 
(in combination with TROSY) is used or not. Another limitation is the availability of 
larger quantities of isotopically labeled protein. For ligand protons because of low 
molecular weight, spectra are less complex, with less overlapping of signals. Therefore, 
changes of ligand proton resonance characterize binding. One of the most common 
applications is the determination of dissociation constants from titration experiments, 
but more sensitive parameters (relaxation and diffusion rates) may be used for ligand-
based NMR screening approaches. 
 
1.2.4 Saturation transfer difference (STD) nuclear magnetic resonance 
experiments to detect ligand binding 
 
  The STD NMR method is capable of identifying the binding epitope of a ligand 
when bound to its receptor protein[24]. In this experiment, resonances of the protein are 
selectively saturated and intramolecular NOE effects build up rapidly and are 
transferred throughout the protein by spin diffusion and transfer of saturation from the 
protein to a bound ligand by intermolecular 1H–1H cross relaxation. Ligand protons that 
are in close contact with the receptor protein receive a higher degree of saturation, and 
as a result stronger STD NMR signals can be observed. Protons that are either less or 
not involved in the binding process reveal no STD NMR signals. In the STD NMR 
experiment signal attenuation of ligand signals in comparison of two separate 
experiments is observed, one recorded with saturation of target resonances (mostly the 
methyl hump of the protein is saturated) and the second one in which irradiation is 
performed far off-resonance (on-resonance experiment and off-resonance experiment). 
Subtraction of the on-resonance and off-resonance spectrum results in the final 
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saturation transfer difference (STD) NMR spectrum showing only signals from ligands 
that have binding affinity (Figure1). If interaction of non-labile protons is the focus, 
STD NMR experiments can be carried out in 100% D2O, eliminating problems arising 
from the dominant water signal. The WATERGATE solvent suppression sequence or 
the excitation sculpting method can be used to suppress the H2O signal in samples 
where labile protons need to be observed.  
 
STD NMR spectroscopy can be utilised to detect binding ligands with KD 
values in the 10-2 to 10–8 M range[25]. High-affinity ligands that undergo slow 
chemical exchange typically reside longer within the protein-binding site and are thus 
not detectable by STD NMR spectroscopy. Temperature can significantly affect STD 
NMR signals intensities and it is recommended to acquire a series of STD NMR spectra 
at different temperatures[26]. Saturation frequency (on-resonance) has to be set to a 
value where only protein resonances and no ligand signals are located. It is 
recommended that the protein saturation frequency is placed away at >700 Hz from the 
closest ligand resonance. 
                    
 
     Figure 1: Scheme showing principle of the STD NMR method. 
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In contrast to transferred NOE experiments STD experiments do not critically 
depend on the ligand to protein ratio, as signal intensity that does not result from the 
saturation transfer process from the protein to the ligand is eliminated and the spectra 
always reflect purely the bound state. But usually a ratio of 1:100 (protein: ligand) is a  
good choice, as it prevents ligands that have already received saturation, from re-
entering the protein-binding site. One major advantage of the new STD techniques is 
that the STD method may be combined with any NMR spectroscopy such as STD 
TOCSY or STD HSQC[24, 27] and  only small amounts of native protein are required 
and no expensive protein labelling is necessary.   
 
1.2.5 Water LOGSY: water-ligand observation with gradient 
spectroscopy  
Water LOGSY is a variant of STD NMR spectroscopy which utilizes the bound 
water at the protein ligand interfaces[28]. It also relies on the transfer of magnetization 
between ligand and target. The transfer path is not direct (as in STD NMR) but uses 
H2O molecules in the binding pocket as an intermediate magnetization pool. Thus, the 
sample solution must consist predominantly of H2O with only a small quantity of D2O 
for locking. Because the sign of the magnetization transfer signals via the nuclear 
Overhauser effect (NOE) is dependent on the molecular weight of the interacting 
molecules under investigation, a signal stemming from transfer between the water and 
the ligand (both of low molecular weight) will have a positive sign in the Water 
LOGSY spectrum. To eliminate artifacts like radiation damping pulsed field gradients 
were employed for proper water suppression. The high sensitivity of the technique 
reduces the amount of biomolecule and ligands needed for the screening. 
 
1.2.6 Transferred intramolecular nuclear overhauser effects (trNOEs)  
 
The observation of transferred NOE is possible for ligand–protein complexes 
that are characterized by dissociation constants KD that are in the "M to mM range and 
receptor sizes in the range of 60–350 kDa. When ligand molecules bind to receptor 
proteins the NOEs undergo drastic changes leading to the observation of transferred 
NOEs (trNOEs). Too tight binding places the systems outside the range of fast 
exchange on the NMR time scale and no transferred NOEs are observed as the 
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exchange process between the free and bound forms of the ligand is not fast enough to 
ensure proper averaging of the NMR observables; on the other hand, the population of 
the bound ligand for weaker complexes becomes too low to observe a change in the 
NOE sign[29].  
 
The amplitude and sign of NOEs depend on the rates of molecular motion 
(overall tumbling and internal mobility), which are usually characterized by an 
effective motional correlation time #c. The observation of trNOEs relies on different 
tumbling times #c of free and bound molecules. When a small molecule (ligand) is 
bound to a large-molecular weight protein (the protein receptor molecule) it behaves as 
a part of the large molecule and adopts the corresponding NOE behavior, that is, it 
shows strong negative NOEs, so-called trNOEs (Figure 2). These trNOEs reflect the 
bound conformation of the ligand. Binding of a ligand to a receptor protein can thus 
easily be distinguished by looking at the sign and size of the observed NOEs. 
Furthermore, the discrimination between trNOEs originating from the bound state and 
NOEs of the ligand in solution can also be achieved by the build-up rate, that is, the 
time required to achieve maximum intensity, which for trNOEs is in the range of 50 to 
100 ms, whereas for nonbinding molecules it is four- to ten-times as long[25].   
 
 
Figure 2: NMR measurements to detect carbohydrate binding to proteins by observation of 
transferred NOEs, in the ligand resonances.  
 
The ligand: target concentration ratio [L]: [T] plays a fundamental role in the 
observation of transferred-NOE effects. The optimal [L]: [T] concentration ratio 
depends on the size of the target and on the kinetic constants involved. It is advisable to 
work at low protein concentrations and adjust the NOESY mixing time to obtain a good 
signal-to-noise ratio[14]. In many cases, this optimum is at a molar ratio of 
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carbohydrate to protein between 10 and 50 to 1. The effect of binding kinetics plays a 
role towards the sensitivity and thus the quality of the attained spectra. Intermolecular 
cross-relaxation between ligand and protein cannot be neglected and can lead to serious 
errors in the structure of the bound conformation of the ligand if derived from trNOE 
intensities, because of spin diffusion effects. Several techniques like QUIET-BAND-
NOESY and QUIET-ET-NOESY have been developed to suppress spin diffusion[30]; 
[31]. Intermolecular NOEs between protein and ligand are sometimes desirable because 
it allows detecting the orientation of the ligand in the protein binding pockets. Another 
complication of trNOE is the possibility of non specific interaction of the ligand[32]. 
Specificity of the interaction can be best demonstrated by a competition experiment 
with a strong binder. 
 
1.2.6.1 The transferred ROESY experiment 
It is an alternative method observing distances through space between nuclei in 
a molecule. In many cases the spin-diffusion effects can lead to the observation of 
'false' trNOEs that do not reflect direct dipolar contacts between carbohydrate-ligand 
protons, but originate from magnetization transfer via protons attached to amino acids 
in the binding site of the protein receptor or via other ligand protons[33, 34].  It was 
found that transferred NOEs in the rotating frame, trROEs, are well suited to identify 
such spin diffusion pathways. In this experiment, spin-diffusion (three spin) effects 
appear as positive cross peaks and therefore, the application of this experiment permits 
one to distinguish direct from indirect enhancements, and thus complements those 
measured under regular conditions, providing conformational information which is less 
contaminated by artifacts. 
 
1.2.7 Isotope filtering/editing using labeled ligands  
Isotope filtering/editing NMR techniques make use of differential isotopic labeling to 
simplify spectra and thus more easily extract information from complex systems. The 
basic idea is to selectively observe the subspectra of the labeled or unlabelled 
components only (Figure 3). Isotope editing means selecting the protons, which are 
directly, bound to an NMR active heteronucleus (1H - 13C, 1H – 15N). Isotope filtering 
suppresses the signals leaving only the signals from the proton bound to the NMR 
inactive heteronuclei (1H -12C, 1H-14N) as well as protons  not bound to carbon and 
nitrogen at all (mainly –SH , -OH ). These methods rely on 1J H, X coupling, since these 
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are i) relatively large (requiring only short coupling evolution delays) and ii) fairly 
uniform (allowing exact tuning of delays). In these experiments the species actually 
observed is the complex itself. This is the important difference from trNOE or 
saturation techniques, where the existence of equilibrium between the bound and free 
species and a certain rate of exchange between them is essential. So the other general 
conditions for these experiments are identical to those required for standard protein 
NMR techniques. The systems under study should be in the strong binding regime to 
prevent the signals from significant concentration of the free species (in trNOEs 
intermediate affinity is preferred). 
 
 
Figure 3: Schematic of isotope-filtered and -edited 1H NMR as applied to a protein –ligand 
complex. In this example the protein is labelled uniformly with 15N and 13C, while the ligand is 
at natural isotopic abundance. Correlations within the labelled protein may be selectively 
observed using isotope-edited experiments (thin arrows). Correlations within the unlabelled 
ligand may be selectively observed using isotope-filtered experiments (curved arrow). 
Intermolecular NOE correlations between macromolecule and ligand may be selectively 
recorded using experiments that are isotope-filtered with respect to one proton dimension and 
isotope-edited or -separated with respect to the other (dashed arrows). 
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The main labeling strategy for these experiments are 1) One component is 
isotopically enriched to a reasonable extent and the other contains unlabelled species. 2) 
One component is practically 100% enriched with NMR active nuclei isotope, while the 
other component contains this isotope only to a much lower degree. In NMR studies of 
protein ligand interactions, isotope filters are an important concept for simplifying 
spectra of the systems otherwise too complex for an analysis. In this way, intra- and 
intermolecular NOEs involving ligand protons directly attached to 13C and 15N can be 
selectively detected. Only one component is labeled with stable NMR–active isotope 
(usually 15N and /or 13C) and the other one used in natural isotopic abundance. The 
NMR–active isotope can then be used for signal assignment via 2D or 3D heteronuclear 
correlation spectra and for improved resolution by adding a third dimension to 2D 1H 
TOCSY or NOESY experiments. Since these pulse sequences require 15N or 13C spins, 
only the labeled part of the complex will show signals.  
 
1.2.8 Spin labelling  
A spin label (SL) is an organic molecule, which possesses an unpaired electron, 
usually on a nitrogen atom, and has the ability to bind to another molecule. The 
application of spin labels to NMR spectroscopy was based on the increase of relaxation 
rates of neighbouring protons caused by the paramagnetic center, the so-called 
paramagnetic relaxation enhancement (PRE)[35, 36]. The spectral perturbations caused 
by the electron spin labels decrease rapidly with increasing distance from the 
paramagnetic center (prop. r-6). Both the increased proton relaxation rates and the 
altered 1H chemical shifts can be evaluated to determine the distance of the perturbed 
nuclear spins from the unpaired electron[37]. It can be used to measure distances up to 
20 Å  which are too long to be measured by NOE experiments, or to study the dynamics 
of peptides or proteins by sampling all conformations that lead to short proton-radical 
distances.  
 
The paramagnetic relaxation contribution to the line widths can be distinguished 
from chemical-exchange broadening by a control experiment in which the nitroxide 
spin label is reduced with ascorbic acid[36]. An additional consequence of 
paramagnetism is partial alignment of the paramagnetic molecule in the magnetic field, 
due to its anisotropic magnetic susceptibility[38]. Hence dipolar couplings do not 
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average out and residual dipolar couplings can be measured which provide long–range 
constraints for structure determination. 
 
Table 3: A brief outline of NMR spectroscopy techniques for the identification and 
characterization of binding of ligands to proteins. Modified from reference 25.  
 
1.3 Other methods to investigate protein-carbohydrate interactions 
1.3.1 Molecular dynamics simulations 
In many cases, not all of the required information can be obtained directly by 
experimental studies, so theoretical molecular modeling is usually required to 
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supplement experimental data, both in solution and in the solid state. Different 
modeling protocols have been proposed to locate protein binding sites[39]. Some of 
them can be used to calculate the interaction energies between ligand and receptor.  
 
Other methods are designed to explore systematically all the positions and 
orientations that the sugar may adopt within the binding site[40]. Molecular docking 
increasingly becomes a valuable tool for exploring protein ligand interactions. It 
calculates the binding geometry and binding free energy of the complex if the spatial 
structure of protein and ligand is provided. Starting with the spatial structures of the 
binding molecules, a structure-generation step produces a great number of putative 
complex structures. These many complexes are then filtered by suitable fast filters or 
scoring functions in order to reduce the number of candidates. The top-scored structures 
are then evaluated energetically with an accurate energy function, thus yielding 
approximations of the binding mode and binding free energy of the complex. Thus 
docking schemes try and find local minima, while scoring functions try and look at the 
interactions from a global perspective.  
 
The important features of protein carbohydrate interactions, which should be 
considered  for molecular modeling approaches are 1) the large number of freely 
rotatable polar hydroxyl groups which leads to increased hydrogen bonding and strong 
electrostatic interactions, 2) the geometric complementarity of the ligand and the 
binding pocket in protein is less pronounced, because the sugar binding regions are 
often shallow grooves[41], 3) the glycosidic bonds of the carbohydrates are very 
flexible  without pronounced rotameric states, resulting in a huge conformational space. 
In addition, due to the polar nature of the many hydroxyl groups their interactions are 
often dominated by solvation effects. 
 
1.3.2 X-Ray crystallography 
Crystal structures of protein-ligand complexes provide a detailed view of their 
spatial arrangement and interaction. X-ray crystallographic analysis has the potential 
advantage over NMR and theoretical methods that it can provide a complete 
oligosaccharide conformation from experimental data. In the case of stable, unreactive 
ligands, such as inhibitors or allosteric regulators, the complexes can be generated by 
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co-crystallization or by soaking the ligand into fully grown crystals. Protein complexes 
with reactive short-lived species that occur in chemical or binding reactions can be 
determined using monochromatic X-ray diffraction techniques via kinetic trapping 
approaches. Crystals of macromolecules are characterized by a high content of solvent 
(typically 30 to 80%), which is arranged in large, interstitial channels spanning the 
crystals. Affinities may change at crystallization conditions so affinities should be 
determined under near crystallization conditions[42]. If the protein–ligand affinity is 
not very high (lower than micromolar) the ligand should be added with the appropriate 
concentration to all solutions to which the crystal is exposed, particularly the 
cryoprotectant. As a rule of thumb, to ensure very high occupancy at the binding site of 
a protein P, the concentration of the ligand L should be about ten times higher than the 
dissociation constant KD[43]. 
 
The major limitation of this technique is that it requires regular crystals. Crystal 
production can be difficult and time consuming and sometimes impossible. Due to 
crystallisation conditions the structure may not wholly represent as it exists in solution. 
Surface residues may be influenced by crystal packing. Because the surfaces of proteins 
are usually where they interact with other proteins or with their ligands, these 
differences, although small, are likely to be biologically relevant. 
 
1.3.3 Fluorescence spectrometry in studies of carbohydrate-protein 
interactions 
Fluorescence techniques are widely used in the study of protein–ligand 
interactions because of their inherent sensitivity, and the fact that they can be 
implemented at true equilibrium conditions. Techniques for assessing the affinity used 
are measurement on fluorescence intensity change, lifetime, polarization anisotropy, 
and energy transfer[44]. In many cases, protein–ligand interactions can be studied by 
following changes in fluorescence intensities of a probe or in the intrinsic fluorescence 
of the protein subsequent to ligand binding. In systems, in which intensity changes do 
not occur or are minimal, polarization or anisotropy determinations are extremely 
useful since they rely upon changes in rotational mobility between free and bound 
probes. 
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1.3.3.1 Polarisation and anistropy  
A small molecule moves and rotates freely and very rapidly in solution, so that a 
fluorescent probe attached to it will be free of directionality (i.e., isotropic). However, 
when such a molecule is bound to a large molecule which is relatively slow in rotation 
and tumbling, then the fluorescent probe on the small molecule can acquire 
directionality (i.e., anisotropic) and is said to be "polarized." Polarization (P) is defined 
as 
P= (I #-I $)/ (I # + I $) 
 
where I# and  I$ are the intensities observed parallel and perpendicular, respectively, to 
an arbitrary axis. The extent of such polarization is related to tightness of the binding, 
and therefore measurement of polarization anisotropy can lead to determination of 
association constant. The most critical consideration is probably the choice of 
fluorophore. Another critical consideration is the fluorescence lifetime of the 
fluorophore. 
 
1.3.3.2 FRET 
FRET is the physical process by which energy is transferred non-radiatively 
from an excited molecular chromophore (the donor, D) to another chromophore (the 
acceptor, A) by means of intermolecular long-range dipole-dipole coupling (0.5-10 nm) 
and is thus complementary to NOEs, which allow measuring distances in the range of 
0.1-0.5nm). For FRET to occur efficiently, the donor emission peak and the acceptor 
excitation peak must overlap as much as possible. FRET is governed by Förster's 
equation as shown below: 
       E = R5/(R5+r6 ) 
where E is the efficiency of energy transfer, r is the distance between the donor and the 
acceptor, and R is the Forster constant which has to be determined for each specific pair 
of fluorescent donor-acceptor and the specific experimental conditions[45].  
 
1.3.4 Calorimetric experiments 
1.3.4.1 Isothermal titration calorimetry (ITC)  
Isothermal titration calorimetry (ITC) is primarily employed to investigate the 
thermodynamics of ligand-macromolecule interactions. ITC directly estimates the 
binding thermodynamics through measurement of the energetics of molecular 
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interactions at constant temperature. A series of data points representing the amount of 
heat released (exothermic) or absorbed (endothermic) per mole of injectant (usually the 
ligand) after each injection is plotted as a function of the molar ratio [LT]/[MT] of the 
total ligand concentration [LT], and the total macromolecule concentration, [MT], to 
generate the binding isotherm. An example of binding isotherm of concavalin A is 
shown in the Figure 4. 
 
Figure 4: Isothermal titration microcalorimetry (ITC) profile of ConA (0.020 mM) with &-d-
mannopyranoside bivalent analog 5 substrate (0.39 mM) at 27°C. Top: Data obtained for 30 
automatic injections, 4 µl each, of 5. Bottom: Integrated curve showing experimental points (%) 
and the best fit (—). The buffer was 0.1 M sodium acetate at pH 5.2 with 0.1 M NaCl and CaCl2 
and MnCl2 (5 mM each)[46]. 
 
ITC measurements provide direct determinations of the binding enthalpy 'H, 
the association constant, Ka and the number of binding sites (n) of the protein. From 
measurements of Ka, the free energy of binding, 'G, can be calculated. The entropy of 
binding 'S is obtained from 'H and 'G. Thus, ITC measurements can determine the 
complete thermodynamics of binding of a carbohydrate to a protein. In addition to 
determining thermodynamic binding parameters, raw ITC data can be used to construct 
Scatchard and Hill plots to determine whether cooperativity effects occur on binding, 
which can provide some important aspects of the binding mechanisms of these 
molecules[46]. 
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1.3.4.2 Differential scanning calorimetry (DSC) 
Differential scanning calorimetry (DSC) is an experimental technique to 
measure the heat energy uptake that takes place in a sample during controlled increase 
or decrease in temperature. It is used to the study of macromolecular conformation and 
interactions in solutions at reasonable concentrations and provides some idea how 
thermal transitions might be effected by ligand binding. ITC is the more direct method 
to study the protein ligand interactions and DSC can provide some preliminary 
information about the binding process. The advantages of calorimetric techniques are 
that they are usually noninvasive and require no chemical modifications or 
immobilization of any of the reactants. If required the formed complexes could be 
further studied by other methods. Furthermore with careful analysis and interpretation 
they directly provide fundamental thermodynamic information about the processes 
involved. 
 
1.3.5 Surface plasmon resonance 
Surface plasmon resonance (SPR) biosensors belong to label-free optical 
biosensing technologies. Their ability to monitor the interaction between a molecule 
immobilized on the surface of the sensor and the interacting molecular partner in a 
solution have made SPR sensors a very powerful tool for biomolecular interaction 
analysis[47]. The specificity, the strength, the kinetics and some thermodynamic 
parameters of sugar-protein interactions are easily assessed by surface plasmon 
resonance (SPR). SPR is particularly suitable to 1) evaluate the macromolecule by 
checking its ability to bind to  its ligand and thus assessing its structural integrity, and 
2) for equilibrium analysis (affinity and enthalpy) of weak interactions (KD >100 
"m)[48] and the precise temperature control makes it possible to estimate the binding 
enthalpy by van’t Hoff analysis[49], 3) the real time binding data is used for the 
analysis of binding kinetics. 
 
Surface plasmon resonance (SPR) imaging is an optical technique that is used to 
spatially monitor localized differences in the reflectivity of incident light from a prism-
gold film interface that result from molecules adsorbing to or desorbing from the gold 
film. In order to detect an interaction one molecule (the ligand) is  immobilized on the 
sensor surface and the analyte is injected continuously through the flow cell and the 
 34 
change in refractive index is measured in real time  and the result plotted as response or 
resonance units (RUs) versus time[50] (Figure5). One RU represents the binding of 
approximately 1 pg protein /mm2. In practice >50 pg/mm2 of analyte binding is 
required. Thus the major advantage of the SPR is that very small amounts of the protein 
are required and binding between the biomolecular recognition element and analyte can 
be observed directly without the use of radioactive or fluorescent labels. 
 
 
                          Figure 5: Example of output from Biacore 
 
There are three factors that can influence the interaction between the adsorbing 
protein and the carbohydrate surface. They are protein-protein interactions between 
adsorbing protein molecules, the carbohydrate surface site density, and the number of 
interactions occurring between the adsorbing protein and the carbohydrate surface[51]. 
Taking care to avoid the pitfalls like aggregation of the analytes, heterogenous 
immobilization, mass transport limitations etc it is a very useful tool to study protein 
carbohydrate interactions. 
 
1.4 Molecules under study 
1.4.1 Lipopolysaccharides 
 Approximately some 120 years ago Richard Pfeiffer, a coworker of Robert 
Koch in Berlin, discovered that cholera bacteria in addition to heat-labile exotoxin 
produce another toxin[52]. In contrast to the secreted exotoxins this new, heat stable 
toxin was found to be a constituent of the bacterial cell and, therefore, Pfeiffer termed it 
endotoxin. Today we know that endotoxin (lipopolysaccharide, LPS) is the main outer 
 35 
membrane component of gram-negative bacteria and plays a key role during severe 
Gram-negative infection, sepsis, and shock[53]. The septic shock syndrome caused by 
endotoxin still has an unacceptably high mortality rate and, owing to increasing 
numbers of resistant strains, remains an ongoing threat throughout the world. 
 
The presence of low amounts of LPS, are rather beneficial for the host and  lead 
to enhanced resistance to infections and malignancy due to its immunostimulatory 
activity[54]. However, this picture changes dramatically when larger amounts of LPS 
are present in the bloodstream, as observed during severe Gram-negative bacterial 
infections (notably after application of antibiotics) or possibly caused by translocation 
of enterobacteria from the gut. Released LPS causes various pathophysiological 
reactions including fever, leukopenia, tachycardia, tachypnoe, hypotension, 
disseminated intravascular coagulation, and multiorgan failure[55]. 
 
1.4.2 Structure and different types of LPS 
Lipopolysaccharides are the characteristic components of the cell wall of Gram-
negative bacteria. They contribute to the integrity of the outer membrane, and protect 
the cell against the action of bile salts and lipophilic antibiotics. Lipopolysaccharides 
are made up of a hydrophobic glycolipid (lipid A, which is responsible for the toxic 
properties of the molecule), a hydrophilic core polysaccharide chain, and a hydrophilic 
O-antigenic polysaccharide side chain (Figure 6). If a wild strain of bacterium is 
irradiated with UV light or exposed to mutagenic compounds, it will mutate and LPS 
with shorter polysaccharide chains Ra, Rb, Rc, Rd, Re, etc may be formed where a, b, 
c, etc. designate 1st, 2nd, 3rd, etc. degree of  the polysaccharide length of a given LPS 
(Figure7). Ra and Re designate the mutants with the longest and shortest chain lengths, 
respectively. The most extreme mutants are the Re mutants which produce an LPS 
which is made up of lipid A and 3-deoxy-D-manno-octulosonic acid (2-Keto-3-
deoxyoctonate, KDO) as the sole constituent of the core[56]. Removal by hydrolysis of 
the polysaccharide chain from LPS produces lipid A, either as the naturally occurring, 
cytotoxic diphosphoryl form[57] or the less toxic monophosphoryl form[58]. 
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Figure 6: Chemical structure of E. coli Re LPS. 
Kdo, 2-Keto-3-deoxyoctonate; GlcN, N-acetylglucosamine. 
 
     LPS was shown to occur in three different structures in the outer membrane: in 
a lamellar orientation, as a hemi-micelle complexed with proteins and as hemi-
micelles introduced by divalent cations and/or polyamines[59]. Neutralisation in part 
of the negative charges of LPS by metal cations helps to stabilize the membrane by 
decreasing the strong electrostatic repulsion between the highly negatively charged 
LPS molecules. Ca2+ and Mg2+ ions are primarily essential for the stability of the 
membrane. The phosphoryl groups on the LPS as well as the carboxyl group on one of 
the KDO units were shown to be involved in binding Ca2+and Mg2+. This was 
confirmed by metal binding studies conducted with heptoseless mutants of E.coli by 
13C and 31P nuclear magnetic resonance[60]. 
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Figure 7: Schematic structure of various LPS rough mutant LPS from S. minnesota. The O-
specific polysaccharide consists of a varying number of repeating units of a pentasaccharide. 
Abbreviations: Hep, L-glycero-D-manno-heptose; Gal, galactose; Glc, glucose; GlcN, 
glucosamine; GlcNAc,N-acetylglucosamine; Kdo,3-deoxy-D-manno-oct-2-ulosonic acid; L-
Ara4N, 4-amino-4-deoxy- -arabinose; (•) phosphate. Beside the two phosphate groups in the 
lipid A backbone, further phosphate or pyrophosphoethanolamine groups are present in the 
heptose region for the strains Rz, R5, R345, and R60; (– – –) indicates non-stoichiometric 
substitution.  
 
Removal of divalent cations by chelators like EDTA results in increased outer 
membrane permeability, structural perturbations and at higher concentrations 
extraction of LPS and/or LPS-protein complexes from the cell surface. Similar effects 
may be observed with various polycations including polymyxins, aminoglucosides etc. 
Lipopolysaccharide (LPS) and in particular the core domain lipid A have been 
recognized as valuable targets for antimicrobial agents, e.g. stretogramins, 
glycopeptides, oxazolidines, glycylcyclines, ketolides, &-lactams, & -lactamase 
inhibitors and cationic peptides[61]. Furthermore, a larger number of LPS-binding 
peptides were discovered, spanning from &-helical peptides (e.g. mellitin, efrapeptin) or 
(-sheet forming peptides (e.g. gramicidin S, tyrocidin A). Very few investigations have 
been published, in which interactions of Magainin2, an antimicrobial peptide, with LPS 
incorporated into liposomes were determined; however, no data at atomic resolution 
were presented[62]. 
 
 Structural information about the conformation of LPS during immune recognition 
and signaling events is very important to design ligands capable of neutralizing LPS. 
Until recently the only 3D structure of an intact LPS molecule that is available was 
obtained by X-ray crystallography in an incidental complex with the E. coli 
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ferrichrome-iron receptor FhuA[63]. Very recently in combination with isotope 
labeling by 13C and 15N, assignment of LPS in DHPC micelles was achieved by a 
combination of a large number of modern heteronuclear solution NMR techniques.  
 
 
Figure 8: a) The lowest energy structure of LPS-6 with the GN (GlcN) and KD (KDO) units 
shown in a ball-and-stick representation and the fatty acid chains shown as a cartoon. The lipid 
A part of LPS-6, which is responsible for the endotoxic reaction, is highlighted by a pale blue 
background. The orientation of LPS with respect to the membrane is indicated. b, c) Calculated 
structure ensemble showing the 50 lowest energy structures with the units of GN (b) or KD (c) 
aligned relative to each other[64]. 
 
 The structure (Figure 8) indicates that all GlcN and KDO units of LPS-6 (LPS in 
which the fatty acid chains include only atoms up to C4 atom) are in the glucopyranose 
configuration with a corresponding chair sugar pucker. GlcN-1 is in the &-d 
configuration (3JH1H2 = 2.7 Hz), whereas GlcN-2 is in the ((
3JH1H2 = 9.6 Hz) 
configuration. Based on sugar-sugar and sugar–fatty acid NOEs, it was found that 
GlcN1 shows numerous contacts to Fatty acid 3 (FA3) which is consistent with a tilted 
conformation of GlcN-1 relative to GlcN-2. Numerous strong intra-subunit NOEs 
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between the KDO units indicates restricted rotation around the KDO-KDO glycosidic 
linkage. The relative orientation of the GlcN and KDO units is not well defined due to 
the intrinsic dynamics of the molecule[64]. 
 
1.4.3 Structural requirements for the bioactivity of LPS 
Although there is a great compositional variation among endotoxins derived 
from different bacterial serotypes, they all share a common structural principle. The 
minimal requirement for lipidA bioactivity, referred to as the cytokine inducing 
capacity, is a molecule having two pyranoglucose-configurated hexosamine residues, 
two phosphoryl groups, and six fatty acids as present in E. coli lipidA. LipidA 
structural differences-such as hydroxylation, secondary substitution, as well as the 
presence of longer-than-average length fatty acid chains (C16)-might be potentially 
regulated by the presence of specific environmental factors (pH, divalent cations) and 
specific regulatory mechanisms that respond to these factors[65]. 
   
Figure 9. Chemical structure of endotoxin, lipid A and lipid A analogs 
 
LipidA partial structures deficient in one of these elements are less active or 
non-active regarding the induction of monokines in human monocytes. The synthetic 
lipidA partial structures with the 1'-dephospho derivative and the 4'-dephospho 
derivative were found to be less active than the bisphosphorylated compound, which 
signifies the importance of the two-phosphoryl groups for bioactivity. Also, the 
presence as well as the position of the six fatty acids is of critical importance for the full 
bioactivity of LPS. The lack of the two secondary fatty acids as in the tetraacylated 
lipid A precursor Ia (also known as lipid IVa or LA-14-PP) (Figure 9) makes this 
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molecule completely inactive[66, 67]. Additional acylation as in the highly acylated 
heptaacyl lipid A (S. Minnesota lipid A, compound 516) leads to less bioactivity[68]. A 
potent synthetic LPS-antagonist in vitro as well as in vivo is compound E5531 (Figure 
10) which was synthesized based on the structure of the Rhodobacter spharoides lipid 
A[69]. 
 
 
                         Figure 10: Synthetic LPS-antagonist compound E5531 
 
In addition to the requirements on the chemical structure of LPS or lipid A also 
the physical structure of LPS has an influence on its bioactivity. LPS or lipidA, as 
amphiphilic substances form aggregates in aqueous solution with a distinct three-
dimensional structure. The bioactive lipid A was shown to form nonlammellar 
structures, which are either cubic (S. Minnesota) or hexagonal (R. gelatinosus)[70], 
whereas the inactive lipid A from R. capsulatus forms lamellar aggregates. However, 
this conformational difference between the compounds may only be of significance at 
higher LPS/lipid A concentrations, since it has been found that endotoxicity is 
expressed by monomeric LPS molecules[71]. 
 
1.4.4 Biosynthesis of LPS 
LPS is in general are synthesized as two separate components, the lipid A core 
and the O polysaccharide, which were then ligated to give the complete molecule. 
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Mutants, which make incomplete LPS, are known as rough mutants because the 
colonies on agar plates are flatter, spread further and lack the normal smooth 
appearance of wild type of colonies. LipidA is synthesized on the cytoplasmic leaflet of 
the inner membrane by several steps of acylation of UDP GlcNac with the help of acyl 
carrier protein (ACP) and various specific acyl transferases. The core sugar residues are 
sequentially added on it by specific glycosyltransferases, and the completed lipidA core 
is translocated to face the periplasmic side of the inner membrane. 
 
The heteropolymeric O-units are synthesized on a lipid carrier molecule, 
undecaprenyl phosphate (Und-P). A complete O-unit is flipped to the periplasmic face 
of the inner membrane where Wzy (the O-ag polymerase) polymerizes the O-units and 
Wzz (the O-ag chain length determinator) controls the length of the O-antigen by a not 
yet understandable mechanism. The homopolysaccharide O-chains synthesized onto 
Und-P are completed to their full lengths in the cytoplasm after which they are 
translocated to the periplasmic space by the Wzm and Wzt proteins that are components 
of an ATP binding cassette transporter system. The 13C-enrichment of LPS is valuable 
since NMR assignments could be obtained on the basis of 13C-13C connectivities in 
uniformly labeled E.coli LPS residues. This can be achieved by addition of labelled D-
[1-13C] glucose to defined M9 medium, which directly incorporates glucose as the 
building block for the hexose skeletons in the polysaccharide. Biosynthesis of acyl 
substituents occurrs via the triose pool followed by decarboxylation to give acetyl 
building blocks labeled with 13C at the methyl group. 15N labeling of amino groups of 
the glucosamine moiety is achieved by adding 15N NH4Cl to the M9 medium. Since 
LPS is a component of Gram-negative bacterial outer membranes and established 
protocols for isolating LPS are available, isotopically enriched LPS can be obtained in a 
relatively easy and economical manner. 
 
1.4.5 LPS signaling pathways 
LPS activates monocytes and macrophages to produce cytokines such as TNF-', IL-1, 
and IL-6, which, in turn, serve as endogenous mediators of inflammation through 
receptor-mediated interactions with various target cells. This phenomenon is known as 
“endotoxin tolerance,” while excessive activation of monocytes and macrophages by a 
bolus of LPS can lead to septic shock, a serious systemic disorder that can result in 
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multiple organ failure and death. The molecular mechanisms underlying these 
extremely different responses are as follows. LPS is disaggregated into monomers by 
LPS-binding protein and presented to cell-surface CD14. Toll-like receptors (TLR4) 
then bind to the CD14–LPS complex and gets activated, stimulating a cytoplasmic 
signal transduction cascade (Figure 10), which leads to liberation of free nuclear factor-
(B (NF-(B) and increased transcription of inflammatory genes including tumor 
necrosis factor-& (TNF-&), interleukin-1( (IL-(), and inducible nitric oxide synthase 
(iNOS). The CD11/CD18 integrins are transmembrane proteins. Like CD14, they are 
also capable of mediating LPS-induced cellular activation[72]. LPS can also be 
internalized through an yet unknown mechanism, and may bind to intracellular Nod1 
and result in either activation of transcription factors or processing of a hypothetical 
protein X, which may serve as a true ligand for TLR4. 
 
 
          Figure 10: Schematic representation of LPS signaling[73]. 
 
Although TLR4 receptors are presumably the main LPS signaling receptors they 
are not solely responsible for LPS recognition. After the ligation of CD14 by LPS, 
different signalling molecules must be recruited to the site of ligation, where LPS is 
then briefly released into the lipid bilayer. There it interacts with a complex of 
receptors, which includes Hsp70, Hsp90, CXCR4, GDF5 and TLR4[74]. Thus, it is 
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likely that the assembly of multiple membrane molecules form a LPS receptor domain 
(LRD) occurs. It is well known, that GPI-linked molecules accumulate together with 
cholesterol and glycosphingolipids forming special membrane microdomains called 
rafts or “detergent insoluble glycolipid-enriched domains” (DIG)[75-77]. These 
domains are the loci of numerous cell functions from membrane traffic and cell 
morphogenesis to cell signaling. LPS has been shown to be able to activate the NF-kB, 
ERK1/2 and SAPK/JNK pathways. It is possible that different cell types and different 
supramolecular complexes utilize different intracellular pathways[74]. 
 
1.4.6 Key players of LPS signaling pathway - Endotoxin-binding 
proteins  
1.4.6.1 LBP 
LBP is a soluble acute phase protein that binds to bacterial lipopolysaccharide  
to elicit immune responses by presenting the LPS to important cell surface pattern 
recognition receptors called CD14 and TLR4. LBP is synthesized by hepatocytes and 
intestinal epithelial cells and is present in normal serum at concentrations of 5 to 10 
"g/ml, rising up to 200 "g/ml 24 h after induction of an acute-phase response triggered 
by interleukin-1 (IL-1). LBP has a concentration-dependent dual role: low 
concentrations of LBP enhance the LPS-induced activation of mononuclear cells 
(MNC), whereas the acute-phase rise in LBP concentrations inhibits LPS-induced 
cellular stimulation. LBP binds a variety of LPS (endotoxin) chemotypes from rough 
and smooth strains of gram-negative bacteria and even lipid A, the lipid moiety of 
LPS[78]. 
 
1.4.6.2 BPI 
Bacterial/permeability-increasing protein is a 50 kDa protein first isolated from 
azurophilic granules of neutrophils by Weiss and colleagues[79]. BPI is released from 
neutrophils after stimulation by a variety of compounds including LPS, N-methyl-
formylated chemotactic tripeptides (e.g., f-Met-Leu-Phe), and phorbol esters. It is found 
in extremely high concentration in abscess fluid. BPI has LPS-binding and bactericidal 
activity specific for Gram-negative bacteria and it binds avidly to LPS in a lipid A-
dependent manner. However, BPI lacks the activity of LBP that mediates LPS binding 
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to CD14 and to HDL. The amino-terminal region of BPI, (BPI1–197, rBPI23) retains full 
LPS-binding activity[80]. 
 
1.4.6.3 CD14 
 
CD14 is a GPI-anchored protein constitutively expressed on the surface of 
various cells, including monocytes, macrophages, polymorphonuclear neutrophils, 
chondrocytes, B cells, dendritic cells, gingival fibroblasts, keratinocytes, and human 
intestinal epithelial cell lines. Aside from this membrane-bound (mCD14) state, a 
truncated form of CD14 is also found in a circulating soluble (sCD14) form in serum at 
a concentration of 5-6 µg/ml. Both mCD14 and sCD14 causes LPS mediated activation 
of cells. CD14 has been shown to sensitize the cell types that do not express membrane-
bound CD14, such as endothelial cells, astrocytes and epithelial cells. It has recently 
been demonstrated that sCD14 is a regulatory factor capable of modulating cellular and 
humoral immune responses by interacting directly with T and B cells. Mutant sCD14 
containing the N-terminal 152 amino acid residues were found to have activity 
equivalent to the full length sCD14[81]. Mutational studies indicate that LPS binding 
and cellular activation are separate functional properties of CD14[82]. Studies with 
CD14 derived peptides showed that the peptide comprising amino acids 81 to 100 is 
sufficient to bind and neutralize LPS[83]. The binding of LPS to CD14 can also occur 
in the absence of LBP but only in the presence of a high concentration of LPS; 
however, LBP markedly accelerates this activity. 
 
Besides binding LPS, CD14 may function as a receptor for peptidoglycan, the 
major cell wall component of Gram-positive bacteria[84], other microbial products with 
similar structural features[85], human heat shock protein 60[86], and other ligands 
(ceramide, anionic phospholipids, modified lipoproteins, opsonized particles)[87]. Thus 
CD14 can be defined as a pattern recognition molecule in innate immunity. It also has 
been found that the interaction of LPS/LBP with CD14 causes the exchange of LPS 
with lipids in target membranes[87-89], and this lipid transfer may be  responsible for 
LPS-induced signal transduction. The rate of the exchange reaction depends on the lipid 
composition of the target membranes, which has led to the speculation that CD14 
functions only to direct LPS insertion into particular membrane domains81. High 
concentrations of sCD14 (10–30 "g/mL-1) could compete with mCD14 on myeloid 
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cells for LPS binding and thereby neutralize partly the biological effects of the 
endotoxin molecules[90]. This LPS neutralizing property of sCD14 makes it a potential 
therapeutic agent in septic patients. Thus the exact role of CD14 in physiological and 
pathological situations is not well defined. CD14 was initially described as a specific 
receptor for LPS. At the monocyte surface, the LPS receptor mCD14 and the LPS-
binding protein (LBP) interact with LPS, and form a high affinity trimolecular complex 
that allows monocytes to detect the presence of LPS. In contrast, two opposite functions 
have been described for sCD14. It can either reduce endotoxin-induced activities by 
competing with mCD14 for LPS binding, or it mediates the LPS-induced activation of 
non-CD14-expressing endothelial, epithelial, and smooth-muscle cells.  
 
1.4.6.4 Structure of CD14  
The monomeric subunit of CD14 contains thirteen ( strands, and 11 of them, 
from (3 to (13, overlap with conserved leucine-rich repeats (LRRs) (Figure 11). The 
concave surface of the horseshoe shaped structure consists of a large (-sheets of 11 
parallel and two antiparallel (-strands. The convex surface of CD14 contains both 
helices and loops, in no regular pattern. A large hydrophobic pocket was found on the 
NH2-terminal side. The pocket is the main component of the lipopolysaccharide-
binding site. Dimerization in the crystal is mediated by residues in & 13 and in the loop 
between &12 and &13. Parallel &-sheets from the two monomers interact in an 
antiparallel fashion and form a large and continuous &-sheet encompassing the entire 
CD14 dimer[91]. Unlike mammalian CD14, chicken CD14 appears to have trans-
membrane and cytoplasmic domains, suggesting that it is not GPI-anchored. This has 
important implications for the role of CD14 in the chicken’s response to LPS. Reports 
suggest that chicken cells respond less well to LPS than the equivalent mammalian 
cells[92]. 
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Figure 11: Structure of the CD14 dimer. Two monomers of CD14 in the crystal are colored in 
green and yellow. Disulfide bridges are shown as red spheres. mCD14 is GPI anchored 
membrane protein. Soluble sCD14 lacks the GPI anchor and mutant sCD14 containing N-
terminal 152 amino acid residues sCD14 were found to have activity equivalent to the full 
length sCD14 and this construct was used for our studies. 
 
1.4.6.5 Toll-like receptors 
 
Although there is no doubt that CD14 binds LPS, CD14 is not capable of 
initiating a transmembrane activation signal because it is a glycosyl phosphatidyl 
inositol (GPI)-anchored protein and has no transmembrane domain. The signaling 
protein that mediates this phenomenon is likely to be a member of the Toll-like receptor 
(TLR) family. TLRs are a type of pattern recognition receptor (PRR) that are now 
counted among the key molecules that alert the immune system to the presence of 
microbial infections. They are named for their similarity to Toll, a receptor first 
identified in the fruit fly Drosophila melanogaster, and found to have an essential role 
in the fly's immunity to fungal infection[93], which is achieved by activating the 
synthesis of antimicrobial peptides. Members of the Toll-like receptor (TLR) family 
recognize conserved microbial structures, such as bacterial lipopolysaccharide and viral 
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double-stranded RNA, and activate signaling pathways that result in immune responses 
against microbial infections. All TLRs induce stereotyped responses such as 
inflammation. However, individual TLRs can also induce immune responses that are 
tailored to a given microbial infection. Thus, these receptors are involved in both innate 
and adaptive immune responses[94]. 
 
1.4.7 LPS responsive cells 
1.4.7.1 Monocytes 
The most prominent LPS-sensitive cell populations are cells of the 
monocyte/macrophages lineage. These cells produce a large variety of bioactive protein 
mediators in response to LPS including interleukin 1 (IL-1), IL-6, IL-8, and in 
particular tumor necrosis factor ' (TNF-')[54]. A lot of host cells respond to these 
cytokines and thereby initiating the typical acute phase response (which helps to 
eliminate the invading microorganisms. The massive release of cytokines, however, 
becomes hazardous for the organism by causing shock, cell damage, and multi-organ 
failure[95]. In addition to cytokines, macrophages produce reactive oxygen species 
(superoxide anion, hydrogen peroxide, hydroxyl radicals and nitric oxide) on exposure 
to endotoxin, which also been shown to be involved in the pathophysiology of 
septicemia. 
 
1.4.7.2 Polymorphonuclear leukocytes (PMN) 
The phagocytosis of microorganisms by PMN is drastically enhanced in the 
presence of LPS and presents a good example for the nonspecific immunostimulatory 
capacity of endotoxin. PMN are able to neutralize LPS since they contain enzymes that 
are able to degrade (deacylate and  dephosphorylate) LPS and lipid A to nontoxic 
partial structure derivatives[96]. Furthermore, they express and release antimicrobial 
proteins with strong affinity to LPS and thus neutralize LPS bioactivity. One of these 
proteins is the cationic 55 kDa bactericidal/permeability-increasing protein (BPI), 
which is able to kill bacteria by binding to the bacterial surface. 
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1.4.7.3 B- and T-lymphocytes 
The polyclonal activation of murine B lymphocytes in response to LPS, 
resulting in proliferation, differentiation, and the secretion of immunoglobulins, seems 
to be an early defense mechanism, since it leads to the enhanced release of antibodies 
with various antimicrobial specificity[97]. Activation of T-lymphocytes by LPS 
depends on accessory monocytes providing costimulatory signals[98]. T-lymphocytes 
can be downregulated by lipid A leading to an increased antipolysaccharide antibody 
production[99]. All these findings support the hypothesis that LPS indeed is involved in 
cellular immunity against microorganisms. 
 
1.4.7.4 Vascular cells, epithelial cells 
  Vascular cells (endothelial cells and smooth muscle cells) as well as epithelial 
cells can respond to LPS by the release of cytokines, for example IL-1, IL-6, and/or IL-
8[100]. Additionally, they can produce several other mediators such as prostacyclin, 
nitric oxide, platelet-activating factor, interferons, and colony-stimulating factors. 
 
1.4.8 Strategies of endotoxin antagonism  
Many steps along the pathway from the interaction of LPS with the mammalian 
cell membrane to intracellular signaling events have been considered as potential drug 
targets. They are (1) identification of naturally occurring lipopolysaccharide (LPS)-
binding proteins; (2) generation of novel LPS-binding antibodies, proteins and peptides; 
and (3) characterization of the molecular determinants of LPS binding and making LPS 
antagonists by modification of lipid A structure[101]. 
                  
 1.4.8.1 Anti-endotoxin antibodies 
   
 Polyclonal or monoclonal antibodies to the outer ‘O’ antigens of LPS provide 
serotype specific protection in experimental Gram-negative infection and in patients, 
which offers too limited range of protection against which is against only specific 
strains of bacteria[102]. Antibodies against deep core lipid A region (Anti-DCLA 
mAbs) demonstrate cross-reactive binding activity and protect against many strains of 
bacteria but binding of these agents to smooth bacteria and its LPS have been 
inconsistent and these agents appear to be markedly less potent than those directed 
against the O-antigen polysaccharide region[101].  
 49 
 1.4.8.2 LPS-binding proteins 
 
The identification of LPS-binding proteins such as LBP, sCD14, BPI, and 
LALF has stimulated the development of these anti-LPS agents for preclinical and 
clinical evaluation. LALF is the most avid LPS-binding agent yet identified in 
vitro[103]. The amino-terminal domain of BPI (BPI1–197) contains the full LPS 
neutralizing and bactericidal activity of the parent molecule. LBP-LPS complexes could 
be neutralized by soluble CD14, which would prevent their interaction with 
macrophages and the induction of TNF-'  release. Thus soluble CD14 could be a 
natural inhibitor of the deleterious effects of endotoxin[104]. As discussed above, LBP, 
CD14, and TLR(s) sequentially bind LPS, ultimately leading to transduction of a pro-
inflammatory signal in LPS-responsive cells. The blockade of each successive step in 
this chain has been considered as a potential site of therapeutic intervention. 
 
1.4.8.3 Anti-LPS peptides 
One reason that anti-DCLA mAbs and BPI bind inconsistently to smooth strains 
of bacteria or their derived LPS may be that the DCLA region of LPS is relatively 
inaccessible, being embedded in the outer membrane and shielded by external portions 
of the LPS molecule. The smaller peptide derivatives should more readily access lipid 
A, if steric factors significantly hinder the binding of larger proteins. Endogenous host 
defense peptides, fragments of endotoxin-binding proteins and synthetic anti-endotoxin 
peptides fold into &-helical, (-hairpin, extended and compact conformations without 
regular secondary structure. In animal models many of the peptides have demonstrated 
good in vitro and in vivo endotoxin-neutralizing activity, but up to now none of the 
peptides has been approved for clinical application with an anti-endotoxin 
indication[105]. 
 
1.4.8.4 Antimicrobial peptides 
 
Antimicrobial peptides (AMPs) are crucial humoral components of the innate  
immunity system of virtually all organisms, by which they defend themselves from the 
invasion of attacking pathogens[106]. They had already  existed for at least 500 million 
years[107], before the first glimmerings of the adaptive immune appeared. Hundreds of 
these gene-encoded peptides, usually ranging in size from 12 to 50 residues, have been 
isolated from bacteria, fungi, plants, and animals, including humans. Despite broad 
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divergences in sequence and taxonomy, most antibiotic peptides share a common 
mechanism of action, i.e., membrane permeabilization of the pathogen. Most AMPs are 
amphipathic and cationic molecules. Their net positive charge promotes their binding to 
the membranes of microbes, which are generally negatively charged.  
 
Many AMPs act by compromising the structural and/or functional integrity of 
microbial membranes[108], but some may have additional or alternative modes of 
action[109]. Factors believed to be important for antimicrobial activity have been 
identified, including peptide hydrophobicity, the presence of positively charged 
residues, an amphipathic nature that segregates basic and hydrophobic residues, and 
secondary structure. High hydrophobicity should force a strong partition of the peptide 
into the hydrophobic core of the lipid bilayers, regardless of  the phospholipid head 
group, thereby permeabilizing membranes of both eukaryotes and prokaryotes[110]. In 
addition to their antimicrobial activities, many AMPs also bind strongly to LPS, a 
property required for those peptides selective for gram-negative bacteria which must 
interact with the outer membrane before reaching the cytoplasmic membrane and 
killing the cell[105].  
 
Many of the host defense peptides, which have antimicrobial activity, are also 
able to bind to and neutralize LPS; however, these two activities do not necessarily 
correlate. Polymyxin B (PMX-B) is one of the most efficient compounds for the 
treatment of septic shock, due to its ability to bind and detoxify bacterial 
lipopolysaccharide. The biophysical properties and the mode of action of AMPs with 
LPS determine their biological function, the susceptibility of bacteria to them, the 
ability of LPS to activate the immune system, as well as the potential of AMPs to 
interfere with this activation and to neutralize LPS-induced endotoxic shock. Better 
understanding of the peptides characters involved in antibacterial activity, LPS 
neutralization, toxicity and stability should help us to develop improved antimicrobial 
peptides with desirable properties[111]. 
 
1.4.9 Polymyxins 
Polymyxin B is a strongly cationic cyclic polypeptide antibiotic isolated from  
Bacillus polymyxa[112]. Polymyxin B and the other polymyxin antibiotics act primarily 
by binding membrane phospholipids and disrupting the cytoplasmic membrane, 
 51 
inducing pore formation in bacterial walls. Polymyxin B binds to the lipidA portion of 
the lipopolysaccharide in the cell membrane of gram-negative bacteria. It neutralizes 
the effects of endotoxin at molecular[113, 114] and cellular[115, 116] levels and in 
animal models of endotoxaemia[117]. The interaction was postulated to involve ionic 
forces between amino groups in Polymyxin B and phosphate and carboxyl groups in the 
lipid A-Kdo region, with hydrophobic interactions between the respective acyl groups. 
Data suggest a stoichiometric binding of one LPS monomer to one polymyxin B 
molecule[118, 119]. Polymyxin B has a bactericidal action on most gram-negative 
bacilli, except proteus spp. and is not active against Neisseria species, most fungi and 
Gram-positive bacteria. Activity is inhibited by Fe(II), Co(II), Mn(II) and Mg(II) ions. 
The use of polymyxins is associated with considerable toxicity, mainly nephrotoxicity 
and neurotoxicity[120]. But polymyxins have been recently re-introduced in clinical 
practice for the treatment of patients with multidrug-resistant gram-negative bacterial 
infections. Data from the recent literature suggest that the use of polymyxins is 
associated with lower and less severe toxicity compared to that reported in the old 
literature[121]. 
 
1.4.9.1 Structure of polymyxins  
The general structure (Figure 12) comprises a cyclic heptapeptide bound to a 
linear tripeptide, with six unnatural amino acid such as 2,4-diaminobutyric acid (Dab). 
The )-amino group of Dab-4 is linked via an amide bond to the C-terminus of Thr-10, 
while its '-amino group is connected to Dab-3 of the linear tripeptide. The N terminus 
of Dab-1 is end-capped with a long alkyl chain. They contain one or two D-aminoacids. 
The presence of positive charges, the cyclic structure, the amphipathicity and the 
hydrophobic tail are essential for activity against gram-negative microorganisms[122]. 
 
1.4.9.2 Types of polymyxins 
There are several types of polymyxins, which are produced by fermentation 
from different strains of Bacillus polymyxa. They differ in amino acid composition at 
position 3, 6, 7, as well as in the nature of the fatty acid (Table 4). We studied the 
interactions of Polymyxin B, E and M with E.coli Re-LPS. Polymyxin M  (Figure 13) 
is biosynthetically produced from the B.polymyxa strain. 
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   Figure 12: General structure of polymyxins where A can be D-Leu or D-Phe  
    and B can be L-Thr, L-Leu, L-Phe or L-Ile depending on the type of polymyxin.  
 
 
             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4: Composition of variable regions in different types of polymyxins 
 
 
                  Composition of variable regions  
Type of polymyxin  Fatty Acid chain 3 6 7 
Polymyxin A  6-Methyl octanoic acid  D-Dab D-Leu L-Thr 
Polymyxin B1 
     Ile-B1 
                   B2 
                   B3 
                   B4 
                   B5 
                   B6 
6-Methyl octanoic acid  
6-Methyl octanoic acid  
6-Methyl heptanoic acid 
Octanoic acid 
Heptanoic acid 
NA 
3-OH 6-Methyl octanoic acid  
L-Dab 
L-Dab 
L-Dab 
L-Dab 
L-Dab 
L-Dab 
L-Dab 
 
D- Phe 
D-Phe 
D-Phe 
D-Phe 
D-Phe 
D-Phe 
D-Phe 
L- leu 
L-Ile 
L-Leu 
L-Leu 
L-Leu 
L-Leu 
L-Leu 
Polymyxin D 1 6- Methyl octanoic acid  D-Ser D-Leu L-Thr 
Polymyxin E1 
                   E2 
IOA 
IOA  
L- Dab 
L -Dab 
D-Leu 
D -Leu 
L-Leu 
L-Leu 
Polymyxin M 6-Methyl octanoic acid L-Dab D-Leu L-Thr 
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  Figure 13: Structure of Polymyxin M  
 
1.4.9.3 Mechanism of action  
               Polymyxins, which behave like detergents, are rapidly bactericidal. Their 
target site is the bacterial outer cell membrane. Polymyxins increase permeability of the 
cell envelope, which lead to leakage of cell contents and, subsequently, cell death. 
Polymyxins through electrostatic interactions bind to anionic lipopolysaccharide by 
displacing magnesium (Mg2+) and calcium (Ca2+) from the negatively charged LPS. 
These cyclic decapeptides are created from nondescript sequences of amino acids 
lacking unique epitopes that could serve as the recognition site of a protease required 
for selective destruction of the antibiotic in the presence of cellular protein constituents. 
Neutralization and sequestration of bacterial lipopolysaccharide, which plays a key role 
in gram-negative sepsis is required to block the progression of sepsis at early stages in 
addition to destroying bacteria. Thus, one can envision the use of polymyxin in 
combination with conventional antibiotics to increase killing and at the same time, 
neutralize LPS released by these antibiotics. 
 
1.5 Scope of our study  
Sepsis is a serious source of mortality in many cases accounting for 
approximately 200,000 deaths in the US annually[123]. Owing to increasing numbers 
of resistant strains, it remains an ongoing threat throughout the world. It is known that 
many antibiotics stimulate the release of endotoxin and thus stimulate the occurrence of 
such symptoms[124, 125]. Thus, there is great interest in the development of 
antimicrobial agents, which can reverse rather than promote sepsis, especially given the 
recent disappointing clinical performance of antiendotoxin therapies.  
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Our study was devoted to the interaction of lipopolysaccharide from gram-
negative bacteria with polymyxins. We present a study of interactions of polymyxin B, 
E and M with LPS from the deep rough mutant strain of E.coli in membrane-mimetic 
dodecylphosphocholine (DPC) micelles. First a method for efficient purification of 
biosynthetically produced LPS using RP-HPLC in ternary solvent mixture was 
developed. Polymyxin M was biosynthetically produced from the B.polymyxa strain. 
Then LPS was incorporated into a DPC micelles and its interaction with polymyxins 
was studied by heteronuclear NMR spectroscopy. The chemical shift mapping data 
using isotope labeled LPS or labeled polymyxin as well as isotope-filtered NOESY 
experiments reveals the mode of interaction LPS with polymyxins. Using simulated 
annealing protocol and restraints derived from intermolecular NOEs we have obtained 
the model of LPS – PMX-B complex, which was also in accordance with the chemical 
shift mapping data. The model was further refined by MD calculations, which included 
DPC micelles and explicit water. In the modelled complex the macrocycle of PMX-B is 
centered on the phosphate group at GlcN-B and additional contacts from polar side 
chains are formed to GlcN-A and Kdo-C, while hydrophobic side chains target the acyl 
region.  
 
Our experimental data now confirm the model of the PMX-B LPS complex, 
proposed by Pristovsek et al[10]. Their investigations of the conformational behavior of 
PMX-B and PMX-B in water solution, free and bound to LPS, by homonuclear NMR 
and molecular modeling methods reveal that free peptides exist in equilibria of fast 
exchanging conformations with local preferences for a distorted type II !-turn from 
residues 5-8, and/or a )-turn in residue 10. In the bound conformation they form an 
envelope-like bent cycle, which forms an amphiphilic separation of the two 
hydrophobic residues 6 and 7 from the charged Dab residues 4, 5, 8, and 9 which 
cluster on the lower side of the cycle. The structure does not display any intramolecular 
H-bonding, including the prominent !- and )-turns. While our work confirmed the 
contacts made with moieties of the GlcN units proposed in the model complex from 
Pristovsek it is different in that it emphasizes the importance of contacts to Kdo units, 
in particular to Kdo-C. 
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 In the complex of polymyxin M with LPS the bend in the heptacycle was in the 
opposite direction[126]. This resulted in a less dramatic separation of hydrophobic and 
hydrophilic side chains. In PMX-M position 7 is occupied by Thr, a much more polar 
residue. According to the data from our work, PMX-M may be slightly differently 
oriented, possibly forming some-what stronger contacts to the Kdo units. In the PMX-
M—LPS complex electrostatic or polar interactions involving the Dab residues of 
polymyxin and the carbohydrate moieties of GlcN-B or Kdo-C and to a smaller extent, 
Kdo-D dominate, while in the case of PMX–B or –E additional hydrophobic 
interactions from sidechains of Leu-7 are likely to contribute to binding. 
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                 Chapter 2 
 
 
 2.0 Introduction 
              G protein-coupled receptors, also known as GPCRs, represent a very large sub 
family of receptors[1], which detect a wide range of signaling molecules outside the 
cell and, in response, turn on signaling cascades inside the cell. These integral 
membrane proteins control countless processes in the body, including appetite, vision, 
smell, and heartbeat, endowing this receptor class with enormous therapeutic potential. 
Nearly 800  such receptors are thought to be present in the human genome[2]. Many 
diseases are linked to GPCRs. Not surprisingly half of the drug targets in the 
pharmaceutical industry are GPCRs[3]. Since the cloning of the first receptors, 
extensive experimental work has uncovered multiple aspects of their function and 
challenged many traditional paradigms. 
 
                           
                                                   Figure 1: Schematic representation of GPCR[4]. 
             Despite the remarkable structural diversity of natural GPCR agonists and low 
sequence homology among GPCRs, hydropathy analysis and biochemical data suggest 
that all GPCRs share a common molecular architecture. (Figure1). This raises the 
question, what structural features enable GPCRs to recognize and bind diffusible 
ligands? How structurally conserved are they within the same class and what is the  
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importance of their similarities and differences from a functional point of view .Thus a 
critical need exists for structural information to understand the mechanism of receptor 
activation and regulation and enormous effort has been expended to obtain structural 
details for GPCRs.  
 
           Despite the extensive efforts, only in the past year great strides in the field of 
GPCR structural biology have been achieved with high resolution crystal structures of 
three new members being published[5-8]. Structural studies of intact GPCRs remain a 
challenging problem because of the daunting technical difficulties in expression, 
purification and the problems associated with their structural analysis. When using 
NMR the large size of the GPCR /micellar complex, poor chemical shift dispersion and 
the redundancy of the residues found in the transmembrane region of the receptor 
complicate the analysis. An alternative strategy of production of smaller fragments of 
GPCRs helps to overcome the problems associated with protein expression, and also 
aids in their spectroscopic characterization due to simplification of spectra. 
 
2.1 A brief history of GPCRs 
         The grandparents of modern receptor biology are probably Ehrlich and Langley. 
While Ehrlich was not exactly studying what we consider to be receptors in the modern 
sense, his “side chain theory” attempted to explain how antigens bound to cells. His 
conclusion was “corpora non agunt nisi fixata” – agents cannot act unless they are 
bound – a statement frequently quoted in the context of modern receptor biology[9]. 
However, contained in Langley’s study of the neuromuscular junction, was the first 
reference to a “receptive substance” describing the cellular sites of interaction of drugs 
curare/nicotine and atropine/pilocarpine[10]. The discovery of cyclic AMP and 
adenylyl cyclase by Sutherland marks the historical beginning of study of G-protein 
coupled receptors[11, 12]. In 1971, Rodbell proposed the existence of a guanine 
nucleotide regulatory protein that serves as a transducer between hormone receptors 
and adenylyl cyclase[13]. Gilman and colleagues subsequently demonstrated the 
existence of this protein[14] and later purified the protein and named it Gs[15]. Thus 
hydrolysis of GTP was found to allow heterotrimeric G-proteins to couple receptors 
and to activate or inhibit enzymes and ion channels, allowing modulation of cellular 
physiology by external agents[15-19]. Taken together, these discoveries provided the 
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first chain of molecular events that convey signaling from the outside to the inside of 
the cell. The era of molecular research on the receptors (studies that assess receptor 
properties directly, rather than inferring them from downstream effector function) can 
reasonably be dated to 1970. Until recently, our atomic-level understanding of GPCRs 
has been based on rhodopsin (2000) in its inactive state[20]  After 7 years, the drought 
has been ended with a flurry of papers around the structures of beta adrenergic 
receptors, the target of beta blockers[5-7, 21, 22], human A2A adenosine receptor[7, 8] 
and significant inroads made in resolving the activated state of bovine rhodopsin[23, 
24]. Together these efforts represent the first examples of what is sure to be a 
blossoming of information for this important class of membrane proteins. 
 
2.2 GPCR signaling  
Much of vertebrate physiology is based on GPCR signal transduction. As 
receptors for hormones, neurotransmitters, ions, photons and other stimuli, GPCRs are 
among the essential nodes of communication between the internal and external 
environments of cells. The classical role of GPCRs is to couple the binding of agonists 
to the activation of specific heterotrimeric G proteins, leading to the modulation of 
downstream effector proteins. Natural and synthetic ligands can be grouped into 
different efficacy classes. Full agonists are capable of maximal receptor stimulation; 
partial agonists are unable to elicit full activity even at saturating concentrations; 
neutral antagonists have no effect on signaling activity but can prevent other ligands 
from binding to the receptor; and inverse agonists reduce the level of basal or 
constitutive activity below that of the unliganded receptor.  
 
A wide variety of ligands, including biogenic amines, amino acids, ions, lipids, 
peptides and proteins, use GPCRs to stimulate various cytoplasmic and nuclear targets 
and these ligands vary in size from small molecules to peptides to large proteins. A 
general model of GPCR activation postulates that GPCRs are in equilibrium between 
an active state and an inactive state which differs by disposition of transmembrane 
helices, turns, cytoplasmic domains and the agonists act by stabilizing the activated 
state[25]. 
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GPCRs owe their name to their extensively studied interaction with 
heterotrimeric G proteins (composed of an !-, "- and #-subunit). When a ligand binds to 
the GPCR it causes a conformational change in the GPCR which allows it to act as a 
guanine nucleotide exchange factor (GEF). The GPCR can then activate an associated 
G-protein by exchanging its bound GDP for a GTP. The G-protein's ! subunit, together 
with the bound GTP, can then dissociate from the " and # subunits to further affect 
intracellular signaling proteins or target functional proteins directly depending on the ! 
subunit type (Gs ,Gi, Gq, G12). Consequently, the G!- and G"#- subunits stimulate 
effector molecules, which include adenylyl and guanylyl cyclases, 
phosphodiesterases,phospholipaseA2 (PLA2), phospholipaseC (PLC) and phospho 
inositide3-kinases (PI3Ks), thereby activating or inhibiting the production of a variety 
of second messengers such as cAMP, cGMP, diacylglycerol, inositol(1,4,5)-
trisphosphate (IP3), phosphatidyl inositol(3,4,5)-trisphosphate [PIP3], arachidonic acid 
and phosphatidic acid, in addition to promoting increases in the intracellular 
concentration of Ca2+ and the opening or closing of a variety of ion channels (Figure 2). 
It results in the rapid effects on hormone secretion, muscle contraction and a variety of 
other physiological functions. Long terms changes in gene expression are mediated by 
phosphorylation of transcription factors. 
 
However, beyond the dogma of ‘GPCR–G-protein’, in the late 1990s, evidence 
began accumulating to suggest that some GPCRs are able to signal without G-proteins. 
For example, the adaptor molecule arrestin binds many phosphorylated GPCRs and is 
primarily involved in targeting these receptors for endocytosis. In kidney cells, the 
bradykinin receptor B2 has been shown to interact directly with a protein tyrosine 
phosphatase. Other structural features, which include PDZ, SH2 and SH3 domains, and 
polyproline-containing regions also provide the molecular basis for direct interactions 
between GPCRs and several intracellular signaling molecules[26]. Furthermore, it has 
been shown that a variety of cellular responses are mediated by the activation of 
effector molecules through novel molecular mechanisms, many of which do not involve 
the stimulation of classical second messengers. 
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    . 
  
                                Figure 2: Diversity of G-protein-coupled receptors (GPCRs)[27].  
Abbreviations: DAG, diacylglycerol; FSH, follicle-stimulating hormone; GEF, guanine 
nucleotide exchange factor; LH, leuteinizing hormone; LPA, lysophosphatidic acid; PAF, 
platelet-activating factor; PI3K, phosphoinositide 3-kinase; PKC, protein kinase C; PLC, 
phospholipase C; S1P, sphingosine-1-phosphate; TSH, thyroid-stimulating hormone. 
 
GPCRs become desensitized when exposed to their ligand for a prolonged period of 
time. There are two recognized forms of desensitization:1) homologous desensitization, 
in which the activated GPCR is downregulated; and 2) heterologous desensitization, 
wherein the activated GPCR causes downregulation of a different GPCR. The key 
reaction of this downregulation is the phosphorylation of the intracellular (or 
cytoplasmic) receptor domain by protein kinases. Thus the final outcome of  most 
biological responses mediated by GPCRs are not dependent on a single biochemical 
route, but results from the integration of a complex  network of biochemical responses. 
 
2.3 Significance of GPCRs 
How do we communicate with the outside world? How are our senses of vision, 
smell, taste and pain controlled at the cellular and molecular levels? What causes 
medical conditions like allergies, hypertension, depression, obesity and various central 
nervous system disorders? G-protein coupled receptors (GPCRs) provide a major part 
of the answer to all of these questions. They are involved in the control of several 
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important aspects of our behavior and physiology. Of the 720–800 human GPCRs, 
which accounts for about 2% of the human genome, 380 were found to be unique 
functional non-olfactory/non sensory GPCR sequences, for which endogenous ligands 
are expected. They are referred to as endo-GPCRs[28, 29]. These receptors are 
expressed in different tissues and regulate various aspects of our physiology. The endo-
GPCR group has attracted much attention in recent years. Examples are receptors for 
hormones such as calcitonin and luteinizing hormone or neurotransmitters such as 
serotonin and dopamine. 
 
There is a growing body of evidence that many mutated forms of GPCRs are 
associated with a wide spectrum of disease phenotypes and  predispositions. Mutations 
that cause inactive receptor proteins are often referred to as loss-of-function (LOF) 
mutations. By contrast, constitutively active mutants (CAMs) result in autonomous 
signaling in the absence of agonist. These mutations results in various pathological 
processes which lead to numerous diseases, including cardiovascular, mental disorders, 
retinal degeneration, cancer, AIDS etc. The investigation of these mutations gives 
insight into the causes of human genetic disease and provides perspective on strategies 
for drug discovery that take into account the potential for the development of drugs 
targeted at mutated and wild-type GPCRs[30, 31]; [32]. 
 
2.4 Classification of GPCRs 
The GPCR superfamily is historically classified into three main families[33]. 
Rhodopsin belongs to family 1 and is the most intensively studied GPCR, so family 1 is 
also called the rhodopsin-like family. The other two main subfamilies are the secretin-
like receptor (family 2) and the metabotropic glutamate-like receptor (family 3) as 
shown in Figure 3. Family 1 comprises almost 90% of all GPCRs and is by far the best-
studied subfamily. The members of family 1 GPCRs, possess a characteristic disulfide 
bridge between extracellular loops E-I and E-II. Most of these receptors also have a 
palmitoylated cysteine in the carboxy-terminal tail, which serves as a membrane 
anchor. The crystal structure of rhodopsin has indicated that some of the 
transmembrane domains of family 1 receptors are ‘tilted’ and ‘kinked’ due to the 
presence of certain amino acids such as proline that distort the transmembrane helices. 
A short amphiphilic helix, lying nearly perpendicular to TM VII and therefore parallel 
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to the cytoplasmic membrane, is part of the C-terminal tail. 
 
 
                     Figure 3: Three family classes of GPCRs. 
   Family 1 comprises the rhodopsin-like receptors, which are subdivided into three subfamilies. 
   Family 2 includes hormone receptors 
   Family 3 comprises the metabotropic glutamate receptors. 
   Sites known to be involved in ligand binding are highlighted in orange. 
 
Family 1 can be subdivided into 3 subfamilies family 1a, 1b and 1c. Group la 
contains GPCRs such as rhodopsin, opioid receptors and ß-adrenergic receptors, which 
binds to small ligands. The binding site (orange coloured) is within the seven TM 
helices in the hydrophobic membrane compartment. Receptors of important 
neurotransmitters such as dopamine, serotonin, peptide hormones as well as 
neuropeptides, and in particular NPY are mainly members of family lb with the ligand 
binding site involving the N-terminal part and the extracellular loops. Group lc contains 
receptors for glycoprotein hormones and a large extracellular domain characterizes 
them. Family 2 GPCRs have been found in many animal species but not in plants, fungi 
or prokaryotes. Many members of this family contain two additional structural features 
in addition to the classical 7 TM region: i) a mucin-like region rich in serine and 
threonine residues; ii) a conserved cysteine-rich proteolysis domain[34]. They are 
morphologically very similar to family lc GPCRs although the sequence homology is 
very low and they lack the characteristic disulfide bond and palmitoylation site of 
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family 1 GPCRs. The ligands for the family 2 GPCRs are large peptides including the 
closely related 29-residue peptide glucagon, the 27-residue peptide secretin and the 28-
residue vasoactive intestinal peptide (VIP), or the calcium and phosphate ion 
concentration regulating 32-residue peptide calcitonin and the 84 amino acid peptide 
parathyroid hormone (PTH). 
 
The family 3 GPCRs are receptors for the main neurotransmitters glutamate and 
#-aminobutyric acid, for Ca2+, for sweet and amino acid taste compounds, and for some 
pheromone molecules, as well as for odorants in fish. Although none of these family 3 
receptors have been found in plants, members have been identified in ancient 
organisms, such as slime molds (Dictyostelium) and sponges[35]. A long amino 
terminus and a long carboxy tail characterize these receptors. These receptors possess a 
very large extracellular domain constituted of two lobes (ligand binding regions LBR 1 
and 2) that close like a Venus flytrap upon ligand binding. In spite of the low sequence 
similarity of family 3 receptors with that of rhodopsin-like receptors they share some 
structural similarities like 1) the conserved disulfide bond between  E-I and E-II is also 
conserved in family 3 members, 2) it has an 8th helix (H8) after TM7 like in the 
rhodopsin structure. A unique characteristic of these receptors is that the third 
intracellular loop is short and highly conserved.  
 
     Fredriksson and colleagues divided 802 (known and predicted) human GPCRs 
into families on the basis of phylogenetic criteria. This system classifies most of the 
human GPCRs into five main families (Table.1) termed Glutamate, Rhodopsin, 
Adhesion, Frizzled/Taste2 and Secretin (shortened to the acronym GRAFS)[28] The 
main difference between this nomenclature system and the former classification 
systems is the further division of family 2 into the Secretin family and the Adhesion 
family. Each family covers several subfamilies of GPCRs. In addition, some putative 
families, orphan receptors and non-GPCRs families are also included (refer to 
www.gpcr.org).    
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        Table 1: A summary of properties for the G protein-coupled receptor  
             (GPCR) families[36] 
  
2.5 Expression of GPCRs 
Recombinant overexpression of GPCRs is essential for their structural 
characterization and for the structure based drug design. Heterologous expression of 
functional GPCRs has been accomplished in Escherichia coli, yeast, insect and 
mammalian cells, but with varying degree of success because of the differences in host 
cell environment[37, 38] (Table 2).  E.coli system definitely has the advantage in that it 
is simple, rapid to use, various expression plasmids and E.coli strains are available, 
scale-up costs are reasonable and uniform labeling of the protein for NMR is 
comparatively cheaper than with the other expression systems. The toxic effects of 
GPCRs on bacterial membrane, codon usage efficiency, stability of the expressed 
protein and the lack of post translational modification are the major setbacks of this 
system. Several methods have been developed to overcome these problems and 
increase the protein yield. Notably, fusing target proteins to a highly expressed bacterial 
protein has proven particularly effective for improving the expression level of GPCRs 
in E.coli[39]. Several GPCRs have been functionally expressed in E.coli as fusion 
proteins[40-42] and refolded like h!"#$%&'!()*+,'$'%-.%/01-.2%+'3'4*)+%-015 from 
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inclusion bodies[43]. GPCR expression has been achieved at relatively high levels in 
S.cerevisiae and S.pombe but P.pastoris generated the best expression results. Insect 
and mammalian expression is extremely expensive from a NMR point of view even 
though it serves as the optimal host for GPCR expression. Thus generally insect and 
mammalian cell expression systems have been most frequently employed for 
pharmacological development. For biophysical and structural studies that require large 
amounts of GPCRs, yeast and E.coli systems are attractive for their ease of large-scale 
production but only with a varying degree of success.   
 
Vector  Advantages  Disadvantages  Example Ref 
E.coli  
(Native ) 
rapid , inexpensive ,  
scalable. 
toxic to cells , no post- 
translational  modifications  
fusion protein required . 
human A2A AR 
rat neurotensin receptor 
[40] 
[44] 
E.coli  
(Inclusion body) 
rapid , inexpensive ,  
scalable, high expression  
no post translational    
modifications, 
requires refolding  
BLT1 [43] 
Sacchromyces 
cervisiae 
high biomass, relatively easy to 
use, scalable  
difficulty in clone 
selection, 
hyperglycosylation  
yeast ste2R 
dopamine D1A 
[45] 
[46] 
Pichia pastoris  high yields  difficulty in cloning  
selection, thick cell wall  
human !2-AR [47] 
Baculovirus  mammalian-like  
glycosylation  
more expensive, slow virus 
stock production  
neurokinin -1, human !2- 
AR 
[48] 
[49] 
Mammalian cell 
lines 
properly folded protein  very  expensive , low yield A2A AR 
 
[50] 
Cell – free 
translation  
simple , fast  very low yields  human !2- AR [51] 
     Table 2: Comparison of expression systems for GPCR biosynthesis[52].(Modified) 
 
2.6 Current state of structural studies of GPCRs 
The path to the three dimensional structure of rhodopsin was long and difficult. 
Up to now the molecular structures of only 5 unique GPCRs have been determined 
including bovine rhodopsin with and without the retinal ligand as well as opsin with a 
C-terminal 11-residue peptide fragment of a G"-protein (G"-CT)[20, 23, 24], a highly 
engineered human !2-adrenergic receptor with a replaced intracellular loop3 (C-III)[5, 
6], and a turkey !1-adrenergic receptor with the C-III loop partly removed and most of 
the C-terminus deleted[7] and human A2A-Adenosine receptor with several thermo 
stabilizing mutations and C-terminal deletion[8]. Knowledge about the three-
dimensional structure of these fascinating molecules are crucial for the understanding 
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of its function and are of great interest from the perspective of membrane-protein 
biophysics, cell biology, physiology and drug discovery. X-ray crystallography, 
electron microscopy or diffraction, NMR spectroscopy and molecular modeling are the 
four techniques to obtain such structural information.  
 
2.6.1 General structure 
As shown in Figure 1 all GPCRs have an extracellular N-terminal segment, 
seven TMs, which form the TM core, three extracellular loops, three cytoplasmic loops, 
and a C-terminal segment. A fourth cytoplasmic loop is formed when the C-terminal 
segment is palmitoylated at Cys. Each of the seven TMs is generally composed of 20–
27 amino acids. On the other hand, N-terminal segments (7–595 amino acids), loops 
(5–230 amino acids), and C-terminal segments (12–359 amino acids) vary in size, an 
indication of their diverse structures. The extracellular parts of the receptor can be 
glycosylated. These extracellular loops may also contain two highly-conserved cysteine 
residues that form disulfide bonds to stabilize the receptor structure. 
 
2.6.1.1 Why Seven TMs? 
The ubiquitous adoption of a seven TM structure raises the inevitable question 
concerning its structural and functional merits. Odd numbers of TMs place the N- and 
C-terminal segments at opposite membrane surfaces. It allows glycosylation and ligand 
binding at the N-terminal segment, and phosphorylation and palmitoylation at the C-
terminal segment for desensitization[53] and internalization. Seven TMs may be the 
minimum necessary to form six loops and a TM core with a sufficient size and 
versatility to offer a prodigious number of specificities required for the regulatory 
mechanism. TM "-helices vary in length and can extend beyond the lipid bilayer. 
Therefore, the boundaries between TMs and loops are likely to be uneven and may be 
dynamic. In many GPCRs the transmembrane domains 1, 4 and 7 are significantly more 
hydrophobic than TMs 2, 3, 5 and 6 that contain several ionic and/or neutral residues.%
The seven TMs of animal rhodopsin[54] and adrenergic receptors[55] are arranged as a 
closed loop in the counterclockwise direction from TM 1 to TM 7 when viewed from 
the extracellular surface. This arrangement makes the more hydrophobic TMs 1, 4 and 
7 exposed more to the lipid bilayer than the less hydrophobic 2, 3, 5 and 6. The TM 
core is tightly packed by hydrogen bonds and salt bridges and does not have a vacant 
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pocket, channel, or tunnel structure. The two conserved Cys residues in extracellular 
loops 1 and 2 are known to be linked by a disulfide bond in bovine rhodopsin, the 
Thyroid stimulating hormone (TSH) hormone receptor, the thromboxane receptor, and 
the Gonadotropin releasing hormone (GnRH) receptor.%Thus GPCRs show a far greater 
conservation with regard to the three-dimensional structure than to the primary 
sequence. 
 
2.6.2 The Rhodopsin structure 
             Rhodopsin, a classic G-protein coupled receptor also known as visual purple, is 
a pigment of the retina and consists of the protein moiety opsin (40 kDa) and a 
reversibly covalently bound cofactor, 11-cis retinal (a derivative of vitamin A) through 
a lysine residue[56, 57]. Rhodopsin is involved in the molecular transformation of light 
energy into a neuronal signal transmitted to the secondary neurons of the retina and 
ultimately to the brain. Absorption of a photon by the 11-cis-retinal causes its 
isomerization to all-trans-retinal[58], leading to a conformational change of the protein 
surface and making it capable of binding and activating G-protein which leads to the 
visual signaling cascade.%%
%
The crystal structure of rhodopsin has provided the first three-dimensional 
molecular model for a G-protein-coupled receptor (GPCR) and represented a 
monumental step in this field[20]. The initial structure has been refined at 2.8 Å 
resolution[59] (Figure 4a). The N-terminus of the protein is located on the extracellular 
side of the membrane and it contains five distorted strands. Two oligosaccharide sites 
are located at residues 2 and 15 and they are not involved in any other interactions. 
(Man)3(GluN)10 was the main  glycosylation pattern found at these sites. The loops E-I 
and E-III run along the periphery of the molecule while a part of E-II loop folds deeply 
into the center of rhodopsin. Cys187 forms a disulphide bond with Cys1103.24   at the 
extracellular end of helix-III. 
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                 a           b                                               c 
                 
                   d                                            e           f 
Figure 4:. Available high-resolution structures of GPCRs. (a) bovine rhodopsin; (b) bovine opsin;  
(c) squid rhodopsin; (d) human !2-adrenergic receptor; (e) turkey !1-adrenergic receptor,(f) human 
A2AAdenosine receptor 
                     
2.6.2.1 Transmembrane region 
            The helices are irregular in length and orientation. Helix III is the longest and 
passes through the center of the protein. Helix VIII is a short helical segment on the 
cytoplasmic side of the membrane oriented with its helical axis parallel to the 
membrane surface. The transmembrane helices are not straight, regular " helices but 
kinked and bent. Proline residues are associated with the kinks except in the case for 
the kink in helix II at Gly892.56 and Gly902.57. In addition, it has been noted that turns of 
310 and # helices are also found in this structure. Two short ! strands are located on the 
extracellular side of the protein near the retinal binding site. 
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2.6.2.2 Retinal binding site 
         11-cis-retinal is covalently linked to Lys2967.43 in helix VII by forming a Schiff 
base linkage with the amine group of the lysine residue. The retinal is located between 
the helices towards the extracellular side of the protein (Figure5) and is completely 
buried within the protein. Towards the extracellular surface are found the two short  ! 
strands and extracellular surface loops that make up the TM plug shielding the retinal 
from aqueous environment. The transmembrane helices block ready access of the 
chromophore to the hydrophobic region of the bilayer. The chromophore is not planar. 
The conjugated system is twisted, possibly due to packing interactions with the protein, 
or due to the steric interactions within the chromophore.  
                                                                                                                                                                                                      
                          
%%%%% %%%%%%%%%%%%%%%%%%%%%%%%%Figure 5: Binding sites of bovine rhodopsin with retinal (1U19)[60]%
    
              The chromophore binding environment is made up of a mix of hydrophobic 
and polar/charged groups. At one end 11-cis retinal, the chromophore,covalently binds 
to Lys2967.43.and at the other end, its !-ionone ring is buried in a hydrophobic pocket 
formed by Trp2656.48, Phe2126.47, and Tyr2686.51. The interaction between the !-ionone 
ring and Trp2656.48 forces the side-chain rotamer conformation of Trp2656.48 to be that 
of the inactive state. Switching between this and the active Trp2656.48 conformation 
initiates the so-called ‘‘toggle switch’’ for activation/inactivation of rhodopsin. Polar 
groups such as Thr1183.33 and Tyr2686.51 are located near the center of the polyene, and 
the side chain of Glu1223.37 is close to the !-ionone ring. Also, Glu183 makes a close 
water-mediated approach to the retinal. The Schiff base at the other end of the 
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chromophore is protonated in the activated form of the protein, and Glu1133.28 serves as 
a counterion for it in the interior of the protein. 
 
2.6.2.3 Cytoplasmic surface 
The C-I loop exhibit rigid organization. The C-II loop exhibits an L-shaped 
structure with a beta barrel (Met143 to Phe146) almost along the main axis of 
rhodopsin. The C-III loop is highly flexible and it should be noted that its length varies 
considerably in different GPCRs and may be critical for the functionality and 
specificity in the G-protein activation. The C-IV loop in the cytoplasmic region is 
nearly perpendicular to H-VII and it follows the NPXXY motif a highly conserved 
region of GPCR. The side chains of Cys322 and Cys323 point to the outside of 
rhodopsin indicating its probable palmitic acid  attachment site. 
 
2.6.2.4 Intramolecular interactions and GPCR activation 
Ground-state rhodopsin is inactive, and several of its structural elements 
combine to restrain the structure. Interactions among the extracellular loops, including a 
disulfide bridge limit the conformational flexibility of this part of the molecule under 
dark, non-signaling conditions. In addition, the interactions between the chromophore 
and the protein, both hydrophobic and electrostatic, tighten the inactive receptor 
structure. Mutations of Lys2967.43 or Glu1133.28 eliminating these interactions result in 
constitutively active receptors. The transmembrane region of rhodopsin is stabilized by 
a number of interhelical hydrogen bonds and hydrophobic interactions, and most of 
them are mediated by highly conserved residues in GPCRs. One of the residues that 
exhibit the highest conservation is Asn551.50 in H-I. Its side chain is responsible for two 
interhelical hydrogen bonds to Asp83 in H-II and to the peptide carbonyl of Ala2997.46. 
Asp832.54 is in turn connected via a water molecule to the peptide carbonyl of 
Gly1203.35 in H-III (Figure-6A). Another region that mediates constraints for these 
helices includes Asn782.49 of H-II, which is hydrogen-bonded to OH groups of 
Ser1273.42 of H-III and Thr160, Trp161 of H-IV. Helices H-III, H-IV and H-V can be 
also linked through interaction among Glu1223.37, Met163, and His2115.46 (Figure 6A) 
 
The tripeptide Glu1343.49, Arg1353.50, Tyr1363.51 is part of a highly conserved 
(D/E)R(Y/W) motif  found in GPCRs. These residues participate in several hydrogen 
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bonds with surrounding residues and form an “ionic lock” which is responsible for 
holding the receptor in its inactive state (Figure 6B). The carboxylate of Glu-134 forms 
a salt-bridge with the guanido moiety of the next Arg-1353.50. Arg1353.50 is also 
connected to Glu2476.30 and Thr2516.34 in H-VI. Val1373.52, Val1383.53, to Val1393.54 are 
also closely located to partly cover the cytoplasmic side of Glu1343.49 and Arg1353.50. 
These could be one of the critical constraints keeping rhodopsin in the inactive 
conformation.  
 
 
 
             Structural details of the intramolecular interactions in Rhodopsin [20]  
Figure6A:  Interhelical hydrogen bonds mediated by a highly conserved Asn55, 
connecting H-I, H-II, and H-VII, and by Asn78 for H-II, H-III, and H-IV.  
Figure6B: The tripeptide region, Glu1343.49, Arg1353.50, Tyr1363.51 known as a 
(D/E)R(Y/W) motif located near the cytoplasmic end of H-III forming an ionic lock 
with residues in H-VI.                                                                           
 
The first step in the activation of rhodopsin is the photoisomerization of 11-cis-
retinylidene into all -trans-retinylidene after absorption of a photon. This isomerization 
is fast, and slower conformational adjustments in the protein as well as the 
chromophore eventually give rise to the signaling form of the protein, metarhodopsin 
II. The conformational switching of the chromophore might require reorganization of 
the helical structure of helix VII which disrupts the salt bridge between Glu1133.28 and 
Lys2967.43 and movement of a proton. In addition to this, the helix VII moves away 
from helix I and helix VI moves away from the other helices. Glu2476.30 is no longer 
able to interact with Arg1353.50, which is then able to reorient to the cytoplasmic 
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surface, where it can interact with transducin. Protonation of Glu1343.49 also occurs 
during this conformational transition. Motion of the helix VII has been identified as 
important for the interaction with G-protein. The major structural features of rhodopsin 
structure are represented in the Figure 7. 
 
                              
                          Figure 7:. Stereoview showing the location of structural features in 
rhodopsin[61]. The polypeptide backbone is shown as gray ribbon. Retinal is shown as small 
black spheres. Residues in the   D(E)RY and NPXXY motifs are shown as big black  spheres.  
 
2.6.3 Opsin/Rhodopsin in the activated state 
Comparison of the rhodopsin structure with invertebrate squid rhodopsin 
(Figure 4c), which couples to Gq, reveals that the most distinguishing feature of these 
structures occurred in the intracellular region of helix-V and helix-VI and the 
intervening loop C-III that has a 12-residue insertion compared with rhodopsin. In this 
region, these two helices are longer and rigid, extending well away from the core,[62] 
and form one side of a binding region for an occluded octylglucoside, which indicates 
that the surface around this extended region may be  needed to bind the G-protein. 
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Two bovine opsin papers appeared recently last year. In the more recent one 
opsin is complexed with an eleven amino acid peptide, G"CT, derived from the C-
terminal of the transducin G"t protein (Figure 4b). Opsin is the retinal free 
photoreceptor protein generated after photoactivation and Schiff base hydrolysis of 
rhodopsin. In these structures more dramatic structural changes are observed at the 
cytoplasmic surface especially in the C-III loop and intracellular region of helix-V and 
helix-VI. Residues of the highly conserved E(D)RY and NPXXY motifs play key roles 
in these changes. The end result of the changes from inactive rhodopsin to active-state 
opsin is the creation of a cavity between helix-III, helix-V and helix-VI, in which the G 
protein transducin can bind.  
 
2.6.4 Adrenergic receptors 
The adrenergic receptors (or adrenoceptors) belongs to class A GPCRs that are 
targets of the catecholamines, especially noradrenaline (norepinephrine) and adrenaline 
(epinephrine). The adrenergic receptors in the amine group of class A GPCRs consist of 
two main subfamilies, ! and ", which differ in tissue localization and ligand specificity 
as well as in G protein coupling and downstream effector mechanisms[63]. !-receptors 
have the subtypes !1 (a Gq coupled receptor) and !2 (a Gi coupled receptor) and " 
receptors have the subtypes "1, "2 and "3. All three are linked to Gs proteins (although 
"2 also couples to Gi)[64], which in turn are linked to adenylate cyclase. Genetic 
modifications of adrenergic receptors are associated with diseases as diverse as asthma, 
hypertension, and heart failure[65]. 
 
2.6.4.1 !2-adrenergic G-protein coupled receptor 
The high-resolution !2-AR X-ray structure,(figure 4d) bound to the inverse 
agonist carazolol and timolol was published recently[5, 21, 22] .! The approach of 
splicing T4L into the C-III region and complexation of !2-AR with Fab portion of the 
monoclonal antibody (Mab5) raised against the C-III region of !2-AR were utilized to 
provide conformational stability. The binding of timolol to !2-AR was very similar to 
that of carazolol. In contrast to rhodopsin, instead of short !-sheet the E-III loop 
regions of !2-AR contain a short "-helix that was stabilized by intra- and inter-loop 
disulphide bonds, and the cytoplasmic N-terminal regions were disordered. The overall 
positions of the ligands are slightly more extracellular than 11-cis retinal in rhodopsin. 
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This leads to significant difference in inverse agonist–antagonist interactions with the 
residues Trp2866.48 (human !2-AR) and Trp3036.58(avian !1-AR), which were 
suggested to undergo key rotamer conformational transitions in GPCR activation, 
referred to as the ‘rotamer toggle switch[66]. Ligand binding sites of different GPCRs 
were compared in Figure 8 in the form of 2D interaction map. 
 
    
Figure 8:  Binding sites of bovine rhodopsin with retinal (1U19); the human !2-adrenergic 
receptor with carazolol (2RH1); the turkey !1-adrenergic receptor with cyanopindolol (2VT4); 
the human !2-adrenergic receptor with timolol (3D4S); and the human A2A adenosine receptor 
with ZM241385 (3EML)[60]. 
 
The ‘ionic lock’ between the highly conserved E/DRY motif on TM3 and a 
glutamate residue on TM6 which is seen in rhodopsin is absent in all the ligand-bound 
GPCR structures !1AR, !2AR and !2AR. Instead polar contact between adjacent acidic 
and basic residues on TM3 (Glu1343.49 followed by Arg1353.50 of the E/DRY motif is 
maintained (Figure 9). However, recent MD calculations proposed that the ionic lock 
may also be present in these structures atleast part of the time. Another difference 
between the structures is at the cytoplasmic surface found in the intracellular loop 2 
region (C-II), which includes a short "-helix in the !1-AR and A2AAR structures that is 
absent in !2-AR and rhodopsin. This structure serves as a platform for a hydrogen-
bonding interaction of a conserved tyrosine (on C-II) with the E/DRY motif (on TM3); 
its absence in !2-AR could help to explain the higher relative basal activity of this 
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receptor. In the timolol-!2-AR structure two cholesterol binding sites, which are not 
involved in crystal packing, are revealed. These binding sites may play a role in 
cholesterol-mediated thermal stabilization, allosteric modulation of ligand binding to 
the high-affinity agonist binding state, and receptor trafficking (see Ref. [22] and 
references therein). 
 
     
Figure 9: The ionic-lock residues at the cytoplasmic end of TM3 (R3.50 and E/D3.49), and TM6 
(E6.30) for the four superimposed receptor structures bovine rhodopsin (purple, bound to 11-cis 
retinal), avian "1AR (orange, bound to cyanopindolol), human A2A adenosine receptor (green, 
bound to ZM241385) and human "2AR (blue, bound to carazolol) are shown. R3.50 engages 
Y5.58 on TM5, rather than E6.30 on TM6 in the opsin 'active state'. The rotameric position of E6.30 
differs for the two !2-AR structures[67]. 
 
2.6.4.2 !1-adrenergic G-protein coupled receptor 
Another GPCR structure was from the turkey !1-adrenergic receptor bound to 
the cyanopindolol[7]. Because of the difficulties in crystallization of human !1-AR the 
studies were done with turkey (Meleagris gallopavo) !1-AR. Through extensive 
analyses of the thermal stabilizing effects of various mutants and their combinations, a 
composite of six mutations was introduced to sufficiently stabilize the complex without 
the introduction of a companion (mAb or T4L) protein. There were truncations of some 
residues from N and C-termini as well as from the C-III loop. The close relationship of 
these proteins, i.e., !1-AR vs. !2-AR, makes the comparison of structures particularly 
meaningful. At the sites of the six point mutations, there was no evidence for any 
significant changes in backbone conformation.  
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The overall structure was found to be very similar to !2-AR. (Figure 4e). The 
structures of the three extra-cellular loops   in !1-AR are very similar to those of   !2-
AR. In case of cytoplasmic loops, the C-I loop was similar for rhodopsin, !1-AR and 
!2-AR, but there are major differences in C-II and C-III. The third cytoplasmic loop 
cannot be compared as it was subjected to several modifications in all the GPCR 
structures except rhodopsin. In !1-AR, C-II forms a short "-helix (Pro1463.57 to 
Leu1523.63) parallel to the membrane surface whereas in both !2-AR structures and in 
rhodopsin it is in an extended conformation. Among the more notable differences found 
between the !1-AR and !2-AR structures are the residues in the ‘‘ionic-lock’’ region. 
The ‘‘ionic lock’’ observed in rhodopsin was not formed, indicating that that the ionic 
lock was not an essential feature of inactive state of GPCRs. But the short "-helix 
which was formed in C-II forms an hydrogen bond between Tyr149 on C-II and 
Asp1383.49 of the ‘‘ionic lock’’ DRY motif on H-III which would explain the inactivity 
of the cyanopindolol !1AR structure in contrast to the residual basal activity of the two 
!2AR  complexes with inverse agonists. 
 
The mode of binding of cyanopindolol to !1-AR was found to be similar to that 
of carazolol in !2-AR(Figure 8).. However, the extra ring in the carazolol heterocyclic 
ring, owing to van der Waals contacts with Tyr1995.38 in !2-AR pushes the ligand more 
deeply into the binding site. The nitrogen in the cyano-moiety of cyanopindolol makes 
a weak hydrogen bond with the hydroxyl of Thr2035.34, which was located together 
with Phe2015.32 on E–II. To account for the subtype specificity and the fact that some 
ligands preferentially bind to either !1-AR or !2-AR, there must be differences in 
amino acid residues close to the ligand-binding pocket that directly or indirectly affect 
binding. In between these two adrenergic receptors the respective  residues  were found 
to be Val1724.56 and Phe3257.35 in !1AR which was equivalent to Thr164
4.56 and 
Tyr3087.35 in !2AR. These differences introduce polar residues near the binding pocket 
of !1-AR  relative to !2-AR,  which could affect ligand  selectivity. 
 
2.6.4.3 Architecture of the   Human A2A Adenosine receptor 
A recent publication has now provided the X-ray structure of the A2A adenosine 
receptor in complex with the high-affinity antagonist ZM241385[8] (Figure 4f) .In 
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order to overcome thermal instability problems, human A2AAdenosine receptor was 
expressed as  T4-Lysozyme (T4L) fusion where most of the C-III loop (Leu209
5.70 to  
Ala2216.23) was replaced with T4L and the carboxy terminal tail (Ala317 to Ser412) was 
removed to improve crystallization. In addition the N-Linked glycan associated with 
Asn1544.73 has been removed enzymatically. The structure provides yet more 
information and new insights about GPCRs. There are three major features, which are 
different from the previously reported GPCRs. In the A2A AR structure, the 
organization of the extra cellular loop is markedly different from the other GPCR 
structures reported. It resembles neither the extended !-sheet of rhodopsin nor does it 
include the "-helix structure of the adrenergic receptors,rather, E-II adopts a random 
coil conformation that has three cysteine bridges to E-I and one within E-II, resulting in 
an opening that could allow the  entry of small molecules into the active site. 
 
Secondly, the antagonist ZM241385 binds in an extended conformation 
perpendicular to the plane of the membrane and colinear with transmembrane helix VII, 
(Figure 8) while interacting with both ECL2 and ECL3. The bicyclic triazolotriazine 
core of ZM241385 is anchored by an aromatic stacking interaction with Phe1685.29, an 
aliphatic hydrophobic interaction with Ile2747.39 and a hydrogen-bonding interaction 
with Asn2536.55 (Figure 6). Adjacent to Phe1685.29 the polar residue Glu1695.30 interacts 
with the exocyclic amino group (N15 atom) linked to the bicyclic core of ZM241385. 
Finally the seven transmembrane arrangement was similar to the other GPCRs, 
however there was shift in the relative orientation of the various helices. The conserved 
tryptophan residue on helix VI known as the toggle switch interacts with the ligand and 
modulates the receptor equilibrium between active and inactive state. An interaction 
between the D/ERY motif and Helix VI, which constitutes an ionic lock that restrains 
the fully inactive conformation of rhodopsin, was not seen in the A2A AR. Instead of 
participating in an ionic lock, the arginine residue in the D/ERY motif may play a role 
in stabilizing the deprotonated state of the adjacent aspartate or glutamate residue, 
which would strengthen the polar interactions between the D/ERY motif and both C-II 
and helix II. This set of interactions may have direct implications in G-protein 
activation[68]. The A2A AR ligand–bound structure suggests that there was no general, 
family-conserved receptor-binding pocket, in which selectivity was achieved through 
 84 
different amino acid side chains. Rather, the pocket itself can vary in position and 
orientation so as to offer more opportunity for receptor diversity and ligand selectivity. 
 
2.6.5 Comparative analysis of GPCR crystal structures 
The GPCRs share many hallmark motifs and structural homologies eventhough 
their primary sequences are quite divergent .Structures of the ligand mediated !1-AR, 
!2-AR, and the A2A adenosine GPCRs are providing significant advances in the 
understanding of the partially/fully inactive states, albeit more clarity is needed. These 
structures also provide a valuable template for developing homology models for agonist 
binding and for understanding of the mechanism of GPCR activation. Comparison of 
the opsin/rhodopsin GPCR structure is again leading the way in understanding the 
mechanisms of activation at the atomic level. 
 
 
                          Table3: Challenges in GPCR crystallography[67]hy 
                 
At the same time one must be concerned about the modifications that facilitated 
crystal formation could produce high resolution structure which may  not completely 
the resemble the WT receptors since the fusion protein exhibited slightly elevated 
agonist binding affinities; however, antagonist binding affinities were normal, and only 
minor differences were observed. A summary of the structural modifications required 
to obtain crystals of GPCRs are outlined in the Table 3. Using fluorescent probes, the 
authors showed that agonists can induce protein conformational changes consistent 
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with receptor activation. Nevertheless, a full understanding of the structural basis of 
GPCR activation will require a high-resolution structure of a complex between a 
receptor with an agonist bound and its G-protein, as well as methods such as NMR to 
assess dynamics of their interaction that cannot be captured by the static snapshots 
provided by x-ray crystallography. The important features of the known GPCR 
structures and their significance are presented in the Table 4 and 5 
 
GPCR  type Characteristic Structural determinants Functional  interpretations  
 
Rhodopsin + 11-cis 
retinal -- 2.8  Å 
ECR- one disulphide bridge. 
4 ! sheets interact with N-terminus and C-II loop 
forming compact retinal plug.  
11 – cis retinal interacts with F212 (TM5),Y268and 
W265(TM6),TM3 and C-II loop.  
Ionic lock between E134 ,R135 (DRY motif ;TM3) 
and E247T251 (TM6) constraining the TM6 helix 
bundle inside . 
Y306 from the NPxxY motif (TM7) connected to 
F313 from cytoplasmic helix H8.  
Ionic lock  and absence of 
rotamer toggle switch – 
responsible for absence of basal 
activity ( inactive atate ). 
 
Retinal plug  seals retinal binding 
pocket . 
Squid rhodopsin 
+ 11-cis retinal 
3.7 Å 
ECR- one disulphide bridge. 
TMR: longer TM5 and TM6 with hydrophilic 
extension in cytoplasm forming a compact structure. 
ICR: two cytoplasmic helices H-VIII and H-IX 
linked by a hydrophobic 310 helix, with H-IX 
interacting with C-II, TM5, TM6 and H-VIII. 
The TMs protusion from the 
membrane surface may specify 
the recognition and the coupling 
mode with G!q proteins. 
Bovine ligand free 
opsin in its active G-
protein  interacting 
conformation 
No ligand  
–3.2 Å 
Dimers connected via TM1 and H-VIII.  
ECR: one disulfide bridge, ‘retinal plug’ structure is 
maintained. 
Two openings in the retinal binding pocket between 
TM5/TM6 and between TM1/TM7. 
The ‘ionic lock’ is broken and two new interactions 
(R135-Y223 (TM5), E247/T251-K231 (TM5)) are 
formed that lock and stabilize TM5/TM6 pairing. 
This provides crevice for G!CT interactions and 
binding. 
ICR: G!CT connects DRY (R135, TM3) to NPxxY 
(N310, TM7) and H-VIII (Q312) via a hydrogen 
bond network. 
Two openings – gates for one 
selective for 11-cis retinal and 
other for 11-trans retinal . 
 
Retinal plug  seals retinal binding 
pocket. 
 
Insights into the structural 
changes involved in signal 
transfer from the receptor to G-
protein. 
      Table 4 : Comparative analysis of the known rhodopsin structures [69](Modified).   
Abbrevations: ECR:Extracellular region, ECL: Extracellular loop, TMR: Transmembrane 
region,  TM1-7: Transmembrane helices, ICR: Intracellular region , ICL: Intracellular loo 
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GPCR  type Characteristic Structural determinants Functional  interpretations 
"2AR – Fab + 
carazolol –  
3.4 Å /3.7 Å 
ECR: not visible.  
TMR: absence of the ‘ionic lock’ (R131 is too far from 
E268) Weaker interactions between TM3 (DRY) and TM6 
leading to a more open structure. 
The more open structure may 
account for the high basal activity 
and the structural instability. 
"2AR – T4 
lysozyme  + 
carazolol -
2.4 Å 
ECR: N-terminus not visible; unusual pair of disulfide 
bridges and a short helical segment not present in rhodopsin 
(E-II). Fusion with T4-lysozyme in place of C-III provides 
conformational stability and increases polar surface). 
TMR: presence of 3 molecules of cholesterol per monomer 
 Absence of the ‘ionic lock’ (R131 is too far from E268). 
This structure provides details on 
the interactions with carazolol. 
"2AR – T4 
lysozyme  
+timolol 
2.8 Å 
Specific cholesterol binding site between TMs 1, 2, 3 and 4 
(2 molecules of cholesterol per monomer) . 
Compared to carazolol, timolol binds deeper into the 
receptor. 
A consensus motif predicts 
cholesterol binding for 44 % of 
class A receptors .  
Cholesterol enhances thermal 
stability and shifts the receptor to 
the high affinity agonist binding 
state. 
Allosteric modulation by 
cholesterol . 
Mutated 
turkey ß1AR 
+ 
cyanopindolol 
- 2.7 Å 
ECR: two disulfide bridges stabilizing an !-helix in ECL2  
TMR: 15 residues (TM3, 5, 6, 7 and ECL2) make contact 
with cyanopindolol. 
  Hydrogen bond between DRY (TM3) and Y149 (ICL2) 
In the binding pocket, V172 and F325 could affect ligand 
selectivity. 
Absence of the ‘ionic lock’.  
ICR: short helical segment in C-II parallel to the membrane. 
Structured C-II and its related 
interactions may explain receptor 
low basal activity.     
Both Y149 and the ICL2 !-helix 
have key roles in G-protein 
coupling. 
In the binding pocket, V172 and 
F325 could affect ligand 
selectivity. 
Adenosine 
A2A receptor 
–T4 
Lysosome + 
ZM241385  
 - 2.6 Å 
ECR: four disulfide bridges constraining random coiled 
ECL2. 
Absence of the ‘ionic lock’. 
TMR: the binding pocket is shifted closer to TM6 and TM7  
ZM241385 interacts with the ‘toggle switch’ W246 
Hydrogen bonding between D101 (TM3) and Y112 (ECL2) 
ICR: h8 along the membrane interacting with TM1 Short 
helical segment in C-II. 
Extensive disulfide bond network 
forms a rigid, open structure which 
forces the antagonist to bind 
perpendicularly to the membrane    
ZM241385 restricts movement of 
W246 (involved in the receptor 
activation) -  stabilize receptor 
inactive state. 
DRY motif participates in the 
interactions that restrain ICL2 
conformation and explain receptor 
low basal activity. 
Table 5: Comparative analysis of the known GPCR structures [69]( Modified ).  
Abbrevations: ECR:Extracellular region, ECL: Extracellular loop, TMR: Transmembrane 
region,  TM1-7: Transmembrane helices, ICR: Intracellular region , ICL: Intracellular loop 
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2.7 GPCR oligomerization 
Accumulating evidence of GPCR oligomerization on the one hand and perfect 
functionality of monomeric receptors on the other creates an impression of controversy. 
This is an actively-studied area in GPCR research. Do GPCRs function as monomers, 
dimers or higher-order oligomers? It is very difficult to provide a solid answer for this 
question. Different GPCR subtypes, and even the same receptor at different stages of its 
life cycle, most likely exist in different oligomerization states, from monomers to 
dimers and possibly higher-order oligomers. Another important issue is the stability of 
the oligomers, which might be permanent (as seen in Family 3 GPCRs) or very 
transient or anything in between. One more important aspect that has to be kept in mind 
is that several types of GPCRs reside in micro domains covering a small fraction of the 
cell surface[70]; [71, 72]. Crowding of over expressed receptors in these micro domains 
is sufficient to yield a FRET signal without oligomerization[70]. 
 
 Another problem concerning the monomer–dimer debate is the unambiguous 
interpretation of inherently ambiguous data. Therefore, we should avoid 
overgeneralization. An amazing structural and functional diversity of the GPCR 
superfamily acquired in more than a billion years of evolution makes it highly unlikely 
that every receptor performs every function in exactly the same state. The best-studied 
example of receptor oligomerisation are the metabotropic GABAB receptors[73]. These 
receptors are formed by heterodimerization of GABABR1 and GABABR2 subunits. 
Only expression of the two subunits together leads to plasma membrane expression of 
functional receptor[74, 75]. 
 
2.7.1 GPCR studies in fragments 
  Despite fairly good methods developed for both prokaryotic and eukaryotic 
expression of many soluble cytoplasmic proteins, as mentioned above GPCRs have 
presented major challenges for obtaining high yields in almost every expression system. 
The low expression levels of these seven transmembrane receptors are due to the 
requirements for folding and transport and the cellular toxicity related to heterogenous 
expression in membranes. Another problem which intervenes in the GPCR structural 
studies by NMR is the size of the protein-detergent complex which leads to 
 88 
unfavourable T2 relaxation and broad overlapping resonances. To defeat this relaxation 
problem a partial solution came in the form of deutration, but this requires that 
backbone NHs must be back-exchanged to hydrogen. The unfolding and refolding 
experiments to carry out this exchange works fine with !-barrel membrane proteins but 
for "-helical transmembrane proteins is often problematic. Therefore a critical need 
arises to look for alternative approaches. One very useful method is the study of 
suitably chosen fragments. A significant number of studies provided structural 
information on fragments corresponding to sequences of GPCR helices, loops and 
termini. Eg:  Saccharomyces cerevisiae pheromone receptor[76], cannabinoid 
receptor[77] and Neurokinin-1 receptor[78]. Significant similarities between the 
structures of fragments and the rhodopsin structure were observed.  
 
          
Figure10: (A) Backbone representation of the ensemble of the 20 lowest-energy conformers of 
Ste2p(G31-T110) superimposed over backbone atoms in the region comprising residues 39–
103. Observed long-range NOE contacts are highlighted in red. (B) A single conformer from 
the ensemble additionally displaying the side chains. (C) Structure of a single conformer—view 
from the side of membrane interior. (D) The same as C but viewed from the cytoplasmic 
side.Ref:83 
 
According to Popot and Engelman the transmembrane domains can be thought of as 
independent folding units and can be studied separately[79]. This hypothesis is further 
tested by studying individual peptides corresponding to fragments (turn or a 
transmembrane helix) of rhodopsin, and their structures were overlaid on the 
corresponding part of the crystal structure of native rhodopsin. Good agreement was 
observed between helices in the protein and the structures of the fragments and turns in 
the protein and the structures of the fragments[80-82]. From our group also  Dr. Alexey 
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neumoin studied a construct comprising the first 2 TM domains of the yeast Ste2p 
receptor in LPPG  micelles[83](Figure 10).  
 
2.7.2 Helix –helix interactions 
Helix-helix interactions have been discovered to contribute to stability of 
GPCRs. Specific interfacial interactions between transmembrane "-helices may be 
important in the assembly and function of integral membrane proteins. This was studied 
extensively for the A2A receptor. These studies reported that the neighbouring helices 
enhance the helix stability[84] and  also provide evidence for the self –association of 
transmembrane helix-V which could give some insights for the dimerisation of 
receptors[85]. The presence of motifs like GxxxG, SxxSSxxT (polar clamp) and 
SxxxSSxxT motifs (serine zipper)[86] have been shown to play important role in 
mediating  helix-helix interactions and for oligomerisation of membrane proteins. 
These interactions are specific and strong as reflected in the ability of separately 
expressed bundles of GPCR transmembrane helices to associate correctly[87]. These 
findings suggest that some TM domains might need to interact with other domains to 
properly insert and fold in hydrophobic environments. 
 
2.7.3 A membrane protein folding model 
Unlike soluble proteins, intrinsic membrane proteins are designed to fold and 
exist in a milieu from which water is largely excluded. The lipid bilayer environment 
strongly limits the range of possible structures for transmembrane proteins and makes 
the folding, stability of integral membrane proteins easier to understand than that of 
their soluble counterparts. Only two structural motifs have been observed for 
membrane proteins (MPs), the membrane-spanning "-helix bundles and !-barrels, the 
former being predominant. In 1990, Popot & Engelman[79]  have proposed a two stage 
model for helix-bundle membrane protein folding. According to this model, (Figure11) 
initially transmembrane (TM) helices insert into the bilayer with appropriate topology. 
The second stage involves side by side packing of these preformed helices to produce 
the final folded structure. Individual helices are regarded as autonomous folding 
domains. 
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In the first step partitioning of unfolded polypeptides into the water-membrane 
interface results in increased formation of backbone hydrogen bonds resulting in 
formation of secondary structure. Interactions of the side chains with the lipid 
environment lead to the insertion of transmembrane helices into the bilayer interior. 
Once a hydrophobic sequence has been inserted into a membrane as a helix, the net 
hydrophobicity of these segments precludes their dissociation from the membrane, 
while the cost of breaking hydrogen bonds within a low-dielectric medium prevents the 
helices from unfolding. The second stage is the interaction of the helices to form the 
tertiary fold of the polypeptide. Factors that could contribute to the energetics of stage 
II are the links between helices, packing of helices and lipid molecules, polar 
interactions between helices, and, when applicable, association with prosthetic groups 
or with other proteins. 
 
 
      Figure 11: Steps in membrane protein folding. (From ref 79) 
 
2.7.4 Membrane mimetics 
GPCRs as integral membrane proteins can only exert their functions when they 
are inserted in the membrane. Their requirement for lipids has hampered structure 
determination by conventional approaches. The ability to perform NMR experiments on 
either liquid or solid-state samples provides the opportunity for structure determination 
of these proteins in several membrane mimetic environments. Current model membrane 
systems that have been employed include organic solvents, micelles, mixed micelles, 
bicelles, vesicles and short-chain/long-chain unilamellar vesicles (SLUVs)[76, 88, 89]. 
The more commonly used membrane mimetics are discussed in the following 
paragraphs. 
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2.7.4.1 Organic solvents 
Mixtures of organic solvents are often used as membrane mimetics in structure 
determination of transmembrane proteins by solution NMR. Organic solvent mixtures 
can interact with the transmembrane domains of membrane proteins so that they can be 
solubilized without the need for any solvating lipid or detergent. The most commonly 
used organic solvent or solvent mixtures are DMSO,50% trifluoroethanol-water, 
4:4:1chloroform:methanol:water, 80:20 hexafluoroisopropanol:water etc[81, 90]. The 
properties of proteins in the organic solvents /organic solvent mixture have shown to 
mimic those of the protein in the native environment. But most membrane proteins 
include significant extramembranous water-exposed domain(s), which are not expected 
to remain natively folded in organic solvent mixtures. Hence to summarize, organic 
solvent mixtures may be worth trying as membrane mimetic media for solubilizing 
certain membrane proteins. However, great care should be taken to establish whether or 
not native structure is present before spending much time on making NMR resonance 
assignments, which may represent misplaced effort, if the protein is not properly 
folded.  
 
2.7.4.2 Micelles 
A Micelle is an aggregate of surfactant molecules dispersed in a liquid colloid. 
When detergents are dispersed in water, they are mainly monomeric. However when 
the concentration increases above the critical micelle concentration (CMC), monomeric 
detergent molecules start associating and form a spherical aggregate termed a micelle 
(Figure 12). Hydrophilic head groups point outward interacting with water while the 
hydrophobic tails point inward forming an apolar environment. Detergents can be 
classified into the following categories according to charge: non-ionic (sugar-derived 
detergents) and ionic detergents. Among ionic detergents there are cationic, anionic 
(SDS) and zwitterionic (CHAPS, DPC) detergents. Detergent micelles are by far the 
most widely used membrane mimetic for solution NMR studies[91, 92]  however, it is 
clear that the upper size limit for NMR structure determination of membrane proteins in 
micelles is considerably lower than it is for globular proteins in aqueous solution. 
Indeed, for membrane proteins with more than 50 residues, resonance assignments 
require uniform 13C and 15N labeling and deuteration is often also necessary. 
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2.7.4.3 Bicelles 
Bicelles are discoidal lipid aggregates composed of long-chain phospholipid and 
either detergent or short-chain phospholipids (Figure12). The distinguishing structural 
feature of a bicelle is a central planar bilayer formed by the long-chain phospholipid, 
surrounded by a rim of short-chain phospholipids or detergent that shields the long-
chain lipid tails from water. Bicelles offer the opportunity to study membrane proteins 
in an environment that closely resembles the planar surface of biological 
membranes[88]. The bicelle size is controlled both by the ratio of long-chain:short-
chain phospholipids and the total phospholipid concentration. Bicelle discs orient in the 
magnetic field; therefore, it is possible to measure parameters containing long-range 
angular information, such as residual dipolar couplings. Since the long-chain 
phospholipid in bicelles is sequestered into the planar core region, devoid of short-chain 
phospholipid or detergent, the core region of the bicelles mimics a section of natural 
membrane much better than standard micelles. Bicelles have proven to be very useful 
in solid-state NMR applications, and high-quality spectra are often observed due in part 
to the highly liquid crystalline environment of the bicelle lipids. 
 
 
                  Figure 12: Representation of model membranes. (A) Micelle, (B) bilayer 
 
2.8 Neuropeptide receptors: Aim and scope of the investigation  
Many neuropeptide systems consist of several closely related peptides that bind 
to more than one receptor subtype. Such a multireceptor/multiligand system is the Y-
receptor family. They belong to the rhodopsin-like super family GPCRs, which are 
activated by the closely related peptide hormones neuropeptide Y, peptide YY and 
pancreatic polypeptide PP[93]. At least five Y-receptors have been cloned from 
mammals (Y1, Y2, Y4, Y5, and y6)[94]. The y6 receptor is designated in a lower case 
due to the fact that y6 is a truncated version of Y-receptors in mammals and no 
physiological function has been associated with it so far[95]. The major characteristic 
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features of these receptors are summarized in the Table 6. They are involved in control 
of a diverse set of behavioral processes including appetite, circadian rhythm, and 
anxiety[96, 97]; [98]. These receptors are expressed in the hypothalamus, in the brain 
stem and in peripheral tissues, such as blood vessels, lung, kidney, adrenal glands, 
stomach, colon, heart, pancreas and intestine[99-101]. An unusual feature of the Y-
receptor family is their lack of sequence identity, particularly between Y1, Y2 and Y5 
receptors, that are only 30% identical. A high homology of the Y1 to the Y4 (42%) and 
y6 receptors (51%) was found. The transmembrane regions share 40–43% identity. 
Subtypes of the Y1 receptor are known to exist in fish but not in mammals, while a 
further Y2-like receptor, named Y7, exists in amphibia, sharks and bony fish, but has 
apparently been lost from the mammalian lineage[94]. 
 
Receptor Y1 Y2 Y4 Y5 y6 
Ligands NPY, [P34]-
NPY, 
PYY>>NPY/PY
Y 
fragments, PP 
PYY, NPY, NPY 
(2–36)>>[P34]-
NPY, PP 
PP>>PYY>NPY 
$[P34]-NPY 
>>NPY/PYY 
fragments 
 
NPY,PYY, 
[P34]-NPY, 
NPY(2–36), 
NPY(3–36) 
>PP 
NPY, 
PYY>PP 
Amino acids  384 381 375 455 371 
Signal 
transduction 
                                           
                                        cAMP inhibition , Ca2+ mobilization 
 
Major 
Occurrence 
Periphery, 
hypothalamus 
Brain, 
hippocampus 
Intestine, colon Hypothalamus Not in 
human 
Related 
action  
Vasoconstriction, 
anxiolysis, food           
intake?  
Memory, 
epilepsy, 
secretion 
Gastro-intestinal  
regulation 
Food intake, 
Epilepsy 
Not known  
             Table 6: Characterisation of Y-receptor subtypes. Modified from the reference [102] 
 
All Y-receptor subtypes have two extracellular cysteines that probably may 
form a disulfide bond between extracellular loops I and II as confirmed by the X-ray 
structure of bovine rhodopsin and adrenergic receptor[5, 20]. Furthermore, all Y-
receptors have one or several consensus sites for N-linked glycosylation (Asn– X–
Ser/Thr) and at least one cysteine in the cytoplasmic tail that probably anchors the tail 
to the inside of the membrane by palmitoylation[103]. Studies on the structure-affinity 
and structure-activity relationship of each receptor type with variety of peptide analogs, 
as well as on site-directed mutagenesis and with anti-receptor antibodies, helped to 
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characterize each receptor subtype concerning its interaction with the ligand and its 
biological function[102].  The Y-receptors act via pertussis toxin-sensitive G- proteins, 
like members of the Gi and Go family. Therefore, their activation leads to the inhibition 
of adenylyl cyclase and consequently, to the inhibition of cAMP accumulation in 
tissues and cells. In addition to this, inhibition and stimulation of K+ and Ca2+ channels 
have been observed in neurons[104] and in the vasculature[105]. Apart from the 
regulation of food uptake, recently Y-receptors have been found linked to neoplasia. Y 
receptors were also found to be overexpressed in a variety of human cancers, mainly 
expressed in specific endocrine tumors and epithelial malignancies as well as in 
embryonal tumors[106-108]. NPY receptor expressing tumors are promising candidates 
for an in vivo NPY receptor targeting with radiolabeled and cytotoxic NPY analogs, 
analogous to somatostatin receptor targeting[109, 110].  
 
Evidence suggests that NPY and its receptors are involved in the 
pathophysiology of several disorders, such as the control of food intake, metabolic 
disorders, anxiety, seizures, memory, circadian rhythm, drug addiction, pain, 
cardiovascular diseases, rhinitis and endothelial cell dysfunctions. A better knowledge 
of structure and mechanism of action of these receptors is clearly beneficial for 
pharmaceutical sciences. Even though in the recent years there has been spectacular 
progress in the structure determination of GPCRs by X-ray crystallography, it still 
remains a daunting task to obtain high-quality crystals of membrane proteins.  
 
Nuclear magnetic resonance (NMR) becomes a valuable alternative technique. 
The less stringent requirements on the sample have allowed NMR to be widely applied 
to structural studies on MPs[111-117]. With the advance of NMR spectroscopic 
techniques such as TROSY[118], the generally considered molecular weight limitation 
in NMR studies has been dramatically lifted. It is established that assigning the NMR 
spectra of proteins as part of complexes in the 100 kDa range is now feasible[119-121].  
Purifying milligram amounts of active GPCRs has long been and still is considered a 
highly challenging goal to achieve even for the best skilled research teams. Thus taking 
into account the enormous problems associated with the expression, purification, and 
reconstitution of intact GPCRs into membrane-mimetic environments suitable for 
biophysical studies, investigations on suitably chosen fragments of these proteins seem 
to be well justified. A crucial issue which remains is that, whether these truncated 
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constructs are able to successfully mimic structural features of the intact GPCRs. 
Extensive studies had been carried out to address this issue, which led to the conclusion 
that when a fragment of a membrane protein exhibits secondary structure, that structure 
is similar to the structure of the intact protein[82, 122]. A mentioned already, 
significant number of studies provided structural information on fragments 
corresponding to sequences of GPCR helices, loops and termini. E.g, the   
Saccharomyces cerevisiae pheromone receptor[76], the cannabinoid receptor[77], and 
neurokinin-1 receptor[78]. Furthermore, in our group  we recently determined the 
conformation of a polypeptide corresponding to the 7th TM helix of the yeast Ste2p 
receptor extended by 40 residues from the cytosolic tail[123] when integrated into DPC 
micelles and a construct comprising the first 2 TM domains in LPPG micelles[83]. 
 
      The N-terminal domains from family 1 GPCRs have received little attention, 
most likely because of their short length, usually less than 70 amino acids. However, 
recent studies have suggested a pivotal role of N termini from GPCRs of this class in 
ligand recognition and binding[124-126]. Since these Y- receptors belong to the type 1b 
GPCRs, the ligand binding site involves the N-terminal part and the extracellular loops 
of the receptor. In this work we focussed on the structural studies of the N-terminus of 
the four Y-receptors (Y1, Y2, Y4 and Y5) of the family 1b GPCR that is targeted by 
members of the NPY family. Biosynthetic routes for recombinant production of the 
polypeptides in isotopically labeled form were established. The structure and the 
topology of these N-terminal domains in the presence of DPC or SDS micelles was 
elucidated by high-resolution NMR techniques. The N-terminal domains from all Y- 
receptors are fully unstructured in aqueous solution. On the contrary, in the presence of 
phospholipid micelles, they form helical segments with variable degree of stability. 
 
         Furthermore we developed an expression and purification strategy for the 
production of double transmembrane fragments of Y4 receptor in an isotopically 
enriched form in E. coli. The expression yields were optimized using different strains, 
different growth temperatures and various induction parameters. Even though the non-
fusion (direct expression) method worked well for the N-TM1-TM2 construct 
(comprising the N-terminal domain, the first two transmembrane (TM) helices and the  
first extracellular loop followed by a (His)6 tag) but for the other double-
transmembrane constructs without fusion partner there was no expression at all, most 
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likely because their sequence was much shorter, possibly also because the very 
hydrophilic N-terminal part was not present in these constructs. Therefore we tried 
several fusion partners like the Trp leader, KSI fusion and even the N-terminus of the 
Y4 receptor to optimize the expression yields of the double transmembrane constructs. 
The fusion protein was cleaved using chemical cleavage (CNBr cleavage) method as 
well as enzymatic cleavage using the C3 protease enzyme. Extensive detergent 
screening was performed to yield the high quality of spectra required for our analysis. 
For the N-TM1-TM2 construct with 2H, 13C and 15N labeled protein, the backbone was 
assigned almost completely in the presence of 1% DPC/6% LPPG mixed detergent 
micelles by my colleague Dr. Chao Zou, and now we are trying assign it in organic 
solvent mixture (50%TFE - water mixture) to facilitate assignments. The organic 
solvent mixtures seem appealing for membrane proteins since they give narrow line 
shapes and better resolution due to the smaller effective molecular weight of the protein 
in the absence of detergents. The mixed organic solvents systems are considered as a 
“quasi–native” membrane environment and have been validated for several membrane 
proteins by comparing its structure in the native conditions.  
 
For example, the solution NMR structure of transmembrane H+ transporting 
subunit c of the F1F0 ATP synthase in a single-phase solution of chloroform–methanol–
water (4:4:1) has also been shown to mimic that of the protein in the native 
complex[127]. But one has to be very careful in validating the relevance of the 
structure. However, it is not planned to compute the structure in the organic solvent 
mixture but to rather use the assignments made in this environment to assign the 
NOESY spectra recorded in lipids. These findings together will set the stage for the 
determination of the 3D structure of these large domains of GPCR in micelles using 
high-resolution NMR.  
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                    Chapter 3 
 
 
Expression of sCD14 (1-152) in E.coli and Pichia pastoris  
3.0 Introduction 
                Protein–carbohydrate interactions are at the heart of many important biological 
processes including signaling, recognition and catalysis. The structural details of 
carbohydrate–protein complexes examined by NMR provide site-specific information on 
the architecture, binding selectivity and plasticity of the carbohydrate-binding sites of the 
proteins. So far, structural information at atomic resolution is only available on either the 
carbohydrate receptors, or on isolated (soluble) oligosaccharides and receptor–carbohydrate 
complexes, which are not membrane associated. Significant changes occur in the 
conformation especially in the membrane water interfacial region underlining the necessity 
for the study of protein carbohydrate interactions in this environment. This project aims at 
yielding structural data on the membrane-coupled carbohydrates and to gain insight into 
interactions with their ligands. 
We have focused for our study on two systems: 
              1. Binding of sCD14(1-152) to lipopolysaccharides (LPS). 
              2. Binding of different types of polymyxins to lipopolysaccharides (LPS).  
 
3.1 LPS 
               LPS is a major component of the outer membrane of Gram-negative bacteria, 
contributing greatly to the structural integrity of the bacteria. LPS also increases the 
negative charge of the cell membrane and helps stabilizing the overall membrane structure. 
It comprises three parts:1. The O-antigen (or O-polysaccharide) 2.The core oligosaccharide 
3. LipidA. The lipidA portion of LPS inserts into the phospholipidic membrane and in 
many gram-negative bacteria consists of a  di-glucosamine diphosphate  with 5 to 7 fatty 
acid chains extending to one side of the disaccharide. The lipid A is appended to a region 
(the inner core) of 8-12 variable sugars (including the negatively charged 3-deoxy-D-
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manno-oct-2-ulosonate (Kdo) units) and 3-8 phosphate residues. To the inner core is 
covalently associated the O-antigen, an oligosaccharide chain of variable length and 
chemical composition, depending on the exact type of LPS. Lipopolysaccharides are of 
crucial importance to gram-negative bacteria, and are therefore candidate targets for new 
antimicrobial agents. 
 
 
     Figure 1: Chemical structure of E. coli Re LPS.  
                             Kdo, 2-Keto-3-deoxyoctonate ; GlcN, N-acetylglucosamine.  
 
If a wild strain of bacterium is irradiated with UV light or exposed to mutagenic 
compounds, it will mutate and LPS with shorter polysaccharide chains Ra, Rb, Rc, Rd, 
Re, etc may be formed where a, b, c, etc. designate 1st, 2nd, 3rd, etc. degree of  the 
polysaccharide length of a given LPS. Ra and Re designate the mutants with the longest 
and shortest chain lengths, respectively. The most extreme mutants are the Re mutants 
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which produce an LPS which is made up of lipidA and 3-deoxy-D-manno-octulosonic 
acid (2-Keto-3-deoxyoctonate, KDO) as the sole constituent of the core[1](Figure1). 
 
3.2 CD14 
CD14 is a myelomonocytic differentiation antigen in mammals[2]. Human CD14 
is a single-copy gene encoding two protein forms: a 50–55-kDa glycosylphosphatidyl-
inositol (GPI)-anchored membrane protein (mCD14) and a monocyte or liver-derived 
soluble serum protein (sCD14) that lacks the anchor[3]. CD14 is the lipopolysaccharide 
(LPS)-LPS binding protein (LBP) receptor, forming a multi-protein complex containing 
at least CD14, MD-2 and TLR4[4]. The crucial role of CD14 in LPS signalling has been 
confirmed with knock-out mice; CD14-deficient mice are highly resistant to septic shock 
initiated by injection of either LPS or live bacteria[5]. Both mCD14 and sCD14 are 
critical for LPS-dependent signal transduction, and sCD14 confers LPS sensitivity to 
cells lacking mCD14. Mutant sCD14 containing only the N-terminal 152 amino acid 
residues were found to have activity equivalent to the full length sCD14[6].  
 
The monomeric subunit of CD14 contains thirteen ! strands, and 11 of them, from 
!-3 to !-13, overlap with conserved leucine-rich repeats (LRRs) (Figure 2). The concave 
surface of the horse-shoe-shaped structure consists of a large !-sheet of 11 parallel and 
two antiparallel beta strands. The convex surface of CD14 contains both helices and 
loops, in no regular pattern. A large hydrophobic pocket was found on the NH2-terminal 
side. The pocket is the main component of the lipopolysaccharide-binding site. 
Dimerization in the crystal is mediated by residues in ! 13 and in the loop between ! 12 
and ! 13. Parallel !-sheets from the two monomers interact in an antiparallel fashion and 
form a large and continuous !-sheet encompassing the entire CD14 dimer[7]. CD14 is the 
primary receptor of the LPS signaling pathway, which leads to fatal septic shock 
syndrome. The structure provides evidence that different regions around the NH2-
terminal pocket contribute to LPS binding and signaling. To this end, we wanted to study 
the interaction of sCD14(1-152) with  LPS in the presence of DPC micelles. I will 
explain briefly about the attempts which were made to express sCD14(1-152) in a 
properly folded form (see Table-1). 
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Figure 2: Structure of the CD14 dimer. Two monomers of CD14 in the crystal are colored in 
green and yellow. Disulfide bridges are shown as red spheres. mCD14 is GPI anchored 
membrane protein. Soluble sCD14 lacks the GPI anchor and mutant sCD14 containing N-
terminal 152 amino acid residues sCD14 were found to have activity equivalent to the full length 
sCD14 and this construct was used for our studies. 
 
3.3 Summary of expression of sCD14 (1-152) 
3.3.1 Recombinant expression of sCD14(1-152)
 
in E.coli  
Escherichia coli is one of the most widely used host for protein expression 
because of its relative simplicity, its inexpensive and fast high-density cultivation, the 
well-known genetics and the large number of compatible tools available for 
biotechnology. Although often simple for soluble proteins, major obstacles are 
encountered in the expression of many heterologous proteins but a considerable amount 
of effort has been directed at improving the performance and versatility of this workhorse 
microorganism. We used C41(DE3) strain as the expression host for all the constructs as 
transformation with other strains like BL21(DE3) and BL21(DE3)pLysS was not 
successful. The proteins were purified from inclusion bodies under denaturing conditions. 
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The group of Jerala was able to express the recombinant CD14 and a CD14 
fragment consisting of its first 152 residues in bacterial and the yeast Pichia pastoris 
expression system. Both bacterial and yeast recombinant CD14s were able to bind 
lipopolysaccharides with high affinity by dot blot assay and native PAGE gel shift assay. 
Initially, sCD14(1-152) was produced by Jerala for NMR studies[8, 9]. Unfortunately, 
although the protein was not precipitating NMR studies quickly revealed that the protein 
was heavily aggregated and not amenable to solution NMR studies. To reduce the extent 
of aggregation we measured 
15
N-labelled sCD14(1-152) in presence of DPC micelles 
(Figure 4). Unfortunately, only a fraction of the expected signals with largely varying 
line-widths are observed, and the signal dispersion was limited.  
 
 
                  Figure 3 A: Pure CD14-His protein by SDS- PAGE analysis. 
        3 B: Western blotting of CD14-His protein with anti-human CD14 raised in mouse. 
 
We suspected that our expression product did not display correctly formed 
disulfide bonds and therefore decided to use Origami host strains. Those are K-12 
derivatives that have mutations in both the thioredoxin reductase (trxB) and glutathione 
reductase (gor) genes, which greatly enhances disulfide bond formation in the cytoplasm. 
We tried expression of sCD14(1-152) in OrigamiDE3 competent cells, which provides an 
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oxidative environment for the bacterial cytoplasm to allow formation of disulphide 
bonds, but the growth was very poor in M9 medium. 
 
 
Figure 4:  [
15
N,
1
H]-HSQC spectrum of 2 mM CD14-His  protein in 300 mM  
d38-DPC,  20 mM PO4 Buffer  pH 6.8, T=310K. 
 
We therefore decided to attach a solubility enhancing tag to the protein. Wagner 
had been able to demonstrate that such a tag both increases levels of expression but also 
stabilizes the protein in monomeric state at much higher concentrations[10]. Expression 
vectors have been designed which encode the immunoglobulin–binding domain of 
streptococcal protein G (GB1; 56 residues) linked to the N-terminus of CD14 protein. 
This fusion strategy takes the advantage of small size, stable fold and high bacterial 
expression capability of the GB1 domain to allow direct NMR spectroscopic analysis 
without the need of the removal of the fusion protein. Moreover, the resonance positions 
of GB1 are known and assigned, and can thereby be distinguished from resonances of 
CD14. This construct (pET 28a His–GB1-(SG)2CD14) again yielded aggregated protein 
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and hence was not pursued any further. The construction of functional fusion protein 
often requires a linker sequence that adopts an extended conformation to allow for 
maximal flexibility. In this construct (pET 28a-HisG(SG)6CD14) the length of the serine 
glycine linker in between GB1 domain and CD14 was increased relative to the pET 28a-
HisG(SG)2CD14 construct. We increased the length of serine glycine linker from two to 
six by adding four additional aminoacids (two serine and two glycine residues were 
added). The protein expression is good (Figure 5A and B) but it runs in the SDS gel at a 
higher molecular weight. The mass is found to be correct by MS analysis. In this 
construct also the in vitro refolding was not fruitful. 
 
 
Figure 5 A: Pure 28a-His(GS)6CD14 protein by SDS- PAGE analysis. 
B: Western blotting of CD14-His protein with anti-human CD14 raised in mouse 
 
The N-terminal 152 fragment of soluble CD14 is a truncated protein. On both ends 
of the protein it may need a soluble fusion tag to mask the exposed hydrophobic residues 
at the C-terminus of the protein in order to form a properly folded protein. We decided to 
add a C- terminal His tag to CD14. It yielded protein in the soluble fraction, but the 
[
15
N,
1
H]-HSQC revealed that only the GB1 domain was well-folded in the presence of  
300 mM DPC (Figure 7). 
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     Figure 6 A: Pure 30a-G(SG)6CD14 His protein by SDS- PAGE analysis. 
B: Western blotting 30a-G(SG)6CD14 His protein with anti-human CD14 raised in 
mouse. 
 
 
Figure 7: [
15
N,
1
H]-HSQC spectrum of 2 mM 30aG(SG)6CD14His protein. (black 
coloured peaks) overlayed with 0.3 mM GB1 protein( blue peaks) in 300 mM d38-DPC, 20 
mM PO4 Buffer  pH 6.8, T=310K. 
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Sometimes, folded states of proteins can be stabilized upon addition of their native 
ligand, and hence we added LPS, but no improvement was seen (Figure 8). A gel 
filtration chromatography preformed to check the aggregation state of the protein 
revealed that the protein eluted at a volume corresponding to the size of 110 kDa instead 
of 25 kDa while control proteins BSA and Carbonic anhydrase eluted at the expected 
volume. This indicates even though the protein was in the soluble fraction it was still in a 
highly aggregated state.     
 
 
Figure 8:  1D 
1
H NMR of  
15
N 30a-G(SG)6CD14-His protein and 
15
N 30aGB1 domain . 
 
Expression of CD14 from E.coli cytoplasmic inclusion bodies lead to the 
production of insoluble and nonfunctional protein and in vitro refolding was not fruitful 
in our case. We therefore decided to direct these polypeptides to the bacterial periplasmic 
space, with the expectation to find better conditions for proper folding, especially for the 
formation of stabilizing disulphide bond. The periplasm is a compartment where 
oxidation of thiols can occur due to the activity of the disulphide oxidoreductase (Dsb) 
system, and there are fewer proteases in the periplasm compared to the cytoplasm and 
many have specific substrates. Finally, because the periplasm contains fewer protein, 
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easier purification of the target protein is facilitated. The protein (PelB-GB1-(SG)6-
CD14) was expressed in C41(DE3) cells at low temperature (22°C) to favor periplasmic 
expression and then purified by osmotic shock protocol, whereas PelB denotes the 
signaling sequence to direct the fusion for periplasmic expression. Unfortunately, no 
CD14 protein was contained in the soluble fraction, and the mass of the protein was also 
found to be wrong. Some contaminating periplasmic protein was co-purified, but did not 
display bands in the western blot using antiCD14 antibody for the soluble fraction. The 
western blot displayed a positive reaction in the cell pellet only. The reasons for this 
failure may be as follows  
1. The osmotic shock, that releases proteins from the periplasmic space, might not 
have worked properly  
2. There could be a problem in translocation of the fusion to the periplasmic space. 
3. Since CD14 is a receptor for bacterial LPS there could be a problem of binding of 
CD14 to LPS from the cell membrane once it was released from the periplasmic 
space after the osmotic shock. In all the other constructs since it was purified 
under denaturing conditions, and the problem of binding to LPS might not be 
present under those circumstances.  
4. No purification under denaturing condition was attempted since there was no 
affinity tag for further purification. Furthermore, no attempts to solubilize the 
protein from the membrane fraction using detergents were made because once the 
CD14 binds to LPS it would be very difficult to obtain the pure CD14 without the 
LPS contamination. We introduced a His tag at the C-terminus to the above pelB 
fusion in order to allow purification under denaturing condition. Unfortunately, 
this protein also could not be refolded properly. 
 
We tried in vitro refolding for all these constructs with different buffers taking 
into consideration the following aspects: 1. Generation of the native structure requires 
both folding and concomitant formation of the correct disulfide bonds. 2. For the 
formation of proper disulphide bonds we have to provide a redox system in our refolding 
buffer to allow reshuffling of the disulphide bond. In vitro oxidation is a very slow 
process and sufficient time should be given for the formation of appropriate disulphide 
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bond. 3. Aggregation that is, formation of inactive, insoluble protein, is a major problem 
encountered upon reconstitution and to prevent this to occur low molecular weight 
additives like arginine, glutamine etc are included in the refolding buffer. 
The following table -1 summarizes my attempts to express different constructs of CD14 
in E. coli 
 
Construct name  
 
Protein Expression  details 
pET3a  
 
I CD14-His 
 
(Cloned between NdeI and 
BamH1) 
 
 
Purification :by Ni.affinity chromatography under denaturing condition 
Size : 17.78 kDa 
Yield: 40 mg /litre  
Solubility: not Soluble in  PO4 buffer; soluble in DPC   
NMR: the construct looks like an aggregated sample 
W.Blot: positive reaction with antiCD14 antibody. 
Refolding : not successful 
Other Strains:  
 Origami 2(DE3) – To promote the formation of appropriate disulphide bond 
formation we used this competent cells for expression. Transformation worked 
with commercial COM cells. Growth is fine in LB but no growth was observed 
in M9 medium  
MS results: Mass expected-17783.00 Da ; Mass obtained -17650.549 Da . 
Difference of 132.451 which corresponds to the mass of N-terminal 
Methionine (131 Da) 
  
pET30a 
 
II GB1-His  
 
(GB1- Cloned between NdeI 
and BamH1 
 
Purification: by Ni-affinity chromatography under native condition. 
Size: 7.18 kDa 
Yield: 35 mg /liter  
Solubility: Soluble in PO4 buffer and DPC   
NMR: Obtained good spectrum. Looks like properly folded protein 
W.Blot  : no reaction with antiCD14 antibodies 
MS results: Mass expected-1455.56 Da(5 times charged) ; Mass obtained -
1455.1 Da . Difference - 0.4 Da  
pET28a 
 
III His G(SG)2CD14 
GB1- Cloned between NdeI 
and BamH1  
CD14 – Cloned between 
BamHI and  EcoRI 
I have mainly used this construct for further cloning  
Purifcation :by Ni-chromatography under denaturing condition 
Result : protein aggregated upon purification and no further refolding attempts 
were made  
  
pET28a 
 
IV His G(SG)6CD14 
GB1- Cloned between NdeI 
and BamH1  
Six residues of  Serine Glycine 
linker  
CD14 – Cloned between 
BamHI and  EcoRI 
Purifcation: by Ni- affinity chromatography under denaturing condition. 
Size: 25.76 kDa 
Yield: 30 mg /liter ( based on the weight  of precipitate) 
Solubility: not soluble in  PO4 buffer and  DPC   
NMR: looks like aggregated sample 
W.Blot: positive reaction with antiCD14 antibody. 
Refolding : tried refolding similar to the pET3aCD14 construct – not 
successful  
MS results: Mass expected-25757.00 Da ; Mass obtained -25626.5 Da . 
Difference of 131.51 which corresponds to the mass of N-terminal Methionine 
(131 Da) 
 
pET30a 
 
V G(SG)6CD14His  
 
GB1- Cloned between NdeI 
and BamH1. 
Six residues of  Serine Glycine 
linker  
CD14 – Cloned between 
BamHI and  EcoRI 
 
Purification: by Ni. affinity chromatography under denaturing condition. 
Size:24.42 kDa 
Yield: 30 mg /litre  
Solubility.soluble in  PO4 buffer and  DPC   
NMR: in aqueous buffer it looks aggregated. When dissolved in DPC, a part 
of the protein resulted in a spectrum which corresponds to folded protein. But 
when comparing it to the spectrum of the GB1 domain there were no extra 
peaks corresponding to CD14.  
W.Blot: positive reaction with antiCD14 antibody. 
Refolding: not successful. 
Gel filtration: eluted at a volume corresponding to an aggregated sample 
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 MS results: Mass expected-24416.5 Da; Mass obtained -24403.3 Da . 
Difference - 13.2 Da 
.  
pET26b 
 
VII PelB-G(SG)6CD14  
 
GB1- Cloned between NCoI 
and BamH1  
Six residues of  Serine Glycine 
linker  
CD14– Cloned between BamHI 
andEcoRI. 
No His tag 
Pelb sequence cleaved in E.coli 
cell, when it is translocated  to 
the cytoplasm 
Purification: applied osmotic shock and separated the periplasmic fraction 
and then dialyzed the sample. No further purification done because that 
fraction itself did not contain any impurities. 
Size: 26.05 kDa 
Solubility: soluble in PO4 buffer.  
NMR: no NMR data were recorded for this sample, because of the negative 
reaction in the Western blot and the mass also was found to be incorrect.  
W.Blot:1) negative for the soluble periplasmic extract. 2) Positive reaction 
with antiCD14 antibody for the cell pellet after osmotic shock. 
Conclusion: the protein obtained in the soluble fraction was some periplasmic 
contaminating protein. 
MS results: Mass expected-26054.7 Da ; Mass obtained – 28161.00Da . 
Difference – 2107.00 Da. ( some contaminating periplasmic protein) 
. 
pET26b 
 
VI Pelb-G(SG)6CD14His  
 
Pelb GB1(SG)6CD14His  
 
GB1- Cloned between NCoI 
and BamH1 ;CD14 – Cloned 
between BamHI andEcoRI;C- 
Ter His Tag 
 
Pelb sequence cleaved in E.coli 
cell, when it is translocated  to 
the cytoplasm 
Purification: by Ni. affinity chromatography under denaturing condition. 
Size:27.6 kDa 
Result: Only precipitated protein from protein purification under denaturating 
conditions.  
W.Blot:  Protein precipitate gave an positive reaction  with antiCD14 antibody  
 
 
    Table 1: Summary of the different CD14 constructs in E.coli expression system. 
 
Unfortunately, no constructs of well-folded protein in non-aggregated form could 
be produced, although some of them were expressed at reasonable yield. However, the 
NMR experiments quickly revealed that the resulting fusions were either unfolded or 
highly aggregated and hence not amenable to detailed studies by NMR. For example the 
[
15
N,
1
H]-HSQC of the CD14 construct without any fusion partner except C-terminal His 
tag (Figure 4) and an CD14 construct with N-terminal GB1 fusion and C-terminal His tag 
(Figure 7) overlayed with  the properly folded GB1 domain protein spectra is shown. The 
poor spectral dispersion seen in the spectrum in Figure 4 reveals that it is most probably 
in the denatured state. In case of  the spectrum depicted in Figure 7 the [
15
N,
1
H]-HSQC 
reveals that only the GB1 domain was well-folded and that CD14 still remains in the 
aggregated state in the presence of 300mM DPC. We speculated that the failure is largely 
due to the missing folding machinery of E. coli. 
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3.3.2 Recombinant protein expression in Pichia Pastoris 
Although prokaryotic recombinant protein expression systems are often used in 
structural studies, mammalian proteins often accumulate in insoluble form. In vitro 
refolding of the protein is also not successful always. We decided to switch our 
expression host to Pichia pastoris. The Pichia expression system produces high yields of 
recombinant protein in a well-characterized, easy to manage eukaryotic host. The high 
yields with the Pichia expression system are achieved by the key factors like 1) high 
biomass. The cell density of Pichia pastoris can be 10 times greater than Sacchoromyces 
cerevesia. 2) Strong promoters –both inducible and constitutive promoters are available 
to drive high level expression. 3) Efficient secretion - recombinant proteins fused to the 
alpha factor or a native secretion signal will be directed into the medium, simplifying 
purification. Together these features give high levels of expression in a cost–effective 
microbial eukaryotic host.  
 
3.3.2.1 The pichia expression vector 
pPICZ"C is a 3.6 kb vector used to express and secrete recombinant proteins in 
Pichia pastoris. Recombinant proteins are expressed as fusions to a N-terminal peptide 
encoding the Saccharomyces cerevisiae " -factor secretion signal. The Pichia expression 
vectors take advantage of the powerful AOX1 (Alcohol oxidase) promoter and uses 
methanol to induce high-level expression of the gene of interest. The constructs integrate 
into the Pichia pastoris genome, creating a stable host that generates extremely high 
protein expression levels and can be used in any Pichia strain including X-33, 
SMD1168H, and KM71H. The CD14 gene was cloned between Xho1 site and Xba 1 site 
of pPICZ"C vector to include the alpha factor in our construct. But the CD14 gene has an 
internal Xho1 site. Site-directed mutagenesis was performed to mutate this site before 
cloning into pPICZ"C vector. The alpha factor was responsible for targeting the protein 
into the medium and this was necessary for disulfide bond formation. 
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                        Figure 9: pPICZ" plasmid  map    
 
3.3.2.2 How it works 
The host for high-level recombinant protein expression in the Pichia expression 
system is the methylotrophic yeast Pichia pastoris. In the absence of glucose, Pichia 
pastoris uses methanol as the sole carbon source. The first step in the methanol 
metabolism is oxidation of methanol to formaldehyde; this reaction generates also 
hydrogen peroxide. To avoid hydrogen peroxide toxicity, methanol metabolism takes 
place inside the peroxisome, which sequesters the toxic by-products. Alcohol oxidase has 
a poor affinity for O2 and Pichia compensates by producing the enzyme in large 
quantities. The alcohol oxidase (AOX1) promoter controls expression of alcohol oxidase, 
and is used to drive the heterologous protein expression in Pichia. Typically, 30% of the 
total soluble protein in methanol-induced cells is alcohol oxidase. 
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3.3.2.3 Experimental overview  
The following table describes the basic steps needed to clone and express the gene 
of interest in pPICZ"C vetor  
    Table-2:  Overview of pichia expression system 
 
3.3.2.4 Expression of CD14 in Pichia pastoris 
After obtaining the clone, the pPICZ"C+CD14 vector is completely linearized 
with Pme I restriction digestion enzyme which is present in the 5´ AOX1 region of the 
vector. Vector linearized within the 5´ AOX1 region will integrate by gene insertion into 
the P.pastoris host 5´ AOX1 region. The linearized vector is subjected to ethanol 
precipitation and dried which was then  transformed into the following three major strains 
of P. pastoris such as  protease-deficient SMD1163 (his4, pep4,
 
pbr), GS115 (his4+) and 
X-33
 
(wild-type), by electroporation method using freshly prepared competent cells.!
Incubate the plates for 2 to 3 days at 30°C until colonies form" Transformation resulted in 
around ten colonies with the GS115 strain and many colonies with the protease deficient 
strain SMD1163 and no colonies with X-33 strain.  
 
Around 10-20 colonies from both the strains were streaked onto fresh YPDS 
plates (Yeast extract peptone dextrose medium+sorbitol) containing two different 
Step Action 
1 
Propagate pPICZ"C by transformation into a recA, endA1 E. coli strain such as TOP10, DH5", or 
JM109. 
2 
Develop a cloning strategy and ligate the gene into one of the pPICZ "C   vectors in frame with the 
"-factor secretion signal and the C-terminal tag. 
3 Transform into E. coli and select transformants on low-salt LB plates containing 25 µg/ml Zeocin. 
4 
Analyze transformants by restriction mapping or sequencing to confirm in-frame fusion of your 
gene with the "-factor secretion signal and also with C-terminal tag if desired. 
5 Purify and linearize the recombinant plasmid for transformation into Pichia pastoris. 
6 
Transform in to the required Pichia strain and plate onto YPDS plates containing the appropriate 
concentration of Zeocin. 
7 Select for Zeocin-resistant transformants. 
8 Optimize expression of your gene. 
9 Purification of the fusion protein by affinity purification. 
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concentration of zeocin (25ug/ml and 50ug/ml) to select more effectively that they were 
pure Pichia strains with the gene of the interest. Around 10 colonies for each strain was 
inoculated into 25ml BMGH (buffered complex glycerol histidine medium) for around 18 
– 20 hrs at 30ºC (temperature and aeration are critical factors for growth of pichia 
strains). The cells were pelleted down and the pellet was resuspended into 100 -200 ml of 
BMMH (buffered minimal methanol histidine medium) medium (without dextrose) to 
give an OD600 1. Then the culture was induced with 0.5% methanol every 24 hrs and 
allowed to grow at 30ºC for 72 hrs. 1ml of the expression culture was transferred to 
analyse expression level every 24 hrs. At the end of 72hrs, cells were then centrifuged, 
the supernatant was separated. Proteins secreted into the medium should be usually >50% 
homogenous and would require some additional purification. Since the expression level 
was very low, they are concentrated by TCA precipitation/ammonium sulphate 
precipitation. In most of the clones, no precipitate was obtained with the culture 
supernatant. In few, small amount of precipitate was obtained and the protein expression 
was checked by western blot (Figure 10) since I could not detect any expression by SDS 
PAGE electrophoresis.  
 
 
Figure 10:  Western blotting to check the clones for CD14-His protein expression  
in  Pichia strains with anti-human CD14 raised in mouse 
 
Even after screening hundreds of colonies no clones with optimal expression of 
CD14 could be detected. (In very few clones expression could be detected by western 
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blot). This low expression level will not be of any help for our structural studies by NMR. 
The major reasons for the no/low expression could be that the protein is not secreted into 
the medium. But I have checked few of the cell pellets also. But I didn’t see the 
expression of the protein. May be the protein is hyperglycosulated so that it cannot pass 
through the secretion pathway. Other potential reason could be, since the protein is 
excreted into medium there may be proteolysis of the protein or there is some problem in 
incorporation of our target gene into pichia genome or premature transcriptional 
termination of the target gene. Then we decided to move on to the next system, which 
was mainly focused to obtain experimental data on the LPS-Polymyxin complex, thereby 
allowing a detailed understanding of the interacting moieties. 
 
3.3.2.5 Outlook 
 Since this construct sCD14 (1-152) does not give a properly folded protein, it is 
good to try the expression of constructs which are longer or shorter than this construct. It 
is worth trying making a series of peptides and screen them to asses their binding affinity 
for E.coli Re-LPS. By using a very soluble tag on both ends which then can be cleaved 
by using C3 protease or TEV protease enzymes could also help for the production of 
properly folded protein. It is good to try expression of other key players of LPS signaling 
pathway like BPI (bacterial permeability increasing protein) to study their interactions 
with Re-LPS. It was proved that the amino-terminal region of BPI,(BPI1–197, rBPI23) 
retains full LPS-binding activity[11]. 
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                    Chapter 4 
 
 
Interactions of lipopolysaccharide and polymyxin studied 
by NMR spectroscopy 
4.0 Introduction 
Antimicrobial peptides are evolutionarily ancient weapons to evade the harmful 
bacteria and they play a fundamental role for the successful evolution of complex 
multicellular organisms. Many of the host defense peptides, which have antimicrobial 
activity, are also able to bind to and neutralize LPS; however, these two activities do not 
necessarily correlate. In the light of occurrence of bacterial strains with multiple 
resistances against most antibiotics, antimicrobial peptides that interact with the outer 
layer of gram-negative bacteria, such as polymyxin (PMX), have recently received 
increased attention. Polymyxins  a group of cyclic polycationic polypeptides with a long 
hydrophobic tail isolated from various strains of Bacillus polymyxa and related 
species[1]. They are selectively toxic for Gram-negative bacteria due to their specificity 
for the lipopolysaccharide molecule which forms the main constituent of the outer 
membrane of gram-negative bacteria.  
 
LPS is  known for its toxic effects. Septic shock is an overexaggerated host 
immune response to the presence of infection, particularly to LPS and is a significant 
cause of morbidity and mortality in all hospitalized patients. Polymyxin B (PMX-B) is 
one of the most efficient compounds for the treatment of septic shock, due to its ability to 
bind and detoxify bacterial lipopolysaccharide. Here we present a study of the 
interactions of PMX-B, -E and -M with lipopolysaccharide (LPS) from a deep-rough 
mutant strain of E. coli. A method for efficient purification of biosynthetically produced 
LPS using RP-HPLC in combination with ternary solvent mixtures was developed.  
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Polymyxin M (Mattacin) was produced biosynthetically from Paenobacillus 
kobensis M. LPS was incorporated into a membrane model, dodecylphophocholine 
(DPC) micelles, and its interaction with polymyxins was studied by heteronuclear NMR 
spectroscopy. Data from chemical shift mapping using isotope labelled LPS or labelled 
polymyxin, as well as from isotope-filtered NOESY experiments, highlight the mode of 
interaction of LPS with polymyxins. Using MD calculations in explicit water the 
complex of LPS with PMX-B in the presence of DPC micelles was modelled using 
restraints derived from chemical shift mapping data and intermolecular NOEs. In the 
modelled complex the macrocycle of PMX is centered around the phosphate group at 
GlcN-B, and additional contacts from polar side chains are formed to GlcN-A and Kdo-
C, while hydrophobic side chains penetrate the acyl chain region. 
 
 
Figure 1: Chemical structures of LPS from the D31m4 E. coli strain (1), the two model 
compounds for LPS (2 and 3) and PMX-M (4). Note that in PMX-B residue D-Leu-6 is replaced 
by D-Phe and Thr-7 is replaced by Leu, and in polymyxin-E Thr-7 is replaced by Leu. In the text, 
the glycosidic residues of LPS are identified with the letters A-D, starting from the far right GlcN 
residue. 
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4.1 Experimental procedures 
4.1.1 Materials  
15
NH4Cl was purchased from Spectra isotopes (Columbia, USA), perdeuterated 
DPC-d38 (99%-d), and D2O were ordered from Cambridge isotope laboratories 
(Andover, Massachusetts, USA). Methyl-5-doxylstearic acid was bought from Aldrich 
(Buchs, Switzerland). The Re-LPS producing strain D31m4 was purchased from the E. 
coli genetic resource center, New Haven. The PMX-M producing strain Paenibacillus 
kobensis M was obtained from Prof. J.C. Vederas and PMX-B and -E were purchased 
from Sigma Aldrich laboratories. 
 
4.1.2 Production of 
13
C-labelled LPS from the E. coli strain D31m4  
Cells from the D31m4 strain of E. coli were grown at 37
°
C to an OD of around 
1.0 at 600 nm on minimal medium M9 using 4 g 
13
C glucose and 1 g 
15
N ammonium 
chloride supplemented with 100 mg of Trp, His and Pro per liter. After harvest cells were 
resuspended in 50 ml of ice-cold water and pelleted down. To the pellet a minimum 
amount of cold water was added such that a thick paste was formed. LPS together with 
other components was precipitated through addition of 90 ml ice-cold methanol and 
centrifuged at 8000g. The pellet was resuspended in 90 ml ice-cold acetone, 
homogenized and centrifuged again, followed by another acetone washing step. The 
lyophilized cells (ca. 0.7 g) were taken up in 50 ml of a phenol:chloroform:petroleum 
ether (4:10:16; v:v) solvent mixture and centrifuged at 9200g, after which most of the 
LPS was contained in the supernatant. The remaining pellet was extracted once more to 
increase the yield in LPS. The supernatant was concentrated under a nitrogen stream and 
2 ml of water were added dropwise to the concentrate. A waxy precipitate was formed 
followed by three cycles of washing with methanol and subsequent centrifugation. 
Thereafter the pellet was dried and lyophilized, after which it could only be 
resuspended/dissolved in water using repetitive additions of small amounts of water 
followed by sonication. Solubilization was improved upon adding aqueous 0.1M EDTA 
in the first portions. The resulting solution was centrifuged at 200000 g overnight and 
then lyophilized.  
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The lyophilized pellet after resuspension in mixture of solvent A 
(methanol:chloroform:water 57:12:31 v/v/v), and aqueous EDTA was directly loaded 
onto the HPLC column. For optimal purification of LPS a gradient system involving 
ternary solvent mixtures was used consisting of solvent A in 10mM NH4Cl and 
methanol:chloroform (29.8:70.2 v/v, solvent B) in 50mM NH4Cl. LPS (6 mg) was 
dispersed in a two phase system formed from 0.8 ml of solvent A and 0.2 ml of 0.1 M 
aqueous EDTA pH=7 and loaded directly onto the RP-C8 column. Chromatographic 
separation was achieved using the following gradient of solvents A and B: 2 CV of 2% B, 
3 CV (2-17% B), 3.5 CV (17-27% B). UV detection was impossible and hence fractions 
were lyophilized and their content checked by MALDI-TOF using 6-aza-2-thiothymine 
as the matrix. Elution of the desired LPS occurred around 20-23% of solvent B. 
 
4.1.3 Production of 
13
C,
15
N-labelled PMX-M from P. kobensis M  
The producer strain, Paenibacillus kobensis M, was grown aerobically at 30°C on 
tryptic soy agar (TSA). A 1-liter batch of M9 medium was inoculated with a 10-ml P. 
kobensis M preculture (1% inoculum). After a total growth time of 16–24 h at 30°C with 
shaking (200 rpm), the cells were removed by centrifugation (1 hr, 10,000 rpm) and the 
supernatant was then passed through a Amberlite XAD-16 column. After washing with 
30% ethanol, active peptide was then eluted with 70% isopropanol, which was adjusted 
to pH 2 with 12N HCl. All fractions were assessed for antimicrobial activity using a well 
plate assay. The contents of the active fraction were applied to a Superdex peptide 10/300 
column (Amersham Biosciences). Fractions were collected for 3 column volumes with 
pure MilliQ Water and each assayed for activity. All active fractions were pooled, 
concentrated and applied as 20% isopropanol solutions to C18 reverse-phase HPLC. 
Complete purification required two separate steps of C18-HPLC. The first separation 
used a gradient of water/isopropanol gradient (0.1% trifluoroacetic acid), from 20% to 
50% isopropanol, and the second step a water/methanol gradient (0.1% trifluoroacetic 
acid), from 45% to 85% methanol. PMX-M eluted at around 55%. Finally, 8 - 10 mg of 
pure PMX-M was obtained as slightly yellowish powder from a 1-liter culture and its 
chemical nature verified by ES1-MS (exp. mass: 1224.73Da, theoret. mass:1223.57 Da). 
During all steps of expression and purification antimicrobial activity was monitored by 
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inhibition of growth of an indicator strain. Agar plates were prepared by inoculating 
molten TSA (40 g/liter) with a culture of the indicator organism E. coli  (1.0% inoculum). 
Small wells (app 4.6 mm diameter) were made in the seeded agar plates and 50-ml of 
filtered culture supernatant were added to the wells. Plates were incubated at 30°C, and 
the growth of the indicator organism was visible after approx.3 h[2]. 
 
4.1.4 NMR spectroscopy  
LPS samples used in this work contained approx. 1mM LPS, 300 mM d38-DPC in 
40 mM d13-MES D2O buffer pD=5.8. Interaction studies with PMX were performed in 
acetate buffer in D2O or H2O/D2O 9/1 pH=4.4. All spectra were recorded on Bruker AV-
600 or AV-700 NMR spectrometer at T=310K. Proton and carbon chemical shifts were 
calibrated to DSS, and nitrogen shifts were referenced indirectly to liquid NH3[3]. The 
spectra were processed using the Bruker Topspin2.0 software and transferred into CARA 
[4] or SPARKY[5] programs for further analysis.  
 
For chemical shift assignments of 
13
C,
15
N-labeled LPS 2D versions of 3D double- 
and triple-resonance experiments were recorded. In general, experiments used coherence 
selection schemes via pulsed-field gradients[4] and sensitivity-enhancement building 
blocks[6, 7] whenever possible. For assignments of the carbon spin systems in the lipid 
chains and the sugar units (H)CCH experiments recorded with 4 and 12 ms DIPSI-2 C-C 
mixing cycles were used. Linkage of the lipid chains onto the glucosamine parts of lipid 
A was achieved via correlations with the amide nitrogens using HNCA and HN(CO)CA 
experiments. To distinguish the two Kdo units key NOEs derived from a 
13
C-resolved 
NOESY were exploited. Assignment of all resonances of polymyxin was done using 
HN(CO)CACB, HNCACB[8] and (H)CCH experiments[9, 10] analogous to the 
procedure used for proteins. Because of the small size of the peptide 2D versions were 
recorded with a total of less than 12 h measuring time for acquiring all spectra. 
Assignments of polymyxin-B and –E were based on assignments from PMX-M adjusted 
by using additional 2D heteronuclear spectra. In the spin label experiments, a 0.5 mM 
solution of LPS was separated into two aliquots, and to one of these 5-doxylstearate 
methyl ester was added so that the final concentration corresponded to approximately one 
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spin-label per micelle. Signal intensities from the two corresponding constant-time 
[
13
C,
1
H]-HSQC were extracted and the ratio of signal intensities from the samples with 
and without spin label was calculated.Measurements of interactions between LPS and 
PMX by chemical shift mapping observing LPS resonances utilized a 350 mM solution 
of 
15
N,
13
C Re-LPS and equimolar unlabelled peptides. Chemical shift changes in PMX-M 
were monitored in 200 mM solutions of 
15
N,
13
C -labeled  PMX-M and equimolar 
unlabelled Re-LPS.  
 
4.1.5 Molecular dynamics calculations  
All calculations were preformed within the program GROMACS [11]. Briefly, 
coordinates of LPS were adapted from the pdb entry 1QFF and coordinates of polymyxin 
B were built using the program Ghemical[12]. Parameters and topologies of PMX-B and 
LPS as well as partial charges of PMX-B for GROMACS were established based on data 
from PRODRG server[13] and the GROMOS 53a6 forcefield[14]. Partial charges of LPS 
were assigned for a protonation state corresponding to experimental conditions of pH by 
the MPEOP method[15, 16]. Parameters for DPC were derived from values for DPPC 
from the GROMOS force field library.  
 
A detailed description of the methodology persued can be found in the Supp. Mat. 
Briefly, the system was prepared as follows: i) An initial complex between LPS and 
polymyxin B was prepared and equilibrated in the presence of a DPC micelle. ii) A set of 
simulated annealing calculations was performed yielding 450 structures. The DPC 
molecules were explicitly included in the system, water molecules were substituted by 
implicit solvent and the dominant NOE-derived upper distance limits were included 
(force constant was set to 1000 [kJ mol
-1
 nm
-2
]). iii) Those structures were selected, 
which displayed best agreement with the chemical shift mapping data. iv)These were 
then equilibrated with explicit solvent and subjected to further refinement and analysis. 
The latter included an assesment of the stability of the MD trajectory and a comparison of 
the average intermolecular distances with chemical shift mapping data.  
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4.2 Results 
4.2.1 Production and purification of 
13
C-labeled LPS 
  E. coli strains from the deep rough E. coli mutant D31m4 were isolated from the 
membrane fraction of cells grown on minimal medium containing 
13
C-glucose and 
15
N-
NH4Cl as the sole carbon and nitrogen sources, respectively. After PCP extraction and 
further purification using published protocols[17] the yield was ca. 129 mg/l of culture. 
Remaining impurities were removed by RP-HPLC using a ternary solvent mixture. In this 
procedure the solvent system was carefully adapted to form a single phase over the whole 
gradient range of solvent A (methanol: chloroform:water) and solvent B 
(methanol:chloroform) at RT. Importantly, any mixture of these two solvent systems is 
relatively close to a two-phase system, and this condition proved to have favorable 
properties for dissolving LPS. MALDI-TOF spectra of LPS before and after this HPLC 
purification step are depicted in Fig. 2. Sufficient quantities (40 mg) of chemically pure 
LPS for the NMR studies could be produced from 1 L of culture using this protocol. As 
demonstrated in Fig. S4 in the Supp. Mat. this method is capable of separating 
pyrophosphate from the monophosphate derivatives. 
 
 
Figure 2: Comparison of the MALDI-TOFF MS spectrum of commercial LPS with LPS from the 
deep rough D31m4 E. coli strain purified by the protocol that includes an additional HPLC 
purification step. 
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4.2.2 Assignment of LPS and polymyxin resonances 
Chemical shift mapping[18] or NOE-based methods[19] can be used to study 
biomolecular interactions (see also[20-22]). Both methods potentially deliver information 
on interacting moieties but require assignments of chemical shifts. The best chemical 
shift dispersion is usually available in heteronuclear shift correlation spectra (e.g. 
[
15
N,
1
H]-HSQC or [
13
C,
1
H]-HSQC spectra). Importantly, these experiments still work 
well in the presence of the increased line widths that are usually present in systems that 
are stably anchored into phospholipids micelles. In addition, as was unfortunately the 
case in some of our applications, additional exchange broadening occurred upon complex 
formation. To probe integration of LPS into DPC micelles and to study its interaction 
with peptides we decided to label it with 
13
C and 
15
N isotopes and use the corresponding 
HSQC spectra for chemical shift mapping. 
  
To assign all signals in the constant-time [
13
C,
1
H]-HSQC spectrum[23], 3D 
(H)CCH-TOCSY spectra[9, 10] served for assignment of spin systems (Fig. 3). The C,H-
plane of the HNCA[6, 24] and HN(CO)CA[24] experiments were used to establish scalar 
connectivities between terminal carbons of the fatty acid chains and C-2 of the 
glucosamine moieties. Hydroxymyristoyl (HM) can be distinguished from 
lauroxymyristoyl (LM) and thereby helps to differentiate between GlcN-A from GlcN-B 
(see legend of Fig. 1). Due to chemical shift degeneracies it was impossible to assign 
chains of the fatty acids (myristoyl of myristoxy-myristoyl and lauroyl of 
lauroxymyristoyl). The two Kdo units were linked and thereby distinguished from each 
other using several key NOEs in the 3D 
13
C-NOESY spectra.  
 
The unique chemical shifts of the C3 moiety of Kdo is located in a region 
separated from all other sugar resonances, and was used as a starting point for sequential 
assignment. Only the methylene group C3 of Kdo-C is expected to receive an NOE from 
H(C6) of GlcN-B. This assignment was additionally supported by the fact that H(C6) and 
H(C7) of Kdo-C displayed an NOE to H(C3) of both Kdo units, which is unlikely to be 
the case for H(C6) of Kdo-D. The 
1
H,
13
C and 
15
N chemical shifts of LPS in DPC micelles 
are reported in Table 1. 
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Figure 3: Assignment of 
13
C spin systems of a short stretch contained in Kdo-D from LPS using 
(H)CCH-TOCSY spectra. On the right the constant-time [
13
C,
1
H]-HSQC spectrum is shown, in 
the middle a strip from the (H)CCH TOCSY taking at the proton frequency of H-(C4) of Kdo-D. 
  
4.2.3 Topology of LPS and polymyxin insertion into the DPC micelle  
To probe whether LPS properly inserts into the DPC micelles, and whether the 
sugar moieties really protrude into the aqueous phase, the micelle-integrating spin label 
methyl 5-doxylstearate was used. The paramagnetic moiety of the spin label resides in the 
headgroup region[25, 26], and signal reductions in the proton-carbon correlation maps 
indicate proximity to the water-micelle interface. The results from the spin-label 
experiment are depicted in Fig. 4. Strongest attenuations of signals are observed for C,H 
moieties of terminal acyl chain carbons, that are close to the GlcN sugars. Much less 
pronounced attenuations are observed for signals from the GlcN moieties, and the Kdo 
units are essentially not affected. The data demonstrate that LPS inserts into the DPC 
micelles such that the amide moieties of LPS are located in the headgroup region, the 
acyl chains are inserted into the micelle interior, and the carbohydrate units are exposed 
on the surface of the micelles. We additionally probed for the topology of the polymyxin-
micelle complex using the micelle-integrating spin-label methyl 5-doxylstearate as 
described in the previous section. Notably PMX-B, -E and -M differ only for residues in 
position 6 and 7 (see legend of Fig.1). Largest attenuations were observed for the amide 
moieties of the first residue, and for residues 6 and 7, the latter two present hydrophobic 
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or aromatic residues (Table S11), revealing that polymyxins are attached via the N-
terminal lipid chain and the apolar residues to the micelle. 
 
                    
Figure 4: Left: Results from the spin-label experiments displayed on the structure of LPS. The 
size of the sphere is proportional to the remaining signal in the proton-carbon correlation map. 
Because signals from ends of the fatty acid chains are not resolved in the spectra, no encoding is 
shown for these atoms. Right: Sketch of LPS from the D31m4 strain when inserted into DPC 
micelles. The phospholipid headgroups are depicted as grey spheres. 
 
4.2.4 Interactions of LPS with various types of polymyxins  
Studies of interactions of LPS with polymyxin were performed using chemical 
shift mapping and isotope-filtered NOESY experiments. We initially used very simplified 
model compounds of LPS derived from a-(D)-glucose, that lack Kdo and the second 
glucosamine units (Fig.1). Considering the proposed importance of phosphate moieties 
for binding it was not surprising that compound 3 did not display any interactions with 
PMX-B, but also compound 4, that contains the presumably important phosphate group, 
did not cause any changes in the spectra, indicating that the Kd is (much) larger than 
1mM. 
 
The [
15
N,
1
H]- and the [
13
C,
1
H]-HSQC spectra of PMX-M revealed large changes 
(vide infra). The chemical shift changes of LPS carbon and proton frequencies upon 
adding PMX-B,-E or -M are mapped onto the structure in Fig. 5. In general, the largest 
chemical shift changes of LPS resonances were observed for all observable atoms of 
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GlcN-B. Interestingly, resonances from C1 and C2 of GlcN-A were affected only very 
little (Fig. S3A and S3C). In addition, resonances from Kdo-C display significantly larger 
changes than those of Kdo-D, with C-3 of Kdo-C being shifted by the largest extent (see 
Fig. S3F). Moreover, large changes in chemical shift are observed for the alpha (Fig. 
S3G), beta and gamma (Fig. S3H) positions of the fatty acid chains, in particular for 
those of HM2 (note that the second branch of MM and LM cannot be assigned due to 
spectral overlap). The Ca change for HM1 is less pronounced. The alpha position of HM4 
was apparently more affected than of HM3. The chemical shifts changes on the beta 
position were smaller and clear only for HM4.  
 
A comparison of chemical shift changes of LPS between its complexes with 
PMX-B, PMX-E and PMX-M may serve to identify differences in their binding modes. 
Chemical shift changes are almost identical at positions C-4, C-5 of GlcN-B as well as on 
position C-3 of Kdo-C for PMX-B and PMX-E (Fig. S3E and S3F), and very similar 
changes occur for the alpha position of HM2. We suspect that these regions are in contact 
with the conserved parts of polymyxins. However, significant differences were observed 
for C-3 of GlcN-B and moderate differences can be seen at positions of C-3, C-5 and C-6 
of GlcN-A and at position C-1 of GlcN-B (Fig. S3B). Addition of PMX-M results in line-
broadening for resonances of C-4 and C-5 of GlcN-B, as well as for C-3 of Kdo-C, and in 
a chemical shift difference for C-6 of Kdo-C. We address this observation to a slightly 
different binding mode of PMX-M, which results in different contacts to Kdo-C.  
 
 Interactions between LPS and polymyxin were additionally detected in 
heteronuclear spectra when 
13
C,
15
N-labelled PMX-M was mixed with unlabeled LPS. 
Unfortunately, very broad lines and multiple sets of resonances were detected in the 
[
15
N,
1
H]-HSQC of polymyxin-M in presence of LPS indicating the presence of exchange 
processes. Moreover, the fact that the signals were shifted considerably and, even more 
importantly, the presence of very broad line precludes detailed assignment. Even when 
changing pH or adding other detergents such as SDS we have not been able to achieve 
conditions that result in spectra of sufficient quality. Considering that interactions 
between LPS and polymyxin are suggested to be electrostatic in nature[27], we decided 
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to reduce the strength of the interaction by adding small amounts of divalent metal ions. 
When adding PMX-B, -M or –E in the presence of Ca
2+
 or Mg
2+ 
we noticed slight 
precipitation. In the presence of 20 mM MgCl2 a good-quality [
15
N,
1
H]-HSQC was 
obtained, and the peak positions are close to those in the absence of LPS. Fortunately, 
linewidths in the [
13
C,
1
H]-HSQC spectra are smaller such that interactions can be directly 
detected by shift mapping methods.  
 
 
Figure 5: Changes in 
1
H and 
13
C chemical shifts of resonances from LPS when adding 
PMX-B (A), PMX-E(B) and PMX-M(C). The size of the spheres is proportional to the observed 
differences. Deviations of peak positions were extracted from the [
13
C,
1
H]-HSQC spectra and 
computed according to !"=sqrt((!" C)
2
+(10X!" 
1
H)
2
. Those atoms that are exchange-broadened 
beyond detection are depicted by green transparent spheres 
 
The results are summarized in Table S3, and shall only be briefly summarized 
here: largest chemical shift changes occur for Ca resonances of residues 4, 5, 6, 8 and 9 
of polymyxin-M, the members of the macrocyclic ring. Interestingly, smaller differences 
were observed for resonances from the lipid chain or from Dab-1, Thr-2 or Dab-3. The 
fact that only residues from the macrocycle experience large changes, and the 
observation, that the changes in the macrocycle occur at certain but not in all positions, 
indicates that the heptapeptide ring of PMX binds in a rather well-defined manner to 
LPS. In addition to chemical shift mapping we have also conducted isotope-filtered 
NOESY experiments, in which 
13
C-labeled LPS was mixed with unlabelled PMX-B, -E, 
so that the spectra only contain intermolecular NOEs (see Table 2). Interestingly, in the 
case of PMX-B, NOEs between side chain protons of Phe-6 or Leu-7 and the lipid chains 
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of LPS are detected, supporting the results from the shift mapping data. In particular, a 
number of NOEs between protons of the p-system of Phe-6 and the lipid chains are 
observed, in particular to Cg and Ca of HM3. In the case of PMX-M position 7 is 
occupied by the polar Thr residue. The fact that PMX-B or PMX-E form more contacts 
with LPS that involve side chains of residues 6 and 7 indicates that the hydrophobic 
nature of this side chain may be important for orienting polymyxin in the complex with 
LPS. 
 
To obtain a first picture of the complex formed between LPS and PMX-B we 
have performed a MD calculation in which LPS was docked to PMX-B using NOE-
derived upper distance limits (Fig. 6) in explicit water and in the presence of a DPC 
micelle. In the complex backbone amide moieties of the peptide macro-cycle form 
contacts with the phosphate group of GlcN-B. Residues from one hydrophobic site - D-
Phe-6 and Leu-7 - are in proximity to the fatty acid chains of LPS. Leu-7 makes 
additional contacts with the GlcN-B moiety. The amino group of Dab-8 is involved in 
electrostatic contacts with the phosphate group at GlcN-A. Amino groups of Dab-9 and -
3 are possibly forming electrostatic interactions with the carboxyl group of Kdo-C.  
 
The backbone of residues Dab-1 to Dab-3 is located in the acyl region of the 
branched fatty acids originating from GlcN-B. To summarize most contacts in this model 
structure are made with GlcN-B and the adjacent atoms of GlcN-A, as well as with parts 
of Kdo-C, and the model structure is supported by the chemical shift mapping data. In 
addition, interacting moieties of LPS that make contacts common with all polymyxin 
variants are in contact with conserved parts of these peptides (residues 1 to 4 and 8 to 10), 
while those sites that differ in their interaction with the different peptides form contacts 
with non-conserved residues. 
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Figure 6: Left: Structure of the PMX-B—LPS complex as derived from the MD calculation. The 
covalent structure of PMX-B is depicted in yellow. Heavy atoms of LPS are drawn as van der 
Waals spheres, with lipid chains colored in ice-blue, GlcN carbons in dark blue, Kdo carbons in 
orange, and phosphorous atoms in white. DPC molecules are indicated by thin lines. Residue 
numbers of PMX-B are placed close to the corresponding sidechains. Right: Representation 
showing only bonds of LPS and PMX-B. PMX-B is again drawn in yellow, with amino nitrogens 
of DAB residues in blue, while LPS bonds are drawn in ice-blue (lipids) or green (sugar parts). 
 
4.3 Discussion 
Sepsis caused by gram-negative bacteria is a serious source of mortality in many 
clinical cases, accounting for approximately 200,000 deaths in the US annually (see 
David[28] and references therein). The primary trigger for sepsis was identified as 
endotoxin, and endotoxin-neutralizing agents are therefore valuable therapeutics. PMX-B 
is considered as the “gold-standard” for LPS-sequestering agents. It is a highly cationic 
decapeptide containing six diaminobutyric acid (Dab) residues, a macrocylic ring 
involving residues 4 to 10, and an acyl chain coupled to the N terminus. In this work we 
have used polymyxins of different types to study interactions with LPS from the deep 
rough mutant E. coli strain. To our knowledge this work for the first time presents 
experimental data on the interacting moieties in a membrane mimetic environment.The 
conformation of LPS-bound PMX-B and -E was elucidated previously using transfer-
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NOE techniques by Pristovsek. [29] Therein, the LPS-bound peptides assume envelope-
like bent cycles that separate the two hydrophobic residues 6 and 7 from the charged Dab 
residues 4, 5, 8 and 9. The conformation from the transfer-NOE derived structure was 
then docked onto a lipid A model. In the resulting complex the lipid chain forms transient 
contacts with acyl chains A and B from lipid A. Moreover, the two phosphate groups are 
in close contact with the g-NH2 groups of Dab residues 1/5 and 8/9. The data highlight 
the importance of electrostatic interactions between phosphate groups and amino groups 
of polymyxin as well as hydrophobic interactions of the lipid chains with Phe or Leu 
residues. Martin et al. have studied the structure of LPS-bound PMX-M [2], which 
displayed a chair-like confor-mation, in which the side chain of Dab-4 or -8 and Leu-6 or 
Thr-7 point into the opposite directions in a fashion similar to that proposed for PMX-B 
and –E [2]. Pristovsek determined the structure of a LPS-bound synthetic fragment of the 
LALF protein [30] revealing a hairpin-type fold again characterized by spatial separation 
of hydrophobic and cationic residues. In another study Bhunia et al. investigated binding 
of melittin to LPS micelles [31]. Cationic residues have also been postulated to critically 
contribute to binding of LPS to proteins such as MD-2 [32] or FhuA [33, 34].  
 
Herein we set out to determine interactions between LPS and polymyxins in more 
detail. Considering that interacting chemical moieties have not been experimentally 
identified with confidence so far we reasoned that these studies should use chemically 
defined environments in a setup that mimics natural conditions. To achieve chemical 
homogeneity we used biosynthetic LPS to facilitate isotope labeling. LPS from the deep 
rough mutant of E. coli presents a simple system containing all chemical moieties 
believed to be important for the interaction. LPS in gram-negative bacteria is embedded 
in a phospholipid bilayer, and therefore the system was studied in DPC micelles. It could 
be shown that LPS properly inserts into the micelle via integration of the acyl chains into 
the micelle interior, and the GlcN and Kdo portions are fully exposed in the aqueous 
compartment. LPS from the same E. coli strain has been assigned previously using 
homonuclear 2D NMR techniques.[35, 36].  For the purpose of the study the 
development of chromatographic techniques for LPS was very important that allow 
studying the unmodified LPS. Using 
13
C isotope labeling we have been able to fully 
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assign LPS while integrated into DPC micelles. In the latter environment spectra with 
reasonable line widths and resolution can be recorded, allowing the study of interactions 
with polymyxin in sufficient detail. Our experimental data now confirm the model of the 
PMX-B LPS complex, proposed by Pristosek et al. [29] In their complex the macrocycle 
of PMX-B covers the GlcN disaccharide unit, and hydrophobic sidechains of polymyxin 
form contacts with the lipid chains from LPS, and a similar complex topology was 
proposed for the interaction of LPS with PMX-M [2]. Such an arrangement requires a 
reasonable separation of hydrophobic and hydrophilic side chains in polymyxin, so that 
hydrophobicity matching between polymyxin and LPS can help to orient it. It should be 
noticed that LPS in its natural environment is embedded in a phospholipid environment. 
Hydrophobicity matching of moieties of polymyxin with the corresponding parts of LPS 
in that environment is amplified, because similar requirements influence interactions of 
polymyxin with the phospholipids.  
 
It is therefore of little surprise that Leu or Phe residues, for which favorable 
energies for partitioning into the membrane interior or the water-membrane interfacial 
region have been measured [37], form contacts with the a, b, and g acyl chain carbons of 
LPS. In PMX-M position 7 is occupied by Thr, a much more polar residue. According to 
the data from this work, PMX-M may be slightly differently oriented, possibly forming 
some-what stronger contacts to the Kdo units. In the PMX-M—LPS complex 
electrostatic or polar interactions involving the Dab residues of polymyxin and the 
carbohydrate moieties of GlcN-B or Kdo-C and to a smaller extent, Kdo-D dominate, 
while in the case of PMX–B or –E additional hydrophobic interactions from sidechains of 
Leu-7 are likely to contribute to binding. While our work confirmed the contacts made 
with moieties of the GlcN units proposed in the model complex from Pristovsek [29] it is 
different in that it emphasizes the importance of contacts to Kdo units, in particular to 
Kdo-C.  
 
Different models have been proposed for the mechanism of action of polymyxin. 
Shai et al. have proposed that binding of polymyxin to the core part of LPS, lipid A, 
results in disturbance of the LPS-phospholipid bilayer destroying the integrity of the 
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outer membrane, and possibly leading to pore formation [38, 39]. The orientation of LPS 
in the phospholipid micelles as measured using spin labels has demonstrated that the 
carbonyl group region of the LPS lipid chains is located in the headgroup region. Binding 
of polymyxin to LPS therefore places the amphiphilic peptide in a similar position 
compared to binding to pure phospholipid micelles. Accordingly, similar mechanisms for 
membrane permeabilization are plausible.  
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Tables 
Table 1: Carbon and proton chemical shifts of LPS from the deep-rough mutant of E. 
coli, 1mM LPS in 300mM DPC, pH= 5.8; 40mM MES, T=310K 
 
Sugar moieties 
 GlcN-A GlcN-B Kdo-C Kdo-D 
H 1 5.346 4.636   
H 2 3.912 3.854   
H 3 5.136 5.066 1.879 2.079 
H 3   1.929 1.707 
H 4 3.675 3.872 4.066 4.000 
H 5 4.037 3.644 4.067 3.961 
H 6 4.022 3.403 3.644 3.547 
H 6 3.828 3.722   
H 7   3.866 3.909 
H 8   3.848 3.913 
H 8   3.591 3.687 
     
C 1 95.56 104.41   
C 2 54.07 55.57   
C 3 75.42 76.07 35.32 36.61 
C 4 68.62 74.81 70.57 68.04 
C 5 73.36 76.23 66.51 68.39 
C 6 70.53 64.76 73.60 74.53 
C 7   71.90 71.83 
 
 
Lipid chains 
 LM MM   
 L HM2 M HM1 HM-4 HM-3 
HA 2.306* 2.562 * 2.643 2.312 2.383 
HA  2.585 * 2.670 2.366 2.433 
HB 1.563* 5.283 * 5.128 3.890 3.910 
HC 1.210* 1.519 * 1.548 1.303 1.383 
HC  1.559 * 1.601 1.380 1.471 
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HD     1.281 1.392 
       
CA 36.51* 43.15 * 41.10 45.38 44.18 
CB 27.34* 72.37 * 72.50 69.77 69.61 
CG 31.50* 37.18 * 36.25 38.30 40.30 
CD     27.98 28.08 
   * Resonances that cannot be distinguished between L and M because of overlap 
 
Table 2: Intermolecular NOEs as detected in 
13
C-filtered NOESY experiments performed 
with 
13
C-labelled LPS and unlabelled PMX-B and –E. 
 
Polymyxin-B 
HM4-H(C!) Leu7-H"1 w  HM3-H(C#) Phe6-H$ w 
HM4-H(C%) Leu7-H"1 s  HM3-H(C") Phe6-H" s 
HM4-H(C") Leu7-H"1 w  HM3-H(C") Phe6-H$ s 
HM4-H(C") Leu7-H"2 s  HM4-H(C") Phe6-H" s 
HM4-H(C#) Leu7-H"2 s  HM4-H(C") Phe6-H$ w 
HM4-H(C%) Leu7-H"2 s  HM1-H(C%) Phe6-H" w 
HM4-H(C!) Leu7-H"2 s  HM4-H(C%) Phe6-H" w 
HM4-H(C%) Leu7-H# s  HM3-H(C#) Phe6-H" s 
HM4-H(C%) Leu7-H%2 s  HM4-H(C!) Phe6-H" s 
HM4-H(C%) Leu7-H%1 w  HM4-H(C#) Phe6-H" s 
HM3-H(C%) Phe6-H%2 w  HM3-H(C!) Phe6-H" s 
HM1-H(C%) Phe6-H%2 w  HM3-H(C%) Phe6-H" s 
HM2-H(C!) Phe6-H%1 w  HM2-H(C!) Phe6-H" s 
HM4-H(C!) 
DABA8-
H# s 
 HM2-H(C%) Phe6-H$ w 
HM4-H(C%) 
DABA8-
H# w 
 HM4-H(C!) DABA8-HN w 
HM4-H(C#) Phe6-H$ w     
Polymyxin-E 
HM4-H(C!) Leu6-H"1 m  HM2-H(C!) Leu6-H"1 s 
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HM4-H(C!) Leu7-H% m  HM2-H(C!) Leu6-HN m 
HM4-H(C%) Leu6-H# m  HM2-H(C!) Leu6-H# m 
HM4-H(C%) Leu7-H% m  HM2-H(C%) Leu6-H# m 
HM4-H(C%) Leu7-H"1 m  HM1-H(C#) Dab4-HN w 
HM4-H(C%) Leu7-H# w  HM1-H(C#) Leu6-HN m 
HM4-H(C%) Leu7-HN m  HM3-H(C!) Leu6-H"1 m 
HM4-H(C") Leu7-H% w  HM3-H(C%) Leu6-H"1 m 
HM4-H(C#) Leu6-H"1 s  HM3-H(C#) Leu6-H"1 m 
 
4.6 Supplementary materials 
Table S1: Residual intensity of C,H cross peaks of LPS after addition of 4mM Methyl-5-
doxylstearate (pH=4.4, 300mM DPC, 40mM Acetate, T 310K) 
 
Unit Atoms Int/Int(0) Unit Atoms Int/Int(0) 
HM3  C#-H#(2)   0.36 GlcN A   C2-H2   0.79 
HM3  C#-H#(1) 0.37 GlcN A   C1-H1   0.85 
HM1  C#-H#(2)   0.45 GlcN A   C3-H3   0.87 
HM1  C#-H#(1)   0.45 GlcN A   C6-H6   0.87 
HM3  C!-H!(1)   0.46 Kdo C   C6-H6    0.89 
HM3  C%-H%    0.46 Kdo C   C8-H8(2)   0.89 
HM3  C"-H"    0.47 Kdo D   C7-H7    0.89 
HM2  C%-H%    0.47 GlcN A   C6-H6   0.90 
HM1  C!-H!(2)   0.47 Kdo D   C8-H8(1)   0.90 
HM4  C#-H#(1)   0.48 Kdo C   C3-H3(1)   0.90 
HM4  C#-H#(2)   0.50 GlcN B   C4-H4   0.90 
HM3  C!-H!(2)   0.50 Kdo D   C8-H8(2)   0.90 
HM2  C!-H!(1)   0.53 Kdo C   C8-H8(1)   0.91 
HM2  C!-H!(2)   0.53 Kdo C   C4-H4    0.92 
HM2  C#-H#(1)   0.54 GlcN B   C6-H6   0.92 
HM4  C"-H"    0.55 Kdo D   C5-H5    0.92 
HM1  C%-H%    0.55 Kdo C   C5-H5    0.92 
HM2  C#-H#(2)   0.56 GlcN B   C5-H5   0.93 
HM4  C!-H!(1)   0.56 GlcN A   C5-H5   0.94 
HM2  C%-H%    0.56 Kdo C   C7-H7    0.96 
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HM4  C!-H!(2)   0.57 Kdo C   C3-H3(2)   0.96 
GlcN B   C2-H2   0.63 Kdo D   C6-H6    0.96 
GlcN A   C4-H4   0.78 Kdo D   C3-H3(1)   0.97 
GlcN B   C3-H3   0.78 Kdo D   C4-H4    1.00 
GlcN B   C1-H1   0.79       
 
Table S2: Chemical shift differences (in ppm) of LPS upon adding PMX-B, PMX-E and 
PMX-M as derived from the chemical shift mapping experiments. Only changes of 
chemical shifts, which can be accurately measured, are included. 
 
    Polymyxin B Polymyxin E Polymyxin M 
Unit Atoms  !
13
C ! 1H ! 13C ! 1H ! 13C ! 1H  
GlcN A C1-H1 0.084 0.015 0.011 0.018 0.017 0.025 
GlcN A C2-H2 0.015 0.036 0.052 0.021 0.024 0.022 
GlcN A C4-H4 0.312 0.039 0.320 0.090 0.383 0.092 
GlcN A C5-H5 0.154 0.002 0.285 0.024 0.341 0.040 
GlcN A C6-H6 0.109 0.081 0.118 0.084 0.233 0.012 
GlcN A C6-H6 0.038 0.024 0.085 0.004 * * 
GlcN B C1-H1 0.517 0.031 0.714 0.074 0.329 0.051 
GlcN B C4-H4 0.149 0.129 0.156 0.121 * * 
GlcN B C5-H5 0.168 0.042 0.186 0.040 * * 
Kdo C C3-H31 0.552 0.002 0.649 0.009 * * 
Kdo C C3-H32 0.522 0.037 0.603 0.048 * * 
Kdo C C4-H4 0.271 0.006 0.287 0.008 0.288 0.006 
Kdo C C5-H5 0.174 0.023 0.182 0.027 0.118 0.034 
Kdo C C6-H6 0.269 0.027 0.280 0.026 0.241 0.076 
Kdo D C3-H31 0.199 0.002 0.179 0.001 0.206 0.002 
Kdo D C3-H32 0.174 0.012 0.182 0.006 0.218 0.014 
Kdo D C4-H4 0.051 0.007 0.042 0.009 0.064 0.006 
Kdo D C5-H5 0.037 0.006 0.023 0.005 0.002 0.001 
Kdo D C6-H6 0.022 0.018 0.021 0.020 0.081 0.018 
HM4 Ca-Ha 0.061 0.035 0.196 0.054 0.104 0.000 
HM4 Cb-Hb 0.078 0.031 0.083 0.002 * * 
HM4 Cg-Hg 0.013 0.014 0.139 0.000 0.031 0.043 
HM3 Ca-Ha 0.000 0.016 0.042 0.022 0.115 0.019 
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HM3 Cb-Hb 0.078 0.029 0.067 0.025 * * 
HM3 Cg-Hg 0.048 0.007 0.041 0.025 0.021 0.017 
HM2 Ca-Ha 0.371 0.007 0.472 0.015 0.468 0.006 
HM2 Cb-Hb 0.600 0.120 0.928 0.079 1.068 0.067 
HM2 Cg-Hg 0.156 0.005 0.080 0.051 0.285 0.027 
HM1 Ca-Ha 0.068 0.029 0.001 0.047 0.105 0.052 
HM1 Cg-Hg 0.026 0.001 0.264 0.006 0.353 0.006 
 
Fig. S3:  Selected spectral regions of the constant-time [
13
C,
1
H]-HSQC  of 0.35mM LPS in 300 
mM DPC, 40mM acetate pH=4.4, T=310K. Therein, original peak positions are shown in yellow, 
marked with cross and labeled for the carbon atom. The LPS signals that are shifted upon 
addition of equimolar amounts of PMX-B, -E and -M are shown in blue, magenta and green, 
respectively. 
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Fig. S4:  Elution profile for the HPLC purification of LPS in the ternary solvent mixture showing  
MALDI MS spectra of selected fractions. The dominant compound of fraction 3 is the form of 
LPS, which has one phosphate group substituted by pyrophosphate, theoretical MW: 2429.665 
for 100% 
13
C 
15
N. Fractions 5, 6 and 7 contain the desired form of LPS, theoretical MW: 
2349.699. 
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Fig. S5: Anomeric region of the constant-time [
13
C,
1
H]-HSQC of LPS.  The spectrum is shown 
close to the noise level to document the purity of the obtained LPS. 
 
 
 
Fig. S6: Differences in LPS chemical shift changes when adding PMX between PMX-B vs. 
PMX-E (left) and PMX-B vs. PMX-M (right).  
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Fig. S7: Structure of PMX-B in the complex with LPS as derived from the MD calculation. 
Color-coding is according to Figure 6 from the manuscript. Different orientations are shown. 
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Table S8: Chemical shifts of polymyxin E, 310K, 2mM PMX-E, 300 mM DPC, pH=4.4, 40mM 
acetate buffer. All chemical shifts were referenced relative to DSS at 310K (FA: fatty acid chain)  
 
 H
N
 H'# H$ Others 
    FA  2.30 1.56 %CH2   1.29, "CH2  1.18; &CH2 1.10;CH3  0.85 
Dab 1 8.49 4.52 2.07, 2.20 %CH2 3.05, 3.05; "NH3
+ -   
Thr 2 8.23 4.36 4.30- %CH3 1.17; %OH - 
Dab 3 8.81 4.36 2.14, 2.24 %CH2 3.08, 3.08; "NH3
+ 
Dab 4 8.38 4.15 1.93, 1.99 %CH2 3.08, 3.45; "NH 7.62  
Dab 5 8.24 4.47 2.04, 2.16 %CH2 3.00, 3.00; "NH3
+ 
Leu 6 8.60 4.25 1.52, 1.63 %CH  1.67; H" 0.93, 0.91 
Leu 7 8.78 4.31 1.60, 1.67 %CH 1.60; H" 0.85, 0.93 
Dab 8 7.93 4.40 2.14, 2.28 %CH2 3.12, 3.12; "NH3
+ - 
Dab 9 8.23 4.67 2.21, 2.28 %CH2 3.05, 3.05; "NH3
+  - 
Thr 10 7.81 4.11 4.28 %CH3 1.19; %OH - 
 
Table S9: Chemical shifts of polymyxin B, 310K, 2mM of PMX-B, 300 mM DPC, pH 4.4, 40 
mM acetate buffer 
 
 H
N
 H'# H$ others 
FA - 2.30 1.56 %CH2 1.30; "CH2  1.19; CH3  0.91  
Dab 1 8.51 4.53 2.09, 2.20 %CH2 3.05; "NH3
+ - 
Thr 2 8.24 4.35 4.30 %CH3 1.19; %OH - 
Dab 3 8.81 4.38 2.14, 2.24 %CH2 3.09, 3.09; "NH3
+ - 
Dab 4 8.38 4.13 1.93, 1.93 %CH2 3.06, 3.45; "NH  7.62 
Dab 5 8.20 4.44 1.96, 2.09 %CH2 2.90, 2.90; "NH3
+ - 
Phe 6 8.68 4.55 2.98, 3.08 "H 7.26, 7.26; &H 7.16, 7.16; 'H - 
Leu 7 8.61 4.19 1.35, 1.49 %H 0.88; "CH3 0.68, 0.75 
Dab 8 7.96 4.39 2.14, 2.25 %CH2 3.10, 3.10; "NH3
+ - 
Dab 9 8.14 4.39 1.91, 2.01 %CH2 2.85, 2.85; "NH3
+ - 
Thr 10 7.83 4.11 4.26 %CH3 1.18; %OH - 
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Table S10: Chemical shifts of polymyxin M, 310K, 2mM PMX-M, 300 mM DPC, pH=4.4, 
40mM acetate buffer 
 
 H
N
 H'# H$ others 
FA  2.33 1.59 %CH2 1.33; "CH2 1.24; &CH2 1.34; 'CH2 1.25; QD 
0.87;QE 0.87 
Dab 1 8.45 4.56 2.22, 2.12 %CH2 3.10, 3.10; " NH3
+ - 
Thr 2 8.37 4.25 4.23 %CH3 1.25; %OH - 
Dab 3 8.80 4.45 2.27, 1.71 %CH2 3.12, 3.12; "NH3
+ - 
Dab 4 8.15 4.27 2.00, 2.00 %CH2 3.42, 3.16; "NH 7.8 
Dab 5 8.34 4.59 2.23, 2.09 %CH2 3.08, 3.08; "NH3
+ - 
Leu 6 8.77 4.45 1.69, 1.64 %H 1.69; "CH3 0.99, 0.93 
Thr 7 8.56 4.37 4.44 %CH3 1.19; %OH - 
Dab 8 8.35 4.36 2.31, 2.27 %CH2 3.19, 3.19; "NH3
+ - 
Dab 9 8.79 4.29 2.29, 2.17 %CH2 3.11, 3.11; "NH3
+ - 
Thr 10 7.94 4.15 4.26 %CH3 1.22; %OH - 
 
Table S11: Relative attenuations of signals from PMX-B, -E or –M after addition of  5 equiv. of 
Methyl-5-doxylstearate. The experiments used 4mM unlabelled PMX-B, PMX-E and 0.2mM 
13
C,
15
N-labelled PMX-M in 300mM DPC in Acetate buffer pH 4.4, 310K. 
 
Residue Number  PMX-B PMX-E PMX-M 
1 0.11 0.17 0.03 
2 0.71 0.77 0.50 
3 0.84 0.80 0.73 
4 0.90 0.73 0.75 
4(Gamma) 0.50 0.77 0.47 
5 0.74 0.84 0.56 
6 0 0 0.02 
7 0 0 0.22 
8 0.57 0.92 0.93 
10 0.81 0.69 0.68 
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 NMR sample preparation protocol for the shift mapping experiments 
Several milligrams of pure lyophilized LPS powder were accurately weighted, 
dissolved in deionized water. A small amount of deuterated DPC was added, which 
allowed to prepare higher concentrations of LPS. This stock solution was aliquoted and 
lyophilized for further use. (The additional amount of DPC introduced this way was 
negligible with respect to the amount of DPC in the final NMR sample). Several 
milligrams of pure lyophilized polymyxins were weighted and stock solutions were 
prepared by dissolving the peptide in the acetate buffer, which was used for measurement 
of NMR spectra. 
 
For NMR measurements, an aliquoted amount of LPS was dissolved in the 
corresponding DPC/acetate solution. Good homogeneity of the sample was achieved by 
brief (10 s) sonication. In the interaction studies, the amount of acetate buffer, in which 
DPC was dissolved, was reduced by the volume of added polymyxin solution.In separate 
experiments we checked that LPS and polymyxins in concentrations used for the sample 
preparation did not change the pH of the sample. The pH of the sample was not adjusted 
after the mixing to avoid possible contaminations from the electrode electrolyte 
components. 
 
 Protocol and details for the MD simulation 
Setup 
In the first step, a set of structures was generated using a simulated annealing 
protocol. All of the experimentally observed NOEs were incorporated as distance 
restraints in this calculation. Simulated annealing in vacuo allowed fast generation of a 
diverse set of starting structures that fulfill the experimental constraints. The electrostatic 
interactions were scaled by a dielectric constant of 20, which roughly mimicks the 
interface of water/membrane environment.  
 
The set of annealed structures was clustered, so that the most abundant 
conformations can be selected. A representative conformer from each of the resulting 10 
clusters was transferred to the simulation box that included a DPC micelle for further 
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simulation. LPS-polymyxin complexes were placed into vicinity of the equilibrated DPC 
micelle consisting of 54 DPC molecules. The subsequent solvation used the same number 
of water molecules in each case. An artificial atom was placed in the center of the 
simulation box, which was position-restrained by a strong force. Distance restraints were 
between this atom and the atoms at the center of the aliphatic chain of each DPC 
molecule as well of the LPS lipid chains were applied.  
 
The restrained distance corresponds to the approximate average distance of these 
atoms from the center of the micelle. The distance restraints were time averaged giving 
the system sufficient motional freedom. The experimental distance restraints between 
LPS and polymyxin were strongly kept to preserve the structure of LPS-polymyxin 
complex. The system was driven close to equilibrium within half a nanosecond MD 
simulation. Each system was then placed into a smaller simulation box and solvated by 
an accordingly smaller number of water molecules. The distance restraints were then 
released and the system was allowed to equilibrate within a 2 ns simulation, after which a 
short production MD simulation followed.  
 
 Improvement  
To further improve agreement with experimental data a final structure from the 
trajectory described above that gave the best score was used to create new set of diverse 
structures. Therein, simulated annealing cycles were calculated, in which the DPC 
molecules were very weakly position restrained while atoms of LPS and polymyxin were 
allowed to move freely except for the terminal atoms of aliphatic chains of LPS. The 
water was removed and replaced by a implicit solvent model. This setup generated a set 
of diverse conformations, in which steric interactions of atoms of LPS or PMX-B with 
DPC as well as electrostatic interactions were reasonably taken into account. At the end 
of this procedure a set of systems was established that included the DPC micelle into 
which the LPS-polymyxin complex was embedded. During this step, distance restrains 
were exclusively applied to specific interactions involving those aliphatic LPS atoms for 
which significant changes were observed by chemical shift mapping. Since the 
interaction partner atom of PMX-B was unknown, various possibilities were tested. In all 
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cases, long-range distance restraints of Phe6 ring atoms to atoms of the fatty acids were 
used. From a set of 450 annealed structures 45 were selected according to the occurrence 
of experimentally verified interactions. These were then further subjected to a short (120 
ps) equilibration simulation with explicit solvent. Five trajectories were finally computed 
without restraints and a representative snapshot from the most stable trajectory is shown 
in Figure 6 in the main text.  
 
 Analysis 
Each of the resulting MD trajectories was assessed in several steps. First, RMS 
deviations with respect to the start of the production trajectory were calculated to 
monitor, whether the MD trajectory is stable. All atoms of LPS and polymyxin were used 
for RMSD calculation. These trajectories were derived from the conformations based on 
NOE contacts, therefore another experimental information was required to evaluate, how 
they reflect the experimental system. Average distances between each atom of LPS with 
each atom of the polymyxin were calculated over the MD trajectory. Those distances 
were selected for which participating atoms displayed changes in the chemical shift 
mapping experiments. All the analysis was done using tools from the GROMACS MD 
package and by own scripts. Structures were visually inspected by VMD, which was also 
used to prepare figures.  
 
 Simulation parameters 
 Vacuo simulated annealing 
All the interactions were computed without any cutoff for reasons of 
computational stability, the dielectric constant was set to 20, the integration step to 0.5 fs, 
the force constant for distance restraints to 1000 kJ mol-1 nm-2. The annealing cycle had 
the following profile: 80 ps at 1200K, linear cooling to 298 over 5 ps, 55 ps at 298 K, 
linear cooling to 0 K over 50 ps and the cycle was closed by linear heating to 1200K over 
a time of 10ps.  
 
  
 154 
Simulated annealing with implicit solvent 
The atoms of DPC molecules were position restrained with a force constant of 20, 
terminal atoms of LPS aliphatic chains with force constant 100. The dielectric constant 
was set to 80 and the GBSA implicit solvent model as implemented in GROMACS 4.0 
was used. The simulated annealing cycle was shortened 4 times to save computer time.  
 
 Equilibration and production MD 
For initial equilibration the system of DPC, LPS and polymyxin was solvated 
with 12574 SPC water molecules. Equilibration after simulated annealing with implicit 
solvent and the production MD was performed with 7295 water molecules. One Cl
-
 ion 
was added to neutralize the net charge. In the initial equilibration and production MD, the 
integration step was set to 1 and 2 fs, respectively. The simulations were performed in the 
NPT ensemble using periodic boundary conditions. Long-range electrostatics were 
treated by using Particle-mesh Ewald summation. The temperature was weakly coupled 
(coupling time 0.1 ps) to T=310K. Bond lengths were constrained using the LINCS 
algorithm. The pressure was weakly coupled (coupling time 0.5 ps, compressibility 4.5e-
5 bar) to 1 bar. The force constant of distance restraints during the equilibration was set 
to 5000.  
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                   Chapter 5 
 
 
Studies of the structure of the N-terminal domain from 
the Y4 receptor, a G-protein coupled receptor and its 
interaction with hormones from the NPY family 
 5.0 Introduction 
Neuropeptide Y receptors, also called as Y receptors, are members of the 
rhodopsin-like G-protein coupled receptor (GPCR) family 1b. Neuropeptide Y receptors 
occur in multiple forms. At least five Y receptors have been cloned from mammals (Y1, 
Y2, Y4, Y5, and y6). These PP-fold receptors display many of the structural features of 
rhodopsin-like receptors. It is believed to form a disulfide bond between extracellular 
loop (E- I and E- II). In case of Y1, Y4, and y6 they also have two additional cysteines, 
one in the amino-terminal tail and one in E-III that potentially can form a second 
disulfide bound. They have one or several consensus sites for N-linked glycosylation 
(Asn-X-Ser/Thr). The Y1 and Y4 receptors have three such glycosylation sites located on 
the extracellular side in the amino terminus and one in the second extracellular loop 
whereas Y2 has only one and Y5 receptors have two glycosylation sites in the amino 
terminus, respectively. All these receptors have at least one cysteine in the cytoplasmic 
tail that probably anchors the tail to the inside of the membrane by palmitoylation [1]. 
The amino acids which form the ! - helix  after the 7 th transmembrane region in bovine 
rhodopsin  are well conserved among the PP-fold receptors suggesting that this structure 
may be present in these Y- receptors too. 
  
The Y-receptors are activated by neuropeptide Y, pancreatic polypeptide, and 
peptide YY. These three peptides belong to one family of neuroendocrine hormones, the 
so-called NPY hormone family. They are 36-residue peptide amides and are rich in 
tyrosine (Tyr) residues. NPY is widely distributed throughout the mammalian brain and is 
one of the most potent orexigenic factors[2]. PYY exists in two major forms: PYY (1–36) 
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and PYY(3–36).  PYY(3–36) is a peripherally active anorectic signal. PP is a hormone 
that is released primarily from the pancreas in response to food intake. NPY analogues, as 
well as PYY and PP, exhibit varying degrees of affinity and specificity for these Y 
receptors. NPY and PYY posses a similar pharmacology displaying nanomolar affinities 
for all receptor subtypes[3], whereas PP binds with very high affinity and selectivity to 
the Y4 receptor and hence it also called as PP- preferring receptor[4]. The Y4 receptor 
consists of 375 amino acids and it has very low degree of sequence identity between 
species and is found to be one of the most rapidly evolving GPCRs known[5, 6].  Human 
Y4 mRNA is mainly expressed in the colon, small intestine and prostate, although other 
peripheral tissues appear to lack it, and various CNS regions display low expression 
levels[5]. The Y4 receptor is involved in the regulation of food intake and motility of the 
gastrointestinal tract. 
 
In this work we focus on structural studies of the isolated 41 residue N terminus of 
the Y4 receptor. The location of this segment in the context of the entire human Y4 
receptor is shown in snake plot in Fig. S1 (see Supp. Mat.). In addition, we investigate 
possible interactions with the PP fold hormones both qualitatively and quantitatively. By 
limiting the system of the study to just the N-terminal domain and with the help of 
various biophysical methods we were able to develop a rather detailed picture, that would 
presently be difficult to achieve using the entire receptor.  Moreover, we report on the 
synthesis of the difficult to express N-terminal domain suggesting a generally useful 
method to produce these polypeptides in isotopically-labelled form. The structure of N-
Y4 and its topology in the presence of DPC or SDS micelles was elucidated by high-
resolution NMR techniques. While unstructured in solution, in the presence of micelles a 
hydrophobic segment associates with the micelle and folds into a a-helix. Chemical shift 
mapping revealed potential interaction sites between PP and N-Y4. SPR techniques 
quantified the strength of this interaction. Mutagenesis studies identified residues of PP 
that are likely to be important for binding N-Y4. The data indicate that the isolated N- Y4 
is capable of weakly binding to PP, and that much of the binding affinity is due to 
electrostatic interactions. To simulate the receptor milieu the carboxyl terminus of N-Y4 
was additionally conjugated to a C12 fatty amino alcohol (dodecylphospho-
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ethanolamine) chain thereby mimicking its conjugation to the first TM helix in the entire 
receptor. In this lipopeptide the structure of the N-Y4 was not significantly affected. The 
study shows that PP associates to the flexible, central segment of N-Y4 and we speculate 
that transient binding to the N-terminal domain may facilitate transferring PP from the 
membrane-bound state into the receptor-binding pocket.  
 
5.1 Results 
5.1.1 Recombinant production of N-Y4 
The N terminus of the Y4 receptor comprises 41 residues and is highly water-
soluble. However, attempts to express it in form of a soluble ubiquitin fusion in E. coli 
resulted in unspecific fragmentation. To circumvent this problem, the N-Y4 was 
expressed as a fusion to the highly insoluble protein ketosteroidisomerase (KSI), which 
resulted in accumulation of the fusion protein in inclusion bodies. A TEV protease 
cleavage site was introduced to facilitate removal of the fusion partner[7, 8]. The 
sequence recognized by the TEV protease is ENLYFQ with Q as the P1’ residue. To 
achieve the natural peptide sequence after cleavage, the P1’ residue was replaced with the 
first residue from the target sequence (here it is Met)[9], and an additional GSGSGS 
linker was inserted to prevent steric hindrance during cleavage.  
 
A problem of the chosen strategy was that the fusion protein must be solubilized 
in detergent that is compatible with the active protease. After extensive detergent 
screening, we observed that the ionic detergent sarcosyl solubilizes the fusion protein 
while preserving TEV protease activity to some extent. As shown in Fig. 1 cleavage 
efficiency is around 40% allowing recovery of about 2mg of 
15
N-labeled N-Y4 from 1L 
of culture.  
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Figure 1: SDS-PAGE of the cleavage product of the ketosteroid isomerase- N-Y4 fusion after 
cleavage with the TEV protease. A size marker is shown on the left. Note that N-Y4 due to its 
small size cannot be detected on the gel. 
 
5.1.2 The structure of N-Y4 
Although the size of the N-terminal domain is rather small, reduced chemical shift 
dispersion due to the fact that the peptide in water is largely unstructured complicated its 
analysis. Nevertheless, using 3D 
15
N-resolved NOESY and TOCSY spectra it was 
possible to assign the 
15
N,
1
H-correlation map. Furthermore, no NOE crosspeaks between 
amide protons could be detected. Recording a second set of 2D and 3D spectra in the 
presence of DPC micelles resulted in large chemical shift changes in some parts of the 
sequence (see Fig.2). Moreover, sequential NOEs between amide protons as well as 
Ha,Hb (i,i+3) contacts usually only observed in helices were seen (see Supp. Mat.). A 
structure calculation using restraints derived from the NOESY spectra revealed the 
presence of a helical stretch encompassing residues 5 to 10 (shown in Fig.3). 
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Figure 2: Differences of backbone amide 
1
H (top) and 
15
N (bottom) chemical shifts of N-Y4 in 
the presence and absence of DPC micelles.  
 
To verify formation of stable secondary structure 
15
N{
1
H}-NOE spectra were 
recorded both in the absence as well as in the presence of DPC. The heteronuclear NOE 
sensibly reports on the rigidity of the backbone at the corresponding residue, with 
negative values characteristic of flexible parts and values larger than 0.5 usually observed 
in elements of secondary structure. The 
15
N{
1
H}-NOE data show dramatic differences in 
aqueous medium and DPC. Residues 1-27 have values <0 for N-Y4 in water whereas all 
of these residues have 
15
N{
1
H}-NOE values >0 in the DPC bound state (Fig. 4). 
Strikingly, residues 5-10 have a 
15
N{
1
H}-NOE >0.5. Interestingly, a segment 
encompassing residues 26 to 33 is rather rigid, in both environments. We observed 
sequential amide proton contacts in that region for almost all residues, but the 
corresponding Ha, Hb (i,i+3) contacts were generally missing. When comparing chemical 
shifts of amide protons in the two environments the largest differences were observed in 
that segment that obviously becomes structured in the presence of the micelle, indicating 
the presence of a nascent helix in that part. To conclude, the N terminus is largely 
unstructured in the absence of a membrane whereas a short helical stretch comprising a 
hydrophobic segment in the N terminus of the sequence is formed in presence of DPC 
micelles.  
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Figure 3: Comparison of the structures calculated for N-Y4 in the presence of DPC (left) or SDS 
(right) micelles (only bonds from backbone atoms are depicted). Bonds from disordered residues 
16-41 are not shown for clarity. 
 
 
Figure 4: Values of the 
15
N{
1
H}-NOE of N-Y4 in plain buffer (black spheres) and in the 
presence of DPC micelles (red diamonds). Data were recorded on 1mM samples at pH=5.6, 
310K, at 700 MHz proton frequency. 
 
Considering the importance of electrostatic interactions for ligand binding and to 
investigate whether (stabilizing) interactions of the N-terminal domain with the 
membrane head groups might be formed we further initiated structural studies of N-Y4 in 
the presence of SDS micelles, a negatively charged membrane mimetic. Values of the 
15
N{
1
H}-NOE rapidly revealed that N-Y4 was not significantly better structured in this 
environment. Moreover, a structure calculation again revealed the presence of an a-helix 
spanning the region between residues 3 to 10. NOEs between sequential amide protons 
were seen at the C-terminal end from residue 36 on, but the corresponding Ha,Hb (i,i+3) 
contacts were missing, indicating that a transient helix is formed towards the C terminus. 
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Interestingly, this part in the full-length receptor is connected to the first TM. In general, 
sequential amide proton contacts in the more flexible regions were stronger when 
compared to the data recorded in the presence of DPC suggesting that the negatively 
charged surface promotes the formation of transient helical structures to a slightly larger 
extent. This fact is particularly well-documented in the heteronuclear NOEs for residues 
of the segment encompassing residues 19-25, which is much less flexible in the presence 
of SDS micelles (see Fig. S8).  But in general the structural features of the peptide in 
DPC and SDS were similar (for more data on the SDS-recorded sample see the Supp. 
Mat.) 
 
5.1.3 Topology of membrane-association 
The proximity of protons of the N-terminal domain to the micelle surface was 
probed by using micelle-integrating spin labels.  The paramagnetic moiety of 5-doxyl 
stearic acid was shown to reside in the head group region[10]. Consistent with the 
assumption that structuring of the N-terminal segment is induced by binding to the 
micelle, signals from the amide moieties within that segment experienced the largest 
signal reduction (see Fig. S9). The spin-label data indicate that the N-terminal helix is 
tightly associated with the micelle, whereas the central segment makes more transient 
contacts. Motions in that region are likely limited at both ends by the adjacent 
hydrophobic residues 24-30 and the membrane-anchored N-terminal helix.  It was 
previously demonstrated that attenuations in helical regions of surface-associated 
peptides follow periodic patterns[11, 12]. The present data indicate that the helical region 
is not bound in a parallel fashion to the micelle-surface. Moreover, from the lack of a 
clear pattern in the attenuation we conclude that this part is also not anchored in a 
precisely defined mode.  
 
We have additionally tested whether binding of bPP to N-Y4 could possibly trigger 
dissociation of the N terminus from the micelle. However, no decrease of signal 
reduction from the spinlabel could be detected upon addition of bPP to micelle-bound N-
Y4, indicating that N-Y4-micelle contacts are largely unchanged, even in the presence of 
a large excess of bPP (concentration ratio of N-Y4 to bPP 1:30) (data not shown). This 
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indicates that bPP cannot initiate detachment of N-Y4 from the micelle surface, 
supporting the view that the contact site between bPP and Y-4 is not located in the helical 
segment of Y-4 and hence does not interfere with micelle association. 
 
5.1.4 Immobilizing the N terminus on the membrane 
In the native Y4 receptor the segment that has been studied in this work is 
connected to the first TM helix. In order to address whether anchoring of N-Y4 at its C-
terminal end to the membrane influences the structure or the binding properties of the N-
terminal domain a lipopeptide was chemically synthesized, in which receptor residues 1-
41 were covalently linked at their C-terminus to dodecylethanolamine to provide stable 
anchoring of the lipopeptide in the micelles. The lipopeptide was prepared using standard 
amino-acid coupling chemistry, purified, and could be tightly integrated into the DPC 
micelles. A superposition of the NOESY spectra of N-Y4 and the lipopeptide in the 
presence of DPC micelles revealed that chemical shift differences are exclusively 
observed in vicinity of the lipid attachment site. Moreover, cross peaks between amide 
protons occur at identical positions, indicating that the secondary structure of both the 
peptides is highly similar. To conclude, anchoring of N-Y4 onto the micelle does not 
influence its secondary structure, which more likely is determined by partitioning of 
residues of the hydrophobic Leu-rich segment into the membrane. As evident from Fig. 3 
the carboxyl terminal segment of N-Y4 possesses high flexibility both in the presence 
and in the absence of DPC micelles. Whether this will also be true when the C-terminus 
is linked to the first TM helix is presently under investigation.  
  
5.1.5 Interaction between N-Y4 and neuropeptides from the NPY family 
Possible interactions between peptides from the NPY family and N-Y4 were 
probed both by chemical shift mapping as well as by surface plasmon resonance (SPR). 
PP represents a natural ligand for the Y4 receptor, and accordingly the binding affinity 
between N-Y4 and PP was measured under physiological conditions (10mM HEPES pH 
7.4, 150mM NaCl) both in absence and presence of DPC micelles. The data for chemical 
shift mapping were acquired using 
15
N-labeled NPY, PP or PYY and unlabeled N-Y4 as 
well as using 
15
N-labeled NY-4 and unlabelled neuropeptides. The shift mapping 
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experiments revealed significant shift changes in the PP-N-Y4 interaction studies (see 
Fig. 5). Large changes in the PP/N-Y4 system occurred close to positions that were later 
on shown to be sensitive to replacement by Ala residues (vide infra). In addition, the shift 
changes involving PYY and NPY are generally much smaller compared to those with PP 
(data not shown). 
 
 
Figure 5: Differences of chemical shifts of amide proton and nitrogen frequencies of backbone 
resonances of bPP in the presence and absence of N-Y4 ("#= #(bPP(N-Y4)) – # (bPP) (left) and 
of N-Y4 upon addition of bPP (right). Values are computed according to "#c(
1
H,
15
N) = sqrt 
[("#
1
H)
2
 + 0.2X("#
15
N)
2
]. Positions at which mutations were performed (E4K, Q19R and E23A 
in PP and K13A, R20A and K23A in N-Y4) are indicated by grey bars. 
 
The strength of the interaction of PP with N-Y4 was quantified by SPR in absence of 
detergent. Therein, the N-terminally biotinylated neuropeptides were immobilized on a 
Streptavidin-coated chip, and the cells were flushed with solutions of N-Y4 (see Fig. 6). 
The KD derived from both kinetic and steady-state analysis was 50 µM for bPP, whereas 
binding affinity for NPY and PYY was too low to be measured with this technique (> 
1mM).  
 
 164 
 
Figure 6: Left: SPR sensogram of the interaction of N-Y4 with bPP for various concentrations of 
N-Y4 (in the range of 5 to 100 µM). Right: Plot of the steady-state value of the sensograms vs. 
the concentration of N-Y4, used for extraction of the dissociation constant KD. 
 
Measuring binding of membrane-immobilized peptides towards N-Y4 by SPR 
methods is technically very challenging, and hence KD in the presence of micelles were 
measured using NMR data by fitting changes in chemical shifts as derived from peak 
positions of the neuropeptides in [
15
N,
1
H]-HSQC spectra in the  presence of varying 
amounts of  N-Y4. For micelle-bound bPP the KD to N-Y4 is approx. 600µM and 
experiments, in which varying amounts of PP were added to N-Y4, resulted in a very 
similar value. Apparently, the KD in the presence of micelles is much lower than in the 
absence of micelles. This is not really surprising since it presents the affinity of the ligand 
towards the N-terminal domain in the presence of competing membrane binding, and 
hence reflects the difference in binding affinity between the two sites. 
 
NPY and PYY possess 80% sequence identity between each other[13], while PP 
only shares about 50% homology to each of them. All these neuropeptides display a 
remarkable separation of charges along the sequence: The positively charged residues 
occur in the C-terminal half of PP from almost all organisms sequenced so far (see Table 
1). In order to identify residues that may contribute significantly to the different 
pharmacological profiles of NPY/PYY and PP at the Y4 receptor we have aligned the 
sequences. Particular attention was paid to charged or aromatic residues that are known to 
be generally involved in GPCR-ligand interactions. The N termini of all Y receptor 
subtypes are generally negatively charged with the exception of N-Y4 that contains a net 
 165 
positive charge (see Table 1). Considering the high number of positive charges in N-Y4 
and negative charges in the N-terminal half of bPP electrostatic interactions are likely to 
be responsible for binding, and such forces are also expected to result in the observed 
rather weak binding affinities.  
 
Table 1. Sequence alignment of the principal members of the NPY family and of the N-terminal 
domains from the various Y receptor subtypes. Positions in bPP and hN-Y4 replaced by other 
amino acids in this work have been underlined. 
 
pNPY: YPSKPDNPGE DAPAEDMARY YSALRHYINL ITRQRY-NH2 
pPYY: YPAKPEAPGE DASPEELSRY YASLRHYLNL VTRQRY-NH2 
bPP :   APLEPEYPGD NATPEQMAQY AAELRRYINM LTRPRY-NH2 
          *  *  *    *  *    *    ** * *   ** **   
hN-Y1: MNSTLFSQVE NHSVHSNFSE KNAQLLAFEN DDCHLPLAMI 
hN-Y2: MGPIGAEADE NQTVEEMKVE QYGPQTTPRG ELVPDPEPEL IDSTKLIEVQ 
hN-Y4: MNTSHLLALL LPKSPQGENR SKPLGTPYNF SEHCQDSVDV M 
hN-Y5: MSFYSKQDYN MDLELDEYYN KTLATENNTA ATRNSDFPVW DDYKSSVDDLQ 
 
As depicted in Table 1 common acidic residues in PP, NPY and PYY are located 
at positions 6, 10 and 15. PP mutants E4K, Q19R and E23A were produced by site-
directed mutagenesis in order to probe for the importance of differently charged residues 
between PP and NPY/PYY at these positions. The dissociation constant for Q19R-bPP 
was only marginally reduced to 89 µM, whereas binding of E4K-bPP and E23A-bPP to 
N-Y4 was too weak to be detected by SPR. The data indicate that it is the additional 
negative charges in PP and their distribution along the sequence that may be important 
for its different binding affinities at the N-Y4.  
 
In order to verify that electrostatic interactions between acidic residues of PP and 
basic residues in the N-Y4 are contributing to binding, the K13A, R20A and K22A 
mutants of the N-terminal domain of the Y4 receptor were synthesized and investigated 
by SPR. In all of these mutants binding to bPP was significantly reduced. The measured 
values for the KD were 249 µM (R20A), 281µM (K22A) and for K13A binding was too 
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weak to be detected by SPR. The combination of the mutagenesis studies performed on 
acidic residues of PP and basic residues of N-Y4 suggests that the binding affinity 
between the two is determined by electrostatic interactions to a large extent. In this work 
we have abstained from experiments in which residues in PP and N-Y4 were charged-
reversed simultaneously because in those mutants electrostatics are likely to be perturbed 
in both molecules, and hence it is questionable whether activity could have been rescued. 
 
5.2 Discussion 
The mechanism for recognition of ligands by their receptors is of prime biological 
and pharmaceutical interest. Due to the enormous problems in expression, purification 
and reconstitution of sufficient amounts of GPCRs, little progress has been made in 
structural studies over the last decade, and so far bovine rhodopsin and the b-adrenergic 
receptor are the only GPCRs for which high-resolution X-ray data are published. In this 
work we have attempted to investigate the structure of the isolated N-terminal 
extracellular domain of the Y4 receptor, a GPCR targeted by hormones of the NPY 
family, and which binds to PP with very high affinity. Moreover, we determined the 
interaction with PP and the other members of the NPY family and investigated the role of 
specific residues for binding.  
 
Structural studies of GPCR fragments could possibly suffer from the fact that 
interactions with the remainder of the receptor are missing that may be structurally 
relevant. As to the present analysis the N-terminal domain of the published crystal 
structure of b-adrenergic receptor was largely unstructured, and did not display 
interactions with other parts of this GPCR, in particular not with the extracellular loops. 
This supports our contention that the conformations of the N-terminal domains of a 
GPCR are not significantly determined by interactions with the remainder of the receptor. 
Such a study also allows us to directly define contributions of residues from the N-
terminus of the Y-4 receptor to ligand binding. While the N-terminal domain of Y4 is 
largely unfolded in solution upon binding to zwitterionic (DPC) or negatively charged 
(SDS) micelles, a hydrophobic segment comprising residues 5 to 10 forms a rather stable 
a-helix, and the nascent helix encompassing residues 26-35 is slightly rigidified.  
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The central region and the C-terminal hexapeptide remain largely unstructured. 
The helical segment comprising residues 5 to 10 is entirely formed by hydrophobic 
residues. The structural data and the internal backbone dynamics of N-Y4 in the presence 
of zwitterionic (DPC) and anionic (SDS) headgroups display only minor differences 
indicating that the conformation does not depend on specific features of the surrounding 
lipids. Both formation of secondary structure and association with the membrane seem to 
be controlled by the hydrophobicity of the residues and their partitioning into the 
membrane[14].  Strongly favorable values for the latter are encountered only in the a-
helical stretch and in the segment between residues 24 to 30, exactly those regions for 
which the spin-label data indicate proximity to the water-membrane interface. Spin-label, 
dynamics and structural data of Y-4 reveal the central segment to be rather flexible. The 
segregation of N-Y4 into structured and flexible regions is very similar in the presence of 
zitterionic or negatively charged lipid headgroups. As a consequence of these features it 
appears likely that this domain may perform larger movements on the membrane surface, 
and hence could possibly undergo various structural or translational transitions in order to 
interact with the extracellular loops or with the membrane-bound ligands. We like to 
mention at this point that the N-terminal domain of the b-adrenergic receptor was also 
disordered in the crystal structure from Kobilka[15, 16], and that the N-terminal domains 
from many other class-1 GPCRs are predicted to be largely unfolded. This indicates that 
the fact that N-Y4 is mainly flexible is likely not an artifact due to the usage of a receptor 
fragment but rather reflects a commonly encountered feature of these receptors. 
 
We have recently proposed that binding of hormones from the NPY family to 
their receptors is preceded by association of the ligands to the membrane. According to 
ideas originally proposed by Kezdy and Kaiser[17, 18] and later developed into the 
membrane-compartment model by Schwyzer[19, 20] binding to the membrane reduces 
the search for the receptor to two dimensions, increases the concentration in the vicinity 
of the receptor and possibly induces conformations that facilitate receptor binding. 
Structural studies of porcine (p) NPY[11] and PYY[21] and of bovine (b) PP[22] bound 
to membrane-mimicking dodecylphosphocholine (DPC) micelles revealed large 
structural changes occurring during membrane association[23]. From this picture the 
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important question arises how the hormones enter the binding pocket, once the 
membrane-bound species has laterally diffused along the membrane into the proximity of 
the receptor. The seven-helix bundle provides a rather rigid scaffold that does not allow 
large rearrangements of the extracellular loops in order to facilitate diffusion of the 
membrane-bound ligand into the binding pocket. Therefore the hormones need to detach 
from the membrane. Data for binding affinities of the hormones towards phospholipid 
membranes determined by us using SPR indicate that membrane binding is only 
moderate[21]. Any part of the receptor that possesses higher affinity to the peptides than 
the membrane does, and which could be accessed by a ligand that is in proximity to the 
membrane surface, may help to guide the ligand into the binding pocket. The N-terminal 
domains of the Y receptors are 40-50 amino acid residue long polypeptide segments 
located in the extracellular space[24], and hence present potential interaction sites for the 
ligands. This work now indicates that at least for PP transient association with the N-Y4 
may be part of the cascade of events leading to receptor activation. It should be 
emphasized here that transient binding to the N-terminal domain does not exclude larger 
structural changes in the conformations of loop residues that may occur later on when the 
ligands have diffused into the genuine receptor binding pockets. Such changes or 
rotations of the TM helices are believed to be important for receptor activation, and the 
above-described events merely serve to guide the ligand from the membrane-bound state 
into the binding pocket. 
 
Binding of PP to the N-terminal domain of the Y4 receptor, which is often 
referred to as the PP-preferring receptor, is moderate with a dissociation constant of about 
50µM. NPY and PYY, two hormones from the NPY family with very similar 
pharmacology and high sequence similarity with respect to each other, do not bind to this 
domain. Sequence alignments reveal that PP overall is more negatively charged than 
NPY or PYY, particularly in the N-terminal region, and our studies show that 
replacement of E4 or E23 in PP largely abolished binding to N-Y4. Furthermore, 
introduction of Arg into position 19 lead to only marginal changes in binding affinity. 
The N-Y4 domain, in contrast to the N-terminal domains from all other receptor 
subtypes, contains a comparably large number of positively charged residues (K13, R20 
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and K22), which are also relatively close to each other in sequence. Their replacement by 
Ala as described above leads to significant losses in binding affinity. To conclude taking 
the importance of acidic PP and basic N-Y4 residues into account we speculate that 
electrostatic interactions between PP and N-Y4 are crucial for this interaction. However, 
it must be emphasized that a priori it is not clear in our case whether residues from the N 
terminus are interacting with residues from the extracellular loops thereby modulating the 
effective charge experienced by the peptides. This question can only be addressed 
experimentally with confidence when structural studies of the full-length receptor in a 
functional state become available.  
 
Unfortunately, not much pharmacological data is available for the entire Y4 
receptor. In case of the human Y1 receptor an Asp residue at the interface between TM 
helix 6 and the third extracellular loop was proposed to contribute largely to binding 
NPY[25] in the full-length Y1 receptor. Considering that Asp at this position is conserved 
amongst all Y receptor subtypes it was speculated that this residue generally contributes 
to binding in all subtypes. Nicole et al. investigated the role of this Asp
6.59
 in more 
detail[26] and verified the proposed interaction of Arg33 or Arg35 with acidic third 
extracellular loop (ECL3) residues in the other Y receptor subtypes. Our data now 
indicate that in addition to the above-described interaction additional contacts between 
acidic residues of PP and basic residues of the N-terminal domain of the Y4 receptor may 
contribute to binding. Association of the N-Y4 with PP may be therefore not only be of 
transient nature helping the ligand to be transferred from the membrane-bound state into 
the receptor binding pocket, but may also exist in the ligand-bound state, contributing to 
the high binding affinity and selectivity of PP at the Y4 receptor.  
 
5.3 Conclusions 
Based on the data described above, we speculate that the N-terminal domain of 
the Y4 receptor may help in transferring PP from the membrane-bound state into the 
receptor-binding pocket (see Fig. 7). As proposed by us in case of ligands of the Y 
receptors[23] PP initially associates with the membrane. By binding to the membrane the 
effective concentration in vicinity of the receptor is increased, the search is reduced from 
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three to two dimensions, and conformations closer to those of the bound state may be 
induced according to the membrane-compartment model[19, 20]. Biacore data of PP 
binding to phospholipid surfaces indicated that binding to membranes is moderate[27]. 
Accordingly, an equilibrium is formed, in which PP rapidly diffuses on and off the 
membrane, but mostly remains in vicinity of the membrane. When PP has diffused into 
proximity of the receptor where interactions with the latter can occur it may transiently 
bind to N-Y4 from solution. Whether the complex of PP and N-Y4 itself will move into 
vicinity of the extracellular loops, or whether the position of N-Y4 is fixed by 
interactions with the membrane or the remaining portion of the receptor is presently 
unclear.  
 
A scenario, in which N-Y4-bound PP would be transferred into the binding 
pocket by a translational movement of parts of the N-terminal domain is at least 
compatible with the experimental data. These indicate that the binding region for PP is 
located in its central segment, which at the same time is the only part of N-Y4 that is not 
making significant contacts with the membrane surface, and which also possesses 
sufficient internal flexibility to allow the necessary movements. We presently favor a 
view that describes the N-terminal domain as a large flexible loop, anchored onto the 
membrane at the amino terminus via the membrane-associated helix and at the C 
terminus via the first TM. This view is also supported by the recent crystal structures of 
the b-adrenergic receptor in which the N-terminal domain is so flexible that electron 
density in this part could not be traced[15, 16]. We have now initiated work on constructs 
that include parts of the TM bundle to see whether conformational preferences of N-Y4 
are influenced by the remainder of the receptor. 
 
5.4 Materials and methods 
Expression of the N-Y4 sequence as a soluble fusion to ubiquitin resulted in 
heterogeneous fragmentation. In order to prevent in-vivo processing the N-terminal 
domain was fused to the highly insoluble protein ketosteroidisomerase that is encoded in 
the commercial plasmid pET 31b, from which it was liberated by cleavage with the TEV 
protease in mild detergent. 
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5.4.1 Plasmid construction, expression and purification of N-Y4 
The cDNA of the Y4 receptor was obtained from the University of Missouri-Rolla 
(UMR) cDNA Resource Center. The following two primers were used to amplify the 
cDNA corresponding to N-Y4 by PCR. Forward primer: 
GCGCTCGAGGGTTCCGGTTCCGGTTCCGAAAACCTGTACTTCCAGATGAAC
ACCTCTCACCTGCTGGC, in which italic letters denote a XhoI cleavage site, bold 
letters denote a Gly-Ser linker sequence and underlined letters identify a TEV cleavage 
sequence; backward primer: CTGGCTGAGCTCACATCACGTCCACGGAATCCT with 
italic letters denoting an EspI cleavage site. The amplified PCR product and the target 
vector, pET 31b  (Novagen), were simultaneously digested with XhoI and EspI, and 
ligated into the vector with T4 ligase. The construct was confirmed by DNA sequencing 
(Synergene Biotech, Switzerland). All mutants were constructed by site-directed 
mutagenesis using the QuikChange Kit (Stratagene, USA).  
 
The fusion protein was expressed in inclusion bodies using the BL21(DE3) E.coli 
strain. Protein expression was performed by growing cells at 37°C using minimal media 
containing 
15
N-NH4Cl as the sole nitrogen source for 
15
N labeled peptide. 1mM IPTG 
was added to induce protein expression when the OD600 reached 0.8 and cells were 
harvested after 5-6 hours. The fusion protein was purified from inclusion bodies in 6M 
guanidinium hydrochloride by Ni-NTA affinity chromatography. After removal of 
GdnHCl by dialysis the precipitated fusion protein was solubilized in 50mM Tris pH 8.0 
in the presence of 2% N-lauryl sarcosine upon sonication to a final concentration of 
2mg/ml. The resulting solution was dialyzed against a 20-fold excess of 50 mM Tris, pH 
8.0 for 4-6 times. The solution was diluted 10 times with 50 mM Tris pH 8.0 and EDTA 
and DTT were added to a final concentration of 0.5 mM and 1 mM, respectively. TEV 
protease was added to a final concentration of 100 mM and the cleavage mixture was 
kept at 4°C over night. The target peptide was purified by C18-RP-HPLC (Vydac, USA) 
and the correctness of the peptide was verified by MALDI-TOF MS: 
15
N labeled N-Y4: 
4614 Da (theoretical mass (for 100% labeling): 4611.1 Da). 
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5.4.2 Synthesis and purification of the neuropeptides and of unlabelled 
N-terminal fragments 
15
N-labeled peptides from the NPY family were expressed as soluble fusions to 
Ubiquitin. Ubiquitin was liberated from the neuropeptide using the yeast ubiquitin 
hydrolase, and C-terminal amidation was performed using the a-amidating peptidyl 
glycine amidase (PAM). We have used the protocols for expression, ubiquitin cleavage 
and C-terminal amidation many times before and described in them much detail 
elsewhere, e.g. in Bader et al[11].   
 
Wild-type and mutant N-Y4 peptides and peptides from the NPY family 
containing 
15
N nuclei at natural abundance were prepared by solid-phase peptide 
synthesis using a robot system (ABI433A, Applied Biosystems). 2-chlorotrityl chloride 
resin preloaded with Fmoc-Met-OH was used to assemble the linear peptide using 
standard Fmoc chemistry (20% piperidine in DMF for Fmoc deprotection, 4 equiv. 
HOBt/HBTU for activation, diisopropylethylamine as base, and N-methylpyrrolidone as 
solvent). The peptides were cleaved from the resin and deprotected with TFA/water/1,2-
ethanedithiol/triisopropylsilane 95/2.5/2.5/2.5. The product was lyophilized and purified 
by C18 RP-HPLC and correctness was confirmed by ESI-MS: wild-type N-Y4: 4556.8 
Da (theoretical mass: 4556.1 Da); K13A N-Y4: 4501 Da (theoretical mass: 4499 Da); 
R20A N-Y4: 4473 Da (theoretical mass: 4471 Da); K22A N-Y4: 4501 Da (theoretical 
mass: 4499 Da). 
 
In order to synthesize the N-terminally biotinylated forms the peptides were 
mixed with biotin-(PEO)4-NHS-propionate (Molecular Biosciences, USA) in a 1:2 ratio 
in 100mM phosphate buffer, pH 7.0 and incubated for 2 hours at RT and afterwards 
purified by C18 RP-HPLC and confirmed by ESI-MS. To confirm that in case of E4K-
bPP, the biotin was coupled to the N-terminus instead of the side chain of lysine, the 
biotinylated peptide was first digested with pepsin, and subsequently the fragment 
containing residue 1-16 was analyzed by MALDI-TOF MS-MS. The result from this 
analysis demonstrated that the biotin was exclusively coupled to the N terminus. 
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5.4.3 Dodecylphosphoethanolamine coupling to the carboxyl terminus of 
N-Y4 
The peptide from solid-phase peptide synthesis was cleaved off the resin with 
TFA (0.8 vol %) in DCM with all the protecting groups remaining intact. Following 
removal of solvents the protected peptide was precipitated in cold water, lyophilized and 
redissolved in DMF. The solution was stirred at RT for 5 hours with 3 equivalents of 
dodecylphosphoethanolamine (3 equiv.) in presence of of HATU (1 equiv.), HOAt (1 
equiv.) and of DIEA(1.5 equiv). After extraction with a ethyl-acetate:water mixture (1:1 
v/v) the lipopeptide was deprotected under the same conditions as described above. 
Finally, the lipopeptide was purified by C4 RP-HPLC (Vydac, USA), lyophilized and 
purity higher than 95% was confirmed by MALDI-TOF-MS: 4848 Da (theoretical mass: 
4847.1 Da) and LC-MS. 
 
5.4.4 NMR experiments  
All samples of N-Y4 for structural studies were measured at 1mM concentration, 
40mM d-MES at pH 5.6. For measurements mimicking membrane environments 300mM 
d38-DPC or 300mM d25-SDS were added. All experiments were performed at 700 MHz, 
310K using a triple-resonance cryoprobe. Resonance assignments were initially 
performed in the absence of DPC or SDS using [
15
N,
1
H]-HSQC, 3D [
15
N,
1
H]-HSQC-
TOCSY (80ms mixing time) and 300ms 3D [
15
N,
1
H]-HSQC-NOESY experiments. 
Details of the spectroscopy were similar to those described by us earlier[28]. Spectra 
were analyzed using the programs CARA[29] and XEASY[30]. After nearly complete 
resonance assignments in water were obtained, a 200ms 3D [
15
N,
1
H]-HSQC-NOESY was 
recorded in the presence of DPC, and the assignments in water  adjusted to the DPC 
spectra. Upper distance restraints in DPC or SDS were then derived from 50ms 2D 
NOESY spectra. Internal backbone dynamics were studied by measuring a 
1
H-detected 
version of a 
15
N{
1
H}-NOE experiment. Structures were computed based on upper-
distance restraints derived from the NOESY spectra using the program CYANA[31, 32] 
following the standard simulated annealing protocol. 
15
N{
1
H}-NOEs were computed 
from the ratio of integrals from signals in the presence to those in the absence of amide 
proton irradiation[33]. Chemical shifts of the 
15
N,
1
H-correlation map in the absence and 
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full assignments in the presence of DPC and SDS can be found in the Supp. Mat. Proton 
chemical shifts were referenced to the water line, taken as 4.63 ppm at 310K, from which 
the nitrogen scale was derived indirectly through multiplication with the factor 
g(
15
N)/g(
1
H). The coordinates, chemical shift values and heteronucelar NOEs of NY-4 in 
the presence of SDS and DPC have been deposited in the BMRB database under the 
accession number 15708. 
 
5.4.5 Membrane-association topology using spin labels 
In the spin label studies [
15
N,
1
H]-HSQC spectra of 0.5mM solutions of 
15
N-N-Y4 
containing 300mM DPC were measured in absence and presence of 7mM and 8.8mM 5-
doxyl and 16-doxyl stearic acid, respectively. Signal attenuation was computed from the 
ratio of integrals from peaks in the corresponding spectra. The signal attenuation in the 
presence of the spin label is related to proximity of protons to the label. In another set of 
experiments 0.1mM 
15
N-labeled N-Y4 was mixed with various concentrations of bPP in 
order to test whether N-Y4 is released from the micelle upon interaction with PP. 
 
5.4.6 Surface plasmon resonance (SPR) studies 
HBS buffer (10mM HEPES, pH 7.4, 150mM NaCl, 3.4mM EDTA, 0.005% P20) 
was used as the running buffer to achieve physiological pH. N-terminally biotinylated 
neuropeptides were immobilized onto the sensor chip SA (Biacore, Sweden), which 
contains a streptavidin-coated surface, resulting in about 200 response units (RU) on a 
Biacore 1000 instrument (Biacore, Sweden). Different concentrations of N-Y4 spanning a 
range of 5 to 100µM were applied to the surface for 30 seconds at a flow-rate of 
20ml/min at 25°C. After each injection of analytes, the flow-cell was flushed with 
regeneration buffer  (1M NaCl, 50mM NaOH) for 30 seconds. Since unspecific binding 
at concentrations higher than 100µM occurred, KD larger than 100µM could not be 
determined precisely. Nevertheless, trends in reduction of binding could still be 
computed from a limited set of data points, in which values at high concentrations were 
excluded from the analysis. All sensograms were analyzed with the BIA evaluation 
software using a two-state binding model. 
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5.7 Supplementary materials 
 
Fig. S1: “Snake”-plot type presentation of the human Y4 receptor. The plot was downloaded 
from the GPCR.org website. Note that to enhance clarity not all residues from the N-terminal 
domain and the long loops are shown 
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Fig. S2: Summary of the meaningful distance restraints as derived from the unambiguously 
assigned inter-residue NOEs between backbone H
N
,H
!
 and H
"
 of N-Y4 bound to DPC micelles.  
 
 
 
 
Fig. S3: Expansion of the 100ms NOESY displaying the region involving NOEs between 
sequential amide protons (DPC micelles) 
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Table S4: Chemical shifts for N-Y4 bound to DPC micelles 
a
 referenced to the signal of residual 
HDO at 4.63 ppm 
 
Residue H
N
 H! H$ others 
Met 1 - 4.07 -, - %CH2 -, -; &CH3 - 
Asn 2 8.99 4.92 2.92, 2.80 #NH2 7.66, 6.90 
Thr 3 8.63 3.89 4.20 %CH3 1.20; %OH - 
Ser 4 8.43 4.14 3.91, 3.91 %OH - 
His 5 8.11 4.50 3.25, 3.25 #1NH -; #2H 6.89; &1H 7.66; &2NH - 
Leu 6 7.69 3.98 1.74, 1.74 %H 1.67; #CH3 0.90, 0.84 
Leu 7 8.01 3.91 1.75, 1.75 %H 1.58; #CH3 0.85, 0.85 
Ala 8 7.52 4.03 1.44  
Leu 9 7.40 4.09 1.89, 1.89 %H 1.47; #CH3 0.83, 0.83 
Leu 10 7.43 4.20 1.72, 1.72 %H 1.55; #CH3 0.83, 0.79 
Leu 11 7.50 4.51 1.65, 1.65 %H 1.50; #CH3 0.87, 0.87 
Pro 12  - 2.29, 1.86 %CH2 1.98, 1.98; #CH2 3.54, 3.69 
Lys 13 8.35 4.30 1.70, 1.70 %CH2 1.42, 1.42; #CH2 1.78, 1.78; &CH2 
2.96, 2.96; 'NH3
+
 - 
Ser 14 8.30 4.68 3.81, 3.81 %OH - 
Pro 15  4.40 2.24, 1.88 %CH2 1.97, 1.97; #CH2 3.69, 3.79 
Gln 16 8.37 4.27 2.08, 1.94 %CH2 2.33, 2.33; &NH2 7.45, 6.78 
Gly 17 8.27 3.90, 3.90   
Glu 18 8.22 4.26 2.01, 1.88 %CH2 2.24, 2.24; &H - 
Asn 19 8.45 4.64 2.79, 2.71 #NH2 7.53, 6.86 
Arg 20 8.26 4.31 1.85, 1.71 %CH2 1.58, 1.58; #CH2 3.14, 3.14; &NH -; 
'NH2 -,  
Ser 21 8.22 4.37 3.80, 3.80 %OH - 
Lys 22 8.10 4.57 1.65, 1.65 %CH2 1.76, 1.76; #CH2 1.41, 1.41; &CH2 
2.95, 2.95; 'NH3
+
 - 
Pro 23  4.40 2.27, 2.27 %CH2 1.98, 1.98; #CH2 3.55, 3.55 
Leu 24 8.34 4.26 1.63, 1.63 %H 1.55; #CH3 0.86, 0.86 
Gly 25 8.27 3.92, 3.92   
Thr 26 7.94 4.53 4.08 %CH3 1.15; %OH - 
Pro 27  - 2.47, 2.14 %CH2 1.96, 1.82; #CH2 3.75, 3.57 
Tyr 28 7.91 4.34 2.79, 2.79 #H 6.92, 6.92; &H 6.71, 6.71; 'OH - 
Asn 29 8.08 4.61 2.71, 2.59 #NH2 7.48, 6.79 
Phe 30 8.21 4.44 3.13, 3.05 #H 7.24, 7.24; &H 7.14, 7.14; 'H - 
Ser 31 8.07 4.39 3.81, 3.81 %OH - 
Glu 32 8.08 4.16 1.94, 1.85 %CH2 2.21, 2.21; &H - 
His 33 8.24 4.59 3.28, 3.09 #1NH -; #2H -; &1H -; &2NH - 
Cys 34 8.20 4.39 2.86, 2.86 %SH - 
Gln 35 8.43 4.25 2.08, 1.96 %CH2 2.31, 2.31; &NH2 7.43, 6.76 
Asp 36 8.25 4.64 2.76, 2.64 #H - 
Ser 37 8.13 4.42 3.80, 3.80 %OH - 
Val 38 8.01 4.11 2.06 %CH3 0.86, 0.86 
Asp 39 8.27 4.26 2.74, 2.60 #H - 
Val 40 7.94 4.09 2.09 %CH3 0.87, 0.87 
Met 41 7.87 4.26 1.94, 1.94 %CH2 -, -; &CH3 2.04 
a
 1mM in 300mM DPC / 90% H2O/10% 
2
H2O at 310 K ,  20mM MES and pH 5.6 
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Table S5: 
1
H
N
 and 
15
N chemical shifts of N-Y4 in water in the presence and absence of DPC 
micelles. 
 
Res. !(
1
H) [ppm] !(
15
N) [ppm] 
!(
1
H) [ppm] 
DPC 
!(
15
N) [ppm] 
DPC 
M1 - - - - 
N2 - - - - 
T3 8.171 119.838 8.637 116.741 
S4 8.290 114.787 8.413 117.173 
H5 8.260 127.348 - - 
L6 - - 7.652 118.535 
L7 8.006 121.818 8.000 116.495 
A8 7.953 123.247 7.521 118.535 
L9 7.817 119.790 7.395 115.914 
L10 7.915 121.832 7.422 115.509 
L11 7.897 123.675 7.494 117.061 
P12 - - - - 
K13 8.257 120.984 8.350 120.579 
S14 8.221 117.544 8.319 118.053 
P15 - - - - 
Q16 8.338 119.671 8.355 119.671 
G17 8.243 109.457 8.255 109.367 
E18 8.225 120.207 8.232 120.105 
N19 8.454 119.731 8.449 119.615 
R20 8.252 121.321 8.247 121.173 
S21 8.211 116.370 8.214 116.299 
K22 8.092 123.461 8.095 123.333 
P23 - - - - 
L24 8.423 122.478 8.319 121.952 
G25 8.315 109.153 8.286 108.684 
T26 7.874 115.514 7.910 115.127 
P27 - - - - 
Y28 - - 7.886 118.731 
N29 8.083 120.162 8.045 119.607 
F30 7.989 120.843 8.083 120.695 
S31 8.069 116.045 8.084 115.520 
E32 8.133 121.685 8.162 121.566 
H33 8.288 117.461 8.332 117.816 
C34 - - - - 
Q35 8.430 121.020 8.460 121.068 
D36 8.224 120.984 8.289 121.269 
S37 8.096 115.276 8.123 115.324 
V38 8.002 120.362 8.008 120.111 
D39 8.251 122.983 8.247 122.843 
V40 7.918 119.379 7.925 119.118 
M41 7.850 128.423 7.831 127.626 
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Fig. S6: Summary of the meaningful distance restraints as derived from the unambiguously 
assigned inter-residue NOEs between backbone H
N
,H
!
 and H
"
 of N-Y4 bound to SDS micelles.  
 
 
 
 
 
Fig. S7: Comparison of [
15
N,
1
H]-HSQC data of N-Y4 in the presence of DPC  (left) or SDS 
(right) micelles 
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Fig. S8: Comparison of 
15
N{
1
H}-NOE data of N-Y4 in the presence of DPC  (red diamonds) or 
SDS (black circles) micelles. 
 
 
 
 
Fig. S9: Left: Residual signal intensity of cross peaks in the [
15
N,
1
H]-HSQC in the presence of 5-
doxylstearate relative to those in the absence of the spinlabel. Right: Free energies of transfer for 
whole amino acids from bulk aqueous solution into the water-membrane interface. Values were 
taken from Wimley et al
[36]  
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Fig. S10: Left: Overlay of NOESY spectra of N-Y4 with the construct containing the C-terminal 
lipid attachment (green) (all spectra recorded in the presence of DPC micelles). Right: Expansion 
showing the assignment of the helical segment of N-Y4. 
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Table S11: Chemical shifts for N-Y4 bound to SDS micelles
a
 referenced to the signal of residual 
HDO at 4.63 ppm 
 
Residue H
N
 H!
 H
b
 Others 
Met 1 - 4.19 2.19 %CH2 2.55; &CH3 2.19 
Asn 2  8.66 4.98 2.98 , 2.79 #NH2 7.57, 6.86 
Thr 3 8.28 4.26 4.04 %CH3 1.22; %OH - 
Ser 4 8.28 4.23 3.92 %OH - 
His 5 8.06 4.57 3.3 #1NH -; #2H 7.34; &1H 8.64; &2NH - 
Leu 6 7.84 3.99 1.69, 1.78 %H 1.57; CH3 0.87, 0.94 
Leu 7 8.03 3.95 1.57, 1.78 %H 1.58; #CH3 0.87, 0.93 
Ala 8 7.52 4.05 1.47  
Leu 9 7.47 4.14 1.70, 1.87 %H 1.54; #CH3 0.86, 0.93 
Leu 10 7.59 4.22 1.75, 1.80 %H 1.55; #CH3 0.82, 0.86 
Leu 11 7.65 4.37 1.77 %H 1.56; #CH3 0.90, 0.94 
Pro 12  4.45 2.35, 2.05 %CH2 2.0, #CH2 3.54, 3.77 
Lys 13 7.90 4.44 1.81 %CH2 1.46; #CH2 1.63 ; &CH2 - ; 'NH3
+
 6.96 
Ser 14 7.95 3.88 3.80 %OH - 
Pro 15  4.46 2.31, 1.99 %CH2 2.06; #CH2 3.80, 3.75  
Gln 16 8.30 4.31 2.15, 1.97 %CH2 2.30, 2.37; &NH2 7.42, 6.72 
Gly 17 8.18 3.93   
Glu 18 8.14 4.30 2.08, 1.94 %CH2 2.33; &H - 
Asn 19 8.30 4.71 2.84, 2.71 #NH2 7.49, 6.83 
Arg 20 8.0 4.35 1.86, 1.78 %CH2 1.64; #CH2 3.20; &NH 7.2; 'NH2 - 
Ser 21 8.22 4.43 3.83 %OH - 
Lys 22 7.99 4.35  1.87 %CH2 1.45; #CH2 1.75 ; &CH2-; 'NH3
+
 - 
Pro 23  4.44 2.30, 1.98 %CH2 1.91; #CH2 3.77, 3.68 
Leu 24 8.03 4.34 1.72, 1.68 %H 1.58; #CH3 0.94, 0.89 
Gly 25 7.98 4.00, 3.91   
Thr 26 7.82 4.61 4.17 %CH3 1.21; %OH - 
Pro 27   4.39 2.17 %CH2 2.17; #CH2  3.58 
Tyr 28 7.61 4.34 2.71, 2.67 #H 6.88; &H 6.71; 'OH - 
Asn 29 7.93 4.68 2.80, 2.63 #NH2 7.42, 6.76 
Phe 30 8.08 4.43 3.20, 3.07 #H 7.28; &H 7.21; 'H 7.07 
Ser 31 8.18 4.31 3.93, 3.92 %OH - 
Glu 32 7.85 4.23 2.03, 1.91 %CH2 2.23; &H - 
His 33 8.12 4.62 3.34, 3.20 #1NH -; #2H7.31; &1H -; &2NH - 
Cys 34 8.15 4.66 3.22, 2.98 %SH - 
Gln 35 8.24 4.33 2.11, 1.98 %CH2 2.34; &NH2 7.41, 6.75 
Asp 36 8.31 4.65 2.75, 2.69 #H - 
Ser 37 8.18 4.45 3.85 %OH - 
Val 38 8.00 4.14 2.09 %CH3 0.89, 0.85 
Asp 39 8.30 4.62  2.60 #H - 
Val 40 7.94 4.12 2.09 %CH3 0.90 
Met 41 7.89 4.34 1.92 %CH2 2.34; &CH3 - 
                a1mM in 300mM SDS / 90% H2O/10% 
2
H2O at 310 K, 20mM MES and pH 5.6 
 
 185 
Selective N-terminal biotinylation: Proof by MS-MS 
A P L K P E Y P G D N A T P E QMA Q Y A A E L R R Y I N M L T R P R Y-NH2 
MW=4224.8 Da 
Biotin-(PEO)4-NHS-propionate (NHS-(PEO)4-Biotin): MW=588.67 Da, mass added to 
the target: 474.6.Da 
Pepsin was used to digest the biotinylated peptide yielding a fragment corresponding to 
biotinylated 1-16 N-Y4. TOF-TOF MS was utilized to analyze this fragment:  
 
 
 
The non-biotinylated sample served as a control, and the TOF-TOF result is as follows: 
 
 
 
 y3 y4 y5 y6 y7 y8 y9 y10 y11 y12 y13 y14 y15 y16 
Expected 372.3 473.4 544.5 658.6 773.7 830.8 927.9 1091.1 1220 1317.3 1445.5 1558.6 1655.7 1726.8 
Observed  373.4 474.5 544.5 659.5 774.4  928.8 1091.9  1317.8 1445.8  1656.1 1726.9 
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Almost all expected ions from the digest are observed.  Thereafter, the biotinylated 
sample was fragmented under the same conditions, and the TOF-TOF MS spectrum is 
depicted below: 
 
 
If we assume that biotin was coupled to the N terminus, the following expected y ions as 
listed 
 
 y4 y5 y6 y7 y8 y9 y10 y11 y12 y13 y14 y15 y16 
Expected1 473.4 544.5 658.6 773.7 830.8 927.9 1091.1 1220 1317.3 1445.5 1558.6 1655.7 2201.1 
Expected2 473.4 544.5 658.6 773.7 830.8 927.9 1091.1 1220 1317.3 1920.1 2033.2 2130.3 2201.1 
Observed  474.6 545.6 659.8   928.9 1091.8  1317.7 1445.8 1558.9 1656.1 2200.1 
Expected1: expected y ions if biotin was coupled to the N terminus 
Expected2: expected y ions if biotin was coupled to lysine 
 
The observed and expected y ions have been summarized in the table above. It is evident 
that the observed y ions, in particular y ions 13-16 correspond to those where biotin was 
coupled to the N terminus. In addition b1 ions 545.6 can be identified corresponding to 
biotinylated N terminus residue (MW of biotinilyated Alanine b ion=546.0). None of the 
fragments occurring only for Lys-biotinylated peptide was observed. 
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               Chapter 6 
 
 
Properties of the N-terminal domains from Y receptors 
probed by NMR spectroscopy 
6.0 Introduction 
G-protein-coupled receptors (GPCRs), the largest family of membrane proteins, 
represent ideal therapeutic targets for a number of disorders and diseases[1]. Although 
significant progress has been made in structural studies of GPCRs, a much more detailed 
picture still is highly desirable. During the recent years only, we have witnessed a relative 
explosion in the amount of structural information available for the GPCR family with two 
new structures of opsin in the presence and absence of transducin peptide[2, 3]four new 
structures of !-adrenergic receptors [4-7], and a recent structure of the human adenosine 
A2A receptor[8] and structure of squid rhodopsin which stimulates a Gq-type G 
protein[9]. These structures open the door to address many questions of the molecular 
mechanisms of GPCR activation and G-protein coupling and provide initial glimpses of 
the answers. 
 
GPCRs have a structurally homologous core of seven transmembrane " helices, 
but the size and structure of their extracellular and intracellular elements vary wildly, 
with greatest diversity observed in the extracellular N termini, and other regions like the 
third intracellular loops or C termini[10]. The N-terminus sequence is relatively short 
(10–50 amino acids) for monoamine and peptide receptors, and much larger (350–600 
amino acids) for glycoprotein hormone receptors, and the glutamate family receptors. 
The largest amino terminal domains are observed in the adhesion family receptors. 
Mutagenesis and biophysical analysis of several GPCRs indicate that small molecule 
agonists and antagonists bind to a hydrophobic pocket buried in the transmembrane core 
of the receptor.  
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In contrast, peptide ligands bind to both the extracellular and transmembrane 
domains. The N termini from family 3 GPCRs are the largest among all GPCRs, 
comprising usually more than 500 amino acids[11]and shares a low but significant 
sequence similarity with periplasmic binding proteins of bacteria. They constitute of two 
lobes separated by a hinge region, which looks like a Venus’ flytrap upon binding of the 
ligand. Grafting and mutagenesis studies have demonstrated conserved serine and 
threonine residues in these domains are directly involved in ligand binding[12]. 
Surprisingly, the expressed N terminus alone can bind the ligand with affinity similar to 
the one from the full-length receptor.[13] For the family 2 receptors, which are activated 
by large peptides like glucagon or secretin, VIP or PACAP, a conserved region in the 
relatively long N-terminal domain plays a role in the binding of the ligand[11].  
 
In the family 1 GPCRs activated by small ligands like catecholamines (subfamily 
1a), the ligands bind in a cavity formed by TM-III to TM-VI without the involvement of 
N-terminus. Other family 1 GPCRs (subfamily 1b) are activated by short peptides which 
interact with the extracellular loops and the N terminal domain[14]. In case of the 
subfamily 1c GPCRs, a large N-terminal extracellular domain recognizes and binds the 
glycoproteins, and allows them to activate the core domain via its interaction with e1 and 
e3 loops (Ji and Ji, 1995; Fernandez and Puett, 1996). The N-terminal domains from 
family 1 GPCRs have received little attention, most likely because of their short length, 
usually less than 70 amino acids. However, recent studies have suggested a pivotal role of 
N termini from GPCRs of this class in ligand recognition and binding[15-17]. 
Furthermore, mutagenesis data highlight the prominent role of charged residues for 
ligand binding[18, 19]. Koller demonstrated that the N terminus of the calcitonin-like 
receptor is not only essential for binding to the ligands but also presents a determinant for 
ligand specificity[20]. The 35 amino-terminal residues of CCR2, expressed as a 
membrane-bound fusion protein, bind to its ligand with an affinity similar to that of the 
intact, wild-type receptor, indicating that the N terminus is sufficient for ligand binding in 
that case[21]. Based on the mutagenesis data on the N terminus of CX3C receptor and 
previous studies, Chen has proposed a two-step binding model, which comprises ligand 
binding followed by receptor activation. Therein, the residues located in the N-terminal 
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domain play distinct roles during the different processes[22]. Complementary to the 
biological work described above GPCR fragments have been also studied using NMR. 
For example, Pervushin investigated the N-terminal domain of bacteriorhodopsin, a 
protein that is structurally highly related to GPCRs, in SDS micelles[23], and Ulfers 
studied the extracellular domain of the neurokinin-1 receptor in DPC micelles[24]. Riek 
presented a high-quality 3D NMR structure of the extracellular domain of CRF-R2! in 
complex with the peptide antagonist astressin[25]. The group of Yeagle has determined 
conformational preferences for peptides corresponding to the cytosolic loops[26], the 6
th
 
TM helix[27] and the N-terminus[26] of rhodopsin. The extracellular N-terminal domain 
of bovine rhodopsin was surprisingly well-structured and revealed the non-anticipated 
presence of a short anti-parallel beta-sheet, whereas  the corresponding segment of the ! -
adrenergic receptor could not be traced in the electron maps presumably because of its 
inherent flexibility[28, 29].  
 
Neuropeptide Y receptors, also called as Y receptors, are members of the 
rhodopsin-like G-protein coupled receptor (GPCR) family 1b. The neurohormones 
neuropeptide Y (NPY), peptide YY (PYY) and the pancreatic polypeptide (PP) target a 
heterologous population of at least five different receptor subtypes Y1, Y2, Y4, Y5 and 
y6[30]. Their physiological role in the regulation of blood pressure, memory retention, 
food uptake and seizure has been demonstrated. NPY and PYY posses a similar 
pharmacology displaying nanomolar affinities for all receptor subtypes[31], whereas PP 
binds with very high affinity and selectivity to the Y4 receptor[32]. In this work we now 
report on our recent studies on structural properties of N-terminal domains Y1,Y2,Y4,Y5 
the human Y receptors. Synthetic routes for recombinant production of the polypeptides 
in isotopically-labeled form are described and compared to each other. Expression of N-
Y1 and N-Y4 required fusion to the insoluble protein ketosteroidisomerase, from which it 
was liberated by enzymatic cleavage using the TEV protease in the presence of a mild 
detergent. In contrast, N-Y2 and N-Y5 could be expressed as soluble ubiquitin fusions, 
and cleavage was easily achieved with the help of yeast ubiquitin hydrolase. 
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 The N-terminal domains from these Y receptors are fully unstructured in aqueous 
solution, as shown by measurements of the internal backbone dynamics. In contrast, in 
the presence of phospholipid micelles N-Y4 adopts a short a-helix in a segment mainly 
comprised of hydrophobic residues. N-Y1 is largely helical although remaining flexibility 
precludes a detailed structural analysis. N-Y5 is segregated into more structured and 
rather flexible regions, similarly to N-Y4. However, measurements of internal backbone 
dynamics revealed secondary structure to be less stable than in N-Y4. N-Y2 does not 
interact with the micelles and remains unstructured also in that environment. 
 
6.1 Results 
6.1.1 Expression of N-terminal domains in isotopically-labeled form 
     The structure of peptides can mostly be solved by relying solely on homonuclear 
1
H-
1
H correlation experiments. Such peptides are therefore usually produced by solid 
phase peptide synthesis (SPPS)[33, 34]. Isotope labeling, however, is required for the 
study of backbone dynamics using 
15
N relaxation, and such labeling also facilitates 
chemical shift mapping experiments for the study of macromolecular interactions.  The 
high cost of 
13
C- and/or 
15
N-enriched amino acids usually prohibits the usage of SPPS 
and necessitates recombinant production. E.coli is still the expression system of choice 
for most proteins because of the ease of its genetic manipulation and because of the 
ability of E.coli to synthesize amino acids from glucose and inorganic ammonia salts 
serving as the sole sources of carbon and nitrogen, respectively[35].  
 
    Since peptides are rapidly degraded in E.coli, they are usually expressed linked to 
a more stable fusion partner. The chosen fusion partner should allow the expression of 
the fusion constructs in high amounts and it should allow the specific separation of the 
fusion partner and the peptide after the purification of the fusion construct[36]. The first 
aim can usually be achieved by selecting a protein as fusion partner, which itself can be 
produced in high yields in E.coli. Specific cleavage from the fusion partner can be 
accomplished for systems for which a specifically hydrolase is available (method 1), or 
by introducing a unique cleavage site between the fusion partner and the peptide 
sequence of interest (method 2) (see Fig. 1). Such a scission site can be either an amino 
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acid sequence specifically recognized by a protease (method 2a) or a site prone to 
chemical cleavage (method 2b). The most convenient strategy in terms of workload is 
usually method 2b. In this method high yield is achieved by fusing the peptide to a highly 
water insoluble protein which will lead to the accumulation of the fusion construct in 
inclusion bodies[35]. Inclusion bodies already contain the target protein at high 
concentrations, and typically require only very few additional steps of purification. In 
case of cyanobromide cleavage very high efficiencies have been reported[37], but the 
target sequence is not allowed to contain Met residues. Other methods such as 
hydroxylamine cleavage[38], are much less efficient, and often result in further chemical 
modifications of the target peptide. Methods that use enzymatic cleavage (methods 1 and 
2a) require that the fusion protein is soluble under conditions that are compatible with 
enzymatic activity. 
 
 
Figure 1: Scheme showing the two strategies used to produce peptides corresponding to the 
N-terminal domains of the Y receptors in isotope-labeled form. 
 
Since the four Y receptor N-terminal fragments studied herein are all reasonably 
water-soluble and contain Met residues we initially decided to express them in 
15
N-
labelled form as C-terminal fusions to N-terminally decahistidine-tagged yeast 
ubiquitin[39]. After purification of the fusion construct by Ni-affinity chromatography 
the desired peptide was liberated with a hexahistidine-tagged yeast ubiquitin hydrolase 
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(YUH). This system allowed the recovery of about 6 mg of 
15
N-labelled N-Y2 and N-Y5 
from 1 L of culture. Unfortunately, attempts to express N-Y1 and N-Y4 using this 
method resulted in unspecific C-terminal degradation (see supplementary Table S10). To 
circumvent intracellular proteolysis, N-Y1 and N-Y4 were expressed as a fusion to the 
highly water-insoluble protein ketosteroidisomerase (KSI), which resulted in 
accumulation of the fusion protein in inclusion bodies. A TEV protease cleavage site was 
introduced between KSI and the target peptide[40, 41]. The sequence recognized by the 
TEV protease is ENLYFQ with Q as the P1’ residue. To achieve the natural peptide 
sequence after cleavage, the P1’ residue was replaced with the first residue from the 
target sequence (here it is Met)[40], and an additional GSGSGS linker was inserted to 
prevent steric hindrance during cleavage.  
 
 
Figure 2: [
15
N,
1
H]-HSQC spectra of all Y receptor N-terminal domains, recorded at 310 K in the 
presence of DPC micelles. Top left: N-Y1, top right: N-Y2, bottom left: N-Y4, bottom right: N-
Y5. 
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A problem of the chosen strategy was that the water-insoluble fusion protein must 
be solubilized in detergent that is compatible with activity of the TEV protease[42]. After 
extensive detergent screening, we observed that the ionic detergent sarcosyl solubilizes 
the fusion protein while preserving TEV protease activity to a satisfactory extent (see 
Table S10). Cleavage efficiency for this system is around 40% allowing recovery of 
about 2 mg of 
15
N-labelled N-Y1 and N-Y4 from 1 L of bacterial culture. 
 
6.1.2 Assignment of chemical shifts 
Sequence-specific resonance assignments were done using the strategy developed 
by Wüthrich and coworkers[43]. In this strategy spin systems are assigned by 
experiments based on scalar couplings (e.g. COSY-type or TOCSY-type transfer) and 
NOEs are used to link them in sequential order. Due to extensive resonance overlap of 
the poorly folded peptides 
15
N-resolved three-dimensional TOCSY or NOESY data had 
to be utilized for this task. Representative [
15
N,
1
H]-HSQC spectra of all four peptides are 
depicted in Fig. 2. In case of N-Y5 a 
13
C,
15
N-labelled sample, allowing the acquisition of 
triple resonance spectra, was required. For N-Y1, a set of experiments was first recorded 
in aqueous buffer. After completed analysis in water the assignments were transferred 
and adjusted to the spectra recorded in the presence of DPC micelles with the help of 
NOESY spectra. A set of tables containing complete assignments for all the proton-
nitrogen correlation maps, as well as almost all proton chemical shifts of N-Y1 can be 
found in the supplementary materials S1-S5. 
 
6.1.3 Screening structural properties using 
15
N relaxation and CD 
spectroscopy 
CD spectroscopy is a convenient tool to estimate the type and content of 
secondary structure in peptides and proteins. The CD spectra of all N-terminal domains in 
the presence of DPC micelles are depicted in Fig 3. The spectrum of N-Y2 displays its 
maximum around 197 nm, the typical absorption band of unstructured peptides. For all 
other peptides the main band is red-shifted and indicates population of helical 
substructures. The intensities of the absorptions, however, also clearly show that the 
helical content is very low in all cases, and the typical bands at 208 and 222 nm are not 
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visible. For N-Y4, for which we previously observed an a-helix involving residues 4 to 
11, the absorption is stronger than for the other peptides. 
 
 
Figure 3: CD spectra of peptides from all N-terminal domains, recorded at 37 °C in 300 mM 
DPC, 20 mM MES pH 5.6 solution. Data are shown for N-Y1 (solid line), N-Y2 (dotted line), N-
Y4 (dash-dotted line) and N-Y5 (dashed line). Data are converted to molar ellipticities. 
 
The dispersion of the NMR signals in the region of the amide protons is 
traditionally used to estimate to which extent a peptide or protein is folded[44]. In case of 
the N-terminal domains from the Y receptors signal dispersion of all peptides was small, 
indicating that they were largely unfolded. To better access whether these peptides still 
contained folded segments we recorded the 
1
H-
15
N{
1
H}-NOEs (H-NOEs). These values 
range from 0.6 and 0.8 for well-folded elements of secondary structures, and 
progressively decreases for more flexible amide moieties resulting in negative values for 
fully flexible segments[45]. The H-NOE data for all N-terminal peptides reveal that all 
peptides are essentially unstructured in aqueous buffer (data not shown). 
 
Since in the naturally occurring GPCR the N termini are attached to a membrane-
protein the backbone dynamics were additionally probed in the presence of a commonly 
used membrane-mimicking detergent, dodecylphosphocholine (DPC)[46] (see Figure 4). 
Again the peptides are not rigidly structured. In the case of N-Y4 we could previously 
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show that a rather stable hydrophobic a-helix is formed between residues 4 and 11, 
present both in zwitterionic (DPC) as well as in anionic (SDS) micelles[47], reflected by 
H-NOEs exceeding values of 0.6. In contrast, the N termini from all other Y receptors are 
less well ordered. The N-Y2 is fully flexible most likely due to the complete lack of 
interactions with phospholipids surfaces. The absence of such contacts is supported by 
the fact that essentially no chemical shift changes occur between N-Y2 in aqueous buffer 
and in DPC micelles. In contrast, both N-Y1 and N-Y5 reveal short stretches of the 
polypeptide chain that become rigidified in the presence of the micelles. 
 
 
Figure 4: Values of the 
15
N-{
1
H}NOE, recorded at 700 MHz proton frequency along the 
sequence for Y1 (top left), Y2 (top right), Y4 (bottom left) and Y5 (bottom right). The area 
containing values larger than 0.6, indicating rather well folded segments, has been shaded in gray. 
 
6.1.4 Structures of the N-terminal domains in presence of phospholipid 
micelles 
The NOE data of N-Y4 revealed the presence of a hydrophobic helix in the 
segment comprising residues 5 to 11. In addition, a nascent helix was observed in the 
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region including residues 26 to 35. Inspection of the H-NOE data depicted in Figure 4 
clearly indicates that N-Y2 is devoid on any structured segments. Moreover, the H-NOE 
of N-Y5 is generally below 0.6 and mostly values are even smaller than 0.4. In our 
experience secondary structure cannot reliably be determined in these cases. We 
speculate that the molecule, similarly to N-Y4, is segregated into a N-terminal helical 
region, and a much more destabilized shorter C-terminal helical region separated by a 
longer non-ordered segment, but the peptide is not ordered sufficiently well to allow for 
structural characterization by NMR in detail. 
 
In case of N-Y1, however, elevated values of the H-NOE are observed indicating 
that this polypeptide may be amenable to more detailed structural studies. Accordingly, 
we have assigned all proton and nitrogen resonances of N-Y1. Little chemical shift 
dispersion of amide proton resonances complicated the assignment process, and use of 
3D 
15
N-resolved NOESY or TOCSY spectra had to be made. During assignment a larger 
number of contacts involving sequential amide protons were observed, indicating that the 
f,y space of helical backbone conformations was significantly populated. Such stretches 
were for example observed involving residues 4 to 9 and residues 24 to 32. An expansion 
of the spectral region of the [
1
H,
1
H]-NOESY that displays the sequential amide proton 
NOEs in the segment from 24 to 32 is shown in Figure S6 in the supplementary 
materials. However, except for two "N (i,i+3) NOEs observed in the segment 4-9 no 
medium-range contacts were found.  
 
The relative strength of intra-residual and sequential "H,NH contacts changes 
between extended and helical conformations[48], with the intra-residual distance in 
helices stronger than the sequential one, whereas in extended or unfolded segments the 
sequential distance is much shorter. A comparison of peak intensities revealed that the 
sequential NOEs were generally stronger, and in the light of sequential contacts of amide 
protons, indicate conformational averaging between helical and extended conformations 
to some extent. Considering this observation it was not really surprising that persistent 
violations remained in the structure calculations, and helical conformations were only 
seen involving residues 4 to 9, a region, in which the H-NOE is larger than 0.6. The 
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3
J(HN,H") couplings were larger than 6.5 Hz throughout the sequence (data not shown), 
reflecting the remaining conformational instability of N-Y1. To our surprise we have not 
been able to detect any medium range contacts in the segment 15 to 28, which according 
to the dynamics data should also be better ordered. We suspect this region to be 
transiently helical considering the occurrence of sequential amide proton contacts 
throughout this segment. To summarize, the spectroscopic data indicate that N-Y4 and N-
Y5 are similar in that both contain two helical regions separated by a flexible central 
segment, with only the N-terminal helix in N-Y4 being well ordered. N-Y1 is largely 
helical between residues 4 and 28, but the remaining conformational flexibility precludes 
its detailed structural analysis. N-Y2 is fully flexible and devoid of any detectable 
residual structure.  
 
6.1.5 Interaction studies with neuropeptides from the NPY family 
We have recently proposed that the peptides of the NPY family may transiently 
bind to the N-terminal domains in order to become transferred from the membrane-bound 
state into the genuine binding pocket of the receptor[47, 49]. While in that work surface 
plasmon resonance was used to establish the strength of the bPP-NY4 interaction, 
preliminary experiments using bPP or pPYY and the N-terminal domains from the other 
receptors have indicated that the interaction between the peptides and the other N-
terminal domains are too weak to be detected by SPR. In this work we have now utilized 
chemical shift mapping experiments both in the presence and absence of DPC micelles in 
order to derive preliminary data on binding of the peptides from the NPY family to N-Y1, 
N-Y2 and N-Y5. The changes of chemical shifts of the neuropeptides upon adding 2 
equivalents of the N-terminal domains are summarized in Figure 5. First of all we noticed 
that the magnitude of the changes is larger in the presence of DPC micelles as compared 
to aqueous buffer. This was surprising considering that in case of N-Y4 the interaction in 
the absence of micelles was stronger than in the presence as judged by SPR[47]. It should 
be mentioned, however, that changes in chemical shift mapping depend on both the 
population difference between bound and free species, but also on the type of structural 
changes. Contacts with aromatic residues for example will for instance result in larger 
changes than contacts with polar side chains. Detachment of peptides from the micelle 
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surface, possibly required for binding to the receptor N termini, will transfer part of the 
residues into a completely different environment, and we believe this effect to account for 
the larger changes observed in DPC micelles. 
 
In the presence of lipids, chemical shift changes for bPP are much larger than for 
the other peptides. When adding N-Y1 or N-Y5 to bPP the same residues of bPP are 
affected in a similar manner. In all cases the largest changes occur in the N-terminal half 
of bPP or in the segment from residues 26 to 35.  In case of pNPY changes are only 
appreciable for residues 14 and 15 upon addition of N-Y5. Changes in pPYY are very 
similar for all the N-terminal domains, and largest for residues 21, 26 and 27.  
 
In the absence of lipids, larger changes are detected for pNPY throughout the 
sequence upon adding N-Y1 or N-Y2, but are fairly small for bPP and pPYY, except for 
residue 4 of bPP  upon addition of N-Y1. Pronounced differences are observed for pNPY 
residues 6, 14, 24, 26 and 36, and for residues 4 and 10 when adding N-Y1 or N-Y2, 
respectively. We like to emphasize here that the spectra of bPP and pPYY in water are 
concentration independent whereas the oligomerization state of pNPY is strongly 
concentration dependent[50-52]. In addition, the spectrum of pNPY is highly dependent 
on pH and other environmental variables. Although we tried to control these as tightly as 
possible we cannot fully exclude that part of the observed changes may relate to issues 
not directly linked to binding. 
 
To investigate whether pNPY really associates with N-Y2 we have performed a 
titration experiment, in which up to 10 equivalents of pNPY were added to 
15
N-labelled 
N-Y2 (see Fig. 6). The data clearly show concentration-dependent changes of positions of 
resonances from the N-Y2. Resonances in the segments comprising N-Y2 residues 16-21 
and 33-50 are mostly affected. The data point to a low-affinity interaction of pNPY 
towards N-Y2 without much specificity. To summarize the interaction studies we can say 
that significant and reliable effects were only detected in the presence of DPC micelles 
and that all peptides interact with the three N-terminal domains. The interaction with bPP 
results in the largest changes. 
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Figure 5: Chemical shift deviation of bPP (top panel), pPYY (middle panel) and pNPY (bottom 
panel) upon addition of N-Y1(orange bars), N-Y2 (pink bars) and N-Y5 (gray bars) in aqueous 
buffer (left column) or in the presence of DPC micelles (right column). 
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Figure 6: Chemical shift deviation of N-Y2 after addition of 1 and 10 equivalents of pNPY (from 
left to right). For additional data points at 0.5, 2 and 4 equivalents see Figure S12.  
 
6.2 Discussions 
We have postulated that binding of ligands to Y receptors is preceded by 
association of the ligands to the plasma membrane. Thereby, the apparent concentration 
of the ligand is increased and the search for the receptor reduced from three to two 
dimensions [53, 54]. We now studied whether parts of the receptor that protrude into the 
extracellular compartment may help in transferring ligands, which have accumulated in 
vicinity of the membrane, into the binding pocket. Such portions of receptor that point 
into the extracellular space are the N-terminal domains. Herein, we have developed 
strategies to produce these polypeptides recombinantly in isotopically-enriched form for 
use in high-resolution NMR studies. 
 
The work has demonstrated that these peptides can all be expressed as soluble fusions 
to ubiquitin. However, N-Y4 and N-Y1 are degraded in the intracellular milieu, and 
hence much better yields were obtained using insoluble fusions. Cleavage of the target 
sequence from the insoluble fusion partner could be obtained by solubilizing the fusion 
protein in the mild detergent sarcosyl, which proved to be compatible with enzymatic 
activity of the TEV protease used to cleave the peptide from the fusion protein. 
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Studies on the structure and dynamics of the peptides using NMR revealed that they 
are all completely disordered in aqueous buffer. In the presence of phospholipids 
micelles, segments of most receptor N termini became conformationally stabilized, with 
the exception of N-Y2, which remained. Otherwise, more (N-Y4) or less stable (N-Y1 or 
N-Y5) helical segments occurred within the sequences. For all N-terminal peptides 
chemical shit changes occurred in the presence of DPC micelles, except for N-Y2. This 
implies that all other peptides associate with the micelle to some extent. Previously, we 
have made extensive use of the thermodynamic data of Wimley and White for 
partitioning of single amino acids into the water-membrane interface or the membrane 
interior[55] to rationalize how peptides interact with phospholipids micelles. A common 
observation was that the occurrence of the aromatic residues Trp and Tyr help in 
anchoring peptides in the interface[56]. The partitioning values of the four sequences of 
the N-terminal domains from the Y receptor subtypes are shown in Figure S7 in the 
supplementary materials. In N-Y4 a stretch comprising residues 5 to 11 is predicted to 
show partitioning into the micelle interior. This corresponds exactly to the region that 
becomes helically structured in the presence of micelles. In case of N-Y2 many 
negatively charges residues occur throughout the sequence, while they are clustered in 
the central (unstructured) segment in N-Y4. Even more importantly, many Pro residues 
are present in N-Y2 that might prevent formation of secondary structure. The sequence of 
N-Y5 in comparison to N-Y2 is much more amphiphilic in nature, and therefore more 
likely to favorably interact with the micelles. Again, the regions that become better 
structured in the presence of DPC micelles correspond to stretches rich in 
hydrophobic/aromatic residues and hence are predicted to partition into the micelles. 
 
Our interaction studies using chemical shift mapping indicated that bPP strongly 
interacts with all N-terminal domains, but differences in the sensitivity of certain 
positions are observed. In contrast, for pPYY the changes are smaller, but more uniform 
upon addition of the different N termini. For pNPY the changes are very small, although 
the sequence of pNPY displays more than 80% homology to the one of pPYY. The 
difference between pNPY and pPYY is very intriguing. We speculate that this difference 
may be due to structural transitions occurring in pPYY when transiently associating with 
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the N-terminal domain. pPYY in aqueous buffer displays the so-called PP-fold[57], and 
tertiary structure is lost when pPYY associates with the membrane surface, or is 
transferred into a more hydrophobic solvent (e.g. methanol)[58]. Transient binding of 
PYY to any of the N-terminal domains is expected to alter the equilibrium between 
membrane-associated peptide, which is devoid of tertiary structure, and the membrane-
detached peptide, that could possibly re-adopt its PP fold. Such a change will result in 
large chemical shift changes and would explain why the differences in pPYY are so much 
larger than for pNPY upon addition of the different N termini. In addition the changes 
due to such a structural transition may be much larger than those due to direct contacts, 
and therefore can possibly explain, why the changes in pPYY are so uniform across the 
different N-termini. Considering the sensitivity of the chemical shift mapping 
methodology to structural changes, but on the other hand the inherently low sensitivity of 
NMR, we consider results from SPR measurements to be more reliable for quantifying 
(but not for detecting) such interactions. In our Biacore measurements we could detect 
strongest binding (KD approx. 50 µM) for the bPP-NY4 interaction, and chemical shift 
mapping also revealed the largest changes for bPP upon addition of N-Y4. 
 
To summarize this work has described synthetic methods to produce all N-
terminal domains in isotopically labeled form in quantities sufficient, for the analysis by 
various biophysical methods. Structural studies revealed them to be fairly flexible. 
However, while N-Y2 is fully unfolded residual helical structures were detected in N-Y1 
and N-Y5. For the case of N-Y4 we could previously detect a short rather rigid a-helical 
stretch in the presence of DPC micelles. In contrast to N-Y4, the nascent helical regions 
of N-Y1 and N-Y5 contain too much residual motion, so that structure calculations did 
not fully converge towards a-helical structures. All peptides interact with the N terminal 
domains of N-Y1, N-Y2 and N-Y5, but the interactions are weaker than those previously 
described for bPP binding to N-Y4. 
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6.3 Materials and methods 
6.3.1 Materials 
15
NH4Cl was from Spectra Isotopes (Columbia, USA), d38-DPC- (99%-d), and D2O 
was from Cambridge Isotope Laboratories (Andover, Massachusets, USA). 5-
doxylstearic acid was from Aldrich (Buchs, Switzerland). Oligonucleotide primers were 
synthesized by Microsynth GmbH (Balgach, Switzerland). 
 
6.3.2 Expression and purification of N-terminal domains 
Depending on their stability against proteolysis the N-terminal domains were 
either expressed as fusions to ubiquitin (N-Y2 and N-Y5) or to ketosteroidisomerase (N-
Y1 and N-Y4). In case of N-Y2 and N-Y5 the amino acid sequence was reverse 
translated into a DNA sequence taking into account the preferred E.coli codon usage 
including a terminal stop codon and a SalI restriction site. The resulting fragments were 
purified by electrophoresis and gel extraction and digested with SalI, resulting in 
fragments that were then blunt-ended on one side and contained SalI-cohesive end on the 
other end. These fragments were ligated into the pUBK19 vector (gift from T. Kohno, 
Mitsubishi Kasei Institute of Life Science, Tokyo, Japan), which had been digested with 
NsiI and SalI and purified before. The resulting plasmids were sequenced and 
transformed into C41 cells[59].  
 
For production of 
15
N-labeled peptides M9 minimal media containing 
15
N-
ammoniumchloride as the sole nitrogen source was used, otherwise expression was done 
on LB medium. In each case 1 liter of medium containing 50 mg/ml kanamycin was 
inoculated with 10 ml of an overnight LB culture. Cultures were induced at OD600 around 
0.5 with 0.4 mM IPTG. LB- and minimal medium cultures were grown under induction 
for 4 h and 11 h, respectively. Cells were harvested by centrifugation on a Sorval GSA 
rotor at 4 °C and stored at -20 °C. The cell pellets were thawed on ice for 1 h and 
resuspended in 25 ml denaturing basic buffer (50 mM Tris pH 8, 6 M GdmHCl, 100 mM 
NaCl, 1 mM !-mercaptoethanol). The suspension was lysed by sonication on ice. The 
ubiquitin fusion proteins were purified by Ni-NTA chromatography. Refolding was 
achieved by applying a linear gradient to exchange the denaturing basic buffer to native 
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binding buffer (50 mM Tris pH 8, 100 mM NaCl, 1 mM !-mercaptoethanol, 20 mM 
imidazole), and the protein was eluted with binding buffer containing 200 mM imidazole. 
The eluates were diluted 10-fold with basic buffer (50 mM Tris pH 8, 100 mM NaCl, 1 
mM !-mercaptoethanol) and a 1 mg/ml YUH-solution (for expression and purification of 
YUH see supplementary S8) was added in a 20-fold dilution. The cleavage reactions 
were allowed to proceed for 3 hours at 37 °C. 
 
In case of N-Y1 and N-Y4 the DNA sequences were subcloned from wt cDNA of 
the corresponding Y receptor (University of Missouri-Rolla (UMR) cDNA Resource 
Center by PCR). During PCR, a GSGSGS linker followed by TEV cleavage sequence 
was introduced at the N terminus of the target sequence. After digestion with XhoI and 
EspI, the fragments were ligated with T4 DNA ligase into the pET31b vector, which had 
been digested with XhoI and EspI. The correctness of the constructs was verified by 
DNA sequencing (Synergene Biotech, Switzerland). The resulting plasmids were 
transformed into BL21(DE3) for expression. For production of 
15
N-labeled peptides M9 
minimal media containing 
15
N-ammoniumchloride as the sole nitrogen source was used, 
otherwise expression was done in LB medium. In each case 1 liter of medium containing 
50 mg/ml kanamycin was inoculated with 10 ml of an overnight LB culture. Cultures 
were induced at OD600 of 0.7 with 1 mM IPTG, harvested after 5 hours by centrifugation 
on a Sorval GSA rotor at 4 °C and the pellets were stored at -20 °C.  
 
The fusion proteins were purified from inclusion bodies by Ni-NTA 
chromatography in presence of 6 M GdmHCl. After removal of GdmHCl by dialysis the 
precipitated fusion protein was solubilized in 50 mM Tris pH 8.0 in the presence of 2% 
N-lauryl sarcosine upon sonication to a final concentration of 2 mg/ml. The resulting 
solution was dialyzed against a 20-fold excess of 50 mM Tris, pH 8.0 for 4-6 times. The 
solution was diluted 10 times with 50 mM Tris pH 8.0 and EDTA and DTT were added 
to a final concentration of 0.5 mM and 1 mM, respectively. TEV protease (for expression 
and purification of TEV protease see supplementary materials S9) was added to a final 
concentration of 100 µM and the cleavage mixture was incubated at 4°C over night. 
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All target peptides were finally purified by C18-RP-HPLC (Vydac, USA) by 
using a water/acetonitrile/0.1% TFA gradient. Yields ranged from 3 mg to 20 mg peptide 
from 1 liter of culture. The mass of all peptides was confirmed by MALDI-TOF MS or 
ESI MS: N-Y1: 4532.9 Da (theoretical value: 4533.0 Da); 
15
N-N-Y1: 4587.0 Da 
(theoretical value: 4587.0 Da); N-Y2: 5509.3 Da (theoretical value: 5510.0 Da); 
15
N-N-
Y2: 5568.0 Da (theoretical value: 5570.0 Da); N-Y4: 4554.0 Da (theoretical value: 
4556.1 Da); 
15
N-N-Y4: 4614.0 Da (theoretical value: 4611.1 Da); N-Y5: 6053.7 
(theoretical value: 6053.4); 
15
N-N-Y5: 6119.5 Da (theoretical value: 6118.4 Da). 
 
6.3.3 NMR spectroscopy 
For studies of structure or backbone dynamics 1 mM solution of the peptides at 
pH 5.6, 20 mM d13-MES, 300 mM d38-DPC were used. All spectra were recorded on an 
AV-700 Bruker NMR spectrometer at 310 K. Chemical shifts were calibrated to the 
water line at 4.63 ppm and nitrogen shifts were referenced indirectly to liquid NH3. The 
spectra were processed using the Bruker Topspin2.0 software and transferred into the 
XEASY[60] or CARA[61] programs for further analysis.  
 
For chemical shift assignments 3D 
15
N-resolved TOCSY and NOESY[62] were used. 
In case of N-Y5 we decided to use 
13
C,
15
N labeling in combination with experiments that 
directly correlate sequential amide moieties[63]. In general experiments used coherence 
selection schemes via pulsed-field gradients[64] and sensitivity-enhancement building 
blocks[65] whenever possible. Upper-distance limits for structure calculations of N-Y1 
were derived from a 70 ms NOESY spectrum[66]. Structures were calculated in the 
program CYANA[67], that uses restraint molecular dynamics in torsion angle space, and 
the implemented standard simulated annealing protocol in CYANA was used for that 
task. A proton-detected version of the steady-state 
15
N[68] heteronuclear Overhauser 
effect sequence were used for measurement of the hetereonuclear NOE[69]. Therein, the 
buildup of the NOE was achieved through a pulse train of 120 degree proton pulses 
separated by 5 ms over a period of 3 seconds. 
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For measurements of interactions by chemical shift mapping methodology 0.1 
mM solutions of the 
15
N-labeled neurohormones were mixed with the corresponding 
peptides from the N-terminal domains, and the deviations of peak positions were 
extracted from the [
15
N,
1
H]-HSQC spectra and computed according to 
#$=SQRT(#(1H)2+0.2 X #(15N)2). Particular care was taken to ensure that no shifts in pH 
occurred when adding the N-Y peptides. In case of addition of various equivalents of 
pNPY to 
15
N-labelled N-Y2 in the presence of DPC micelles (please describe the 
conditions here) 
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6.6 Supplementary materials 
 
In tables S1-S4 chemical shifts were referenced to the water line taken at 4.63 ppm at 310K. The 
15
N scale was derived indirectly by multiplying the frequency of 0 ppm for protons (the Bruker 
parameter SF) by 0.101329118. Chemical shifts have been deposited in the BMRB data base 
under deposition codes 80.8933262 (N-Y1), 80.6873033 (N-Y2) and 80.74817093 (N-Y5). 
 
Table S1: Chemical shifts of N-Y1 in the presence of DPC micelles. 
 H
N
 H’" H! others 
Met 1 - - -, - %CH2 -, -; &CH3 - 
Asn 2 - - -, - $NH2 -, - 
Ser 3 8.52 4.42 -, - %OH - 
Thr 4 8.32 4.28 4.01 %CH3 1.17; %OH - 
Leu 5 8.23 4.03 1.86, 1.86 %H 1.17; $CH3 0.79, 0.72 
Phe 6 7.97 4.46 2.96, 3.18 $H 7.19; &H -, - ; 'H - 
Ser 7 8.02 4.31 3.86, 3.86 %OH - 
Gln 8 8.25 4.28 2.04, 2.04 %CH2 2.33; &NH2 7.44 
Val 9 7.90 3.94 2.05 %CH3 0.88 
Glu 10 8.26 4.09 1.85, 1.88 %CH2 2.33; &H - 
Asn 11 8.29 4.51 2.69, 2.69 $NH2 7.58, 6.86 
His 12 8.32 4.57 3.05, 3.19 $1NH -; $2H 7.09; &1H -; &2NH - 
Ser 13 8.18 4.40 3.79, 3.79 %OH - 
Val 14 8.15 4.00 2.01 %CH3 0.81 
His 15 8.30 4.61 3.09, 3.09 $1NH -; $2H 7.05; &1H -; &2NH - 
Ser 16 8.22 4.62 3.77, 3.80 %OH - 
Asn 17 8.17 4.19 2.63, 2.63 $NH2 7.50, 6.81 
Phe 18 8.22 4.50 2.99, 3.10 $H 7.17; &H 7.25; 'H - 
Ser 19 8.17 4.29 3.79, 3.79 %OH - 
Glu 20 8.38 4.14 1.96, 1.96 %CH2 2.22; &H - 
Lys 21 8.15 4.18 1.71, 1.71 %CH2 1.37; $CH2 1.94, 2.02; &CH2 2.74; 'NH3
+ - 
Asn 22 8.13 4.57 2.68, 2.68 $NH2 7.49, 6.81 
Ala 23 8.13 4.11 1.36  
Gln 24 8.13 4.15 2.02, 2.02 %CH2 2.31; &NH2 7.49 
Leu 25 8.01 4.16 1.64, 1.64 %H 1.54; $CH3 0.88, 0.81 
Leu 26 7.83 4.17 1.57, 1.57 %H 1.46; $CH3 0.83, 0.79 
Ala 27 7.74 4.19 1.23  
Phe 28 7.97 4.55 3.13, 3.13 $H 7.20; &H 7.04 ; 'H - 
Glu 29 8.33 4.20 1.87, 1.87 %CH2 2.18; &H - 
Asn 30 8.30 4.62 2.78, 2.78 $NH2 7.58, 6.86 
Asp 31 8.19 4.50 2.58, 2.58 $H - 
Asp 32 8.07 4.29 2.78, 2.78 $H - 
Cys 33 8.29 4.75 2.59, 2.65 %SH - 
His 34 8.36 4.66 3.09, 3.09 $1NH -; $2H 7.13; &1H -; &2NH - 
Leu 35 8.32 4.51 1.62, 1.62 %H 1.44; $CH3 0.86 
Pro 36  4.44 1.91, 1.96 %CH2 2.19,2.22 ; $CH2 3.78, 3.83 
Leu 37 8.05 4.18 1.57, 1.57 %H -; $CH3 0.87, 0.81 
Ala 38 8.18 4.27 1.32  
Met 39 8.22 4.38  2.06 %CH2 2.55, 2.66; &CH3 1.96 
Ile 40 7.38 4.01 1.79 %CH2 1.09, 1.37;  $CH3 0.82 
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Table S2: Amide proton and 
15
N chemical shifts of N-Y1. 
 
 N HN 
Met 1     
Asn 2     
Ser 3 116.26 8.52 
Thr 4 116.44 8.36 
Leu 5 122.7 8.27 
Phe 6 115.8 7.99 
Ser 7 114.84 8.04 
Gln 8 120.6 8.25 
Val 9 118.8 7.9 
Glu 10 122.35 8.27 
Asn 11 118.23 8.29 
His 12 119.81 8.26 
Ser 13 115.76 8.24 
Val 14 120.68 8.18 
His 15 120.62 8.38 
Ser 16 116.22 8.2 
Asn 17 119.23 8.2 
Phe 18     
Ser 19 115.9 8.21 
Glu 20 122.3 8.41 
Lys 21 120.03 8.16 
Asn 22 118.11 8.13 
Ala 23 123.09 8.16 
Gln 24 117.35 8.13 
Leu 25 120.96 8.03 
Leu 26 118.6 7.84 
Ala 27 122.05 7.74 
Phe 28 117.83 7.98 
Glu 29 120.35 8.34 
Asn 30 118.61 8.31 
Asp 31 120.03 8.31 
Asp 32 118.07 8.08 
Cys 33 120.08 8.47 
His 34 119.74 8.39 
Leu 35 122.68 8.39 
Pro 36     
Leu 37 120.63 8.05 
Ala 38 122.21 8.2 
Met 39 118.15 8.23 
Ile 40 122.86 7.38 
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Table S3: Amide proton and 
15
N chemical shifts of N-Y2. 
 
 N HN 
Met 1   
Gly 2 112.1 8.59 
Pro 3   
Ile 4 120.1 8.16 
Gly 5 112.9 8.42 
Ala 6 123.6 8.07 
Glu 7 119.4 8.39 
Ala 8 123.9 8.14 
Asp 9 119.1 8.12 
Glu 10 120.9 8.3 
Asn 11 118.7 8.37 
Gln 12 120.3 8.15 
Thr 13 115.7 8.15 
Val 14 122.2 8.09 
Glu 15 123.8 8.33 
Glu 16 121.5 8.26 
Met 17 121.1 8.22 
Lys 18 122.8 8.18 
Val 19 121 8.02 
Glu 20 123.9 8.37 
Gln 21 120.6 8.15 
Tyr 22 120.4 8.12 
Gly 23 109.8 8.06 
Pro 24   
Gln 25 119.8 8.49 
Thr 26 114.7 8.08 
Thr 27 118.5 8.09 
Pro 28   
Arg 29 121 8.33 
Gly 30 109.4 8.28 
Glu 31 119.9 8.15 
Leu 32 122.8 8.19 
Val 33 122.6 8.04 
Pro 34   
Asp 35 121.3 8.23 
Pro 36   
Glu 37 121.8 8.3 
Pro 38   
Glu 39 120.1 8.37 
Leu 40 123.3 8.18 
Ile 41 121.2 7.98 
Asp 42 123.9 8.26 
Ser 43 117.8 8.36 
Thr 44 114.9 8.21 
 214 
Lys 45 122.2 7.83 
Leu 46 122.2 7.92 
Ile 47 120.2 7.83 
Glu 48 124.4 8.26 
Val 49 121.4 8.06 
Gln 50 128.5 7.89 
 
Table S4: Amide proton and 
15
N chemical shifts of N-Y4. 
 
Met 1   
Asn 2 8.171 119.838 
Thr 3 8.29 114.787 
Ser 4 8.26 127.348 
His 5   
Leu 6   
Leu 7 8.006 121.818 
Ala 8 7.953 123.247 
Leu 9 7.817 119.79 
Leu 10 7.915 121.832 
Leu 11 7.897 123.675 
Pro 12   
Lys 13 8.257 120.984 
Ser 14 8.221 117.544 
Pro 15   
Gln 16 8.338 119.671 
Gly 17 8.243 109.457 
Glu 18 8.225 120.207 
Asn 19 8.454 119.731 
Arg 20 8.252 121.321 
Ser 21 8.211 116.37 
Lys 22 8.092 123.461 
Pro 23   
Leu 24 8.423 122.478 
Gly 25 8.315 109.153 
Thr 26 7.874 115.514 
Pro 27   
Tyr 28   
Asn 29 8.083 120.162 
Phe 30 7.989 120.843 
Ser 31 8.069 116.045 
Glu 32 8.133 121.685 
His 33 8.288 117.461 
Cys 34   
Gln 35 8.43 121.02 
Asp 36 8.224 120.984 
Ser 37 8.096 115.276 
Val 38 8.002 120.362 
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Asp 39 8.251 122.983 
Val 40 7.918 119.379 
Met 41 7.85 128.423 
 
Table S5: Amide proton and 
15
N chemical shifts of N-Y5. 
 
 N HN 
Met 1   
Ser 2   
Phe 3 118.81 7.84 
Tyr 4 118.03 7.63 
Ser 5 115.85 8.1 
Lys 6 122.27 8.25 
Gln 7 119.04 8.18 
Asp 8 119.37 8.03 
Tyr 9 120.84 8.43 
Asn 10 119.6 8.25 
Met 11 120.23 8.22 
Asp 12 120.96 8.38 
Leu 13 121.09 7.9 
Glu 14 120.56 8.39 
Leu 15 121.51 8.39 
Asp 16 118.01 8.47 
Glu 17 118.35 8.04 
Tyr 18 117.72 7.86 
Tyr 19 118.5 8.1 
Asn 20 117.52 8.21 
Lys 21 118.77 7.9 
Thr 22 113.27 7.8 
Leu 23 121.69 7.83 
Ala 24 122.63 7.76 
Thr 25 112.49 7.92 
Glu 26 122.74 8.19 
Asn 27 120.23 8.43 
Asn 28 119.29 8.35 
Thr 29 114.05 8.05 
Ala 30 125.61 8.17 
Ala 31 122.26 8.07 
Thr 32 112.43 7.92 
Arg 33 122.34 8.32 
Asn 34 119.25 8.36 
Ser 35 115.51 8.17 
Asp 36 121.69 8.26 
Phe 37 120 8.11 
Pro 38   
Val 39 117.15 8.04 
Trp 40 122.72 8.12 
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Asp 41 118.58 8.12 
Asp 42 118.49 7.95 
Tyr 43 119.01 7.82 
Lys 44 121.02 7.75 
Ser 45 115.33 8.12 
Ser 46 117.18 8.06 
Val 47 118.82 7.84 
Asp 48 122.02 8.04 
Asp 49 119.12 8.03 
Leu 50 121.18 7.9 
Gln 51 124.45 7.67 
 
Figure S6: Expansion of the 70 ms NOESY of N-Y1, displaying the assignment of residues 24 to 
31. 
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Figure S7: Free energies for partitioning residues of the Y receptor N-terminals (top left: N-Y1, 
top right: N-Y2, bottom left: N-Y4 and bottom right: N-Y5) domains into the water-membrane 
interface (circles) or into the membrane interior (diamonds) (data taken from ref. 24). Regions of 
favorable values are shaded in grey.  
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S8: Expression and purification of YUH 
Yeast ubiquitin hydrolase (YUH) was expressed with a C-terminal hexahistidine 
tag and purified on a Ni-NTA column. The plasmid coding for the YUH-construct 
pYUHK20b was a generous gift from Toshiyuki Kohno (Mitsubishi Kasei Institute of 
Life Science, Tokyo, Japan). 5 ml of LB-broth containing 50 µg/ml kanamycin were 
inoculated with a colony of BL21 DE3 pYUHK20b cells, streaked onto plate from a 
glycerol stock, and incubated for 12 h at 37 ˚C and 220 rpm. 0.5 liter of LB-broth 
containing 50 µg/ml kanamycin were inoculated with the 5 ml overnight culture and 
incubated at 37 ˚C and 240 rpm in a 2 l Erlenmeyer flask. The culture was induced with 
0.4 mM IPTG at an OD600 of 0.6-0.7 and grown for another 5 h to a final OD600 of around 
5. The culture was harvested by centrifugation at 5000 rpm and 4 ˚C for 20 min. 7 g of 
wet biomass were obtained from 1 l of culture. The cell pellet was frozen at -20 ˚C. 
 
The cell pellet was thawed on ice and resuspended in 40 ml resuspension buffer 
(50 mM Tris pH 8, 100 mM NaCl, 1 mM !-mercaptoethanol). 9 mg of lysozyme were 
added and the mixture incubated on ice for 15 min. The resuspension mixture was 
sonicated on ice with a Branson Digital Sonifier. The lysate was centrifuged twice at 
190000 rpm and 4 ˚C for 45 min and loaded onto a 10 ml column volume (CV) Ni-NTA-
agarose column previously equilibrated with running buffer (50 mM Tris pH 8, 100 mM 
NaCl, 1 mM !-mercaptoethanol, 10 mM imidazole). Bound protein was eluted with 
elution buffer (50 mM Tris pH 8, 100 mM NaCl, 1 mM !-mercaptoethanol, 100 mM 
imidazole). The eluate was confirmed to contain the target protein by SDS-PAGE. To 10 
ml of eluate 1.1 ml of glycerol were added to yield a final glycerol concentration of 10%. 
The YUH-concentration of this mixture was determined by a Bradford assay to be 7 
mg/ml. This solution was stored at -20 °C in 1 ml aliquots. 
 
S9: Expression and purification of TEV protease 
The plasmid pTH241 was transformed to Rosetta(DE3) pLys cells. 0.5 ml of an 
overnight LB culture containing 100 µg/ml ampicillin and 34 µg/ml chloramphenicol 
were used to inoculate 1 liter of LB also containing 100 µg/ml ampicillin and 34 µg/ml 
chloramphenicol. The culture was incubated at 37 °C. When it reached an OD600 of 0.6 it 
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was induced with 0.1 mM IPTG and the temperature was lowered to 20 °C. After 20 
hours the cells were harvested by centrifugation and the cell pellet was stored at –20 °C. 
 
The cell pellet from 1 liter culture was resuspended in 40 ml washing buffer (50 mM 
sodium phosphate, 300 mM NaCl, 20 mM imidazole, pH 7). The resuspension mixture 
was sonicated on ice with a Branson Digital Sonifier. After centrifugation at 4 °C at 
30000 g for 30 min the supernatant was loaded onto a Ni-NTA column. Unbound protein 
was eluted with washing buffer and bound protein was eluted with elution buffer 
(washing buffer with 200 mM imidazole). EDTA and DTT were added to a final 
concentration of 2 and 10 mM, respectively. 10 ml eluate were dialyzed over night 
against 1 liter dialysis buffer (25 mM sodium phosphate, 200 mM NaCl, 2 mM EDTA, 2 
mM DTT, pH 8) at 4 °C. 10% glycerol were added and the protease solution was stored 
at –20 °C. Susanne van den Berg, Per-Ake Lofdahl, Torleif Hard, Helena Berglund, 
Improved solubility of TEV protease by directed evolution, 2006, J. Biotechnol., 121, 
291-298 
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Table S10: MS fingerprinting of cleavage products from the N-Y4 expression: 
Exp. Theor. _Mass Peptide fragment 
2701 2701.279 0.278 (L)PKSPQGENRSKPLGTPYNFSEHCQ(D) 12-35 
2701 2701.482 0.481 MNTSHLLALLLPKSPQGENRSKPLG(T) 1-25 
2899 2899.582 0.582 MNTSHLLALLLPKSPQGENRSKPLGTP(Y) 1-27 
3176 3176.688 0.688 MNTSHLLALLLPKSPQGENRSKPLGTPYN(F) 1-29 
3323 3323.757 0.756 MNTSHLLALLLPKSPQGENRSKPLGTPYNF(S) 1-30 
4554 4554.221 0.221 MNTSHLLALLLPKSPQGENRSKPLGTPYNFSEHCQDSVDVM 1-41 
 
 
Table S11: Screening of suitable detergents for enzymatic cleavage of the N-Y-KSI 
fusion peptides:  
 
name characteristics concentration 100mMNaCl 
added 
n-Decanoylsucrose nonionic  9mM cannot solubilze the  peptide Improved a little 
dihexanoylphosphatidylcholine zwitterionic 4mM cannot solubilze the  peptide  
n-Octyl-!-D-glucopyranoside nonionic 35mM cannot solubilze the  
peptide 
 
n-Dodecyl-!-D 
maltopyranoside 
nonionic 1-6x CMC cannot solubilze the  
peptide 
 
Fos-choline zwitterionic 1-6x CMC cannot solubilze the  
peptide 
Improved a little 
n-Octyl-!-D-glucopyranoside nonionic 1-6x CMC cannot solubilze the  
peptide 
 
n-Nonyl-!-D-maltoside nonionic 1-6x CMC cannot solubilze the  
peptide 
 
n-Decyl-!-D-glucopyranoside nonionic 1-6x CMC cannot solubilze the  
peptide 
 
Sarcosyl anionic 0.4% can solubilze the  peptide completely 
soluble 
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Figure S12: Titration of N-Y2 with 0.5 (yellow), 1 (orange), 2 (red), 4 (purple), and 10 
(blue) equivalents of pNPY. 
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      Chapter 7 
 
 
Expression of double transmembrane fragments of Y4 
receptor, a human GPCR, for structural studies by NMR 
spectroscopy 
7.0 Introduction 
The Y4 receptor, a class A G-protein coupled receptor (GPCR) primarily targeted 
by the pancreatic polypeptide (PP), is involved in a large number of physiologically 
important functions. It plays a pivotal role in cardiac function, glucose metabolism in 
chronic pancreatitis patients and mediation of intestinal absorption of electrolytes and 
water[1].  
 
        
Figure 1:‘‘Snake’’-plot type presentation of the human Y4 receptor. The plot was modified from a 
download from the GPCR.org website. The parts of the receptor that has been expressed in this work are 
shaded in different colours.  Y4 N-TM1-I1TM2-E1(116) (green coloured circles), Y4 I2(147)TM4-E2-
TM5-I3(259) (orange coloured circles) and Y4 I3(260)TM6-E3-TM7-C (blue coloured circles). The 
numbering used follows that of the intact receptor. The omitted sequences for parts of the N terminus, C 
terminus and the loops are indicated separately in the box.  
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 Our understanding of GPCR structures at the molecular level has been considerably 
improved over the last few years. However, it still remains a formidable challenge to 
obtain high-resolution structural data for intact GPCRs. Determination of membrane 
protein structure has proven a more difficult subject than the determination of soluble 
protein structure largely due to the notorious difficulty in achieving reasonable 
expression levels of active receptor and also due to the hydrophobic nature of membrane 
proteins and their resulting insolubility in aqueous medium. The recent development of 
new expression systems, mutant cell strains, and the availability of new lipids for 
membrane protein reconstitution and the effective methods for both selective and uniform 
labeling of proteins  have opened the field of structural biology to many membrane 
proteins that were previously not readily accessible for examination. These advances, 
together with the parallel development of new pulse sequences, for both solution and 
solid-state NMR, provide a powerful means to tackle the problem of GPCR structure 
determination. 
 
In this chapter we describe about the expression and purification strategy for the 
production of double transmembrane fragments I2(147)TM4-E2-TM5-I3(259) and 
I3(260)TM6-E3-TM7-C of the Y4 receptor in isotopically enriched form in E. coli. Both 
the double transmembrane constructs were successfully expressed as a Trp!LE fusion 
protein, from which it was liberated by cyanogen bromide (CNBr) cleavage or by 
enzymatic cleavage in the presence of detergents using C3 protease and purified by RP-
HPLC. Expression yields were optimized using different strains and growth temperatures 
as well as various induction parameters. The cleavage conditions were optimized. 
Extensive detergent screening was done to yield reasonable quality of spectra but still 
requires final optimization which is required for our analysis. Spectra with good quality 
could only be obtained when working under reducing conditions to eliminate fragment 
oligomerization through formation of intermolecular disulfide bonds. These experiments 
set the stage for the determination of the 3D structures of these large domains of GPCR in 
micelles using high resolution NMR. 
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There is no universal expression system suitable for functional production of all 
GPCRs, and the right combination between the target receptor and expression host must 
be found empirically. The E.coli expression system is of the first choice, because of its 
simplicity and cost effectiveness. Constructing expression vectors and trying out different 
expression strategies can be accomplished with relative ease, as compared to eukaryotic 
systems for which more sophisticated methods and a more expensive maintenance are 
required. Mutant proteins can also be rapidly generated and characterized. There are two 
strategies for the expression of GPCRs in E.coli: (a) expression of functional, membrane-
inserted receptors[2-4] (b) expression of incorrectly folded, aggregated protein and 
refolding from inclusion bodies[5]. In both expression strategies, two types of expression 
methods were used. A direct expression, often used for the expression of large proteins 
offers the advantage that the chemical/enzymatic cleavage step is skipped a step that is 
often time-consuming and inefficient cleavage often results in low overall yields. 
Unfortunately this expression has been hampered by the relatively low yields of GPCRs 
owing to the toxic effects caused by these 7TM receptors when inserted into bacterial 
membranes. To circumvent this problem several strategies has been developed. Notably, 
fusing target proteins to a highly expressed bacterial protein has proven particularly 
effective for improving the expression level of membrane proteins in E. coli[6]. The type 
of fusion protein can be divided into two categories: soluble fusions and insoluble 
fusions.  
 
 Soluble fusions, as indicated by the name, can increase the solubility of the whole 
fusion protein and thus simplify the subsequent purification. In case of membrane 
proteins were highly hydrophobic transmembrane helices are present, the relatively large 
soluble fusion proteins like maltose binding protein (MBP) and glutathione S transferase 
(GST) are preferred provided that the fusion protein can be expressed in soluble form. 
After purification of the soluble fusion protein, removal of the soluble fusion is essential, 
and in most cases this is accomplished by enzymatic cleavage. The problem with the 
soluble fusion approach is that it is difficult to predict whether the fusion protein will be 
soluble or not. If the fusion protein is insoluble, tag removal then adds another layer of 
complexity, and low cleavage efficiency is often observed.  
 225 
 
Insoluble fusion partners have been widely used to isolate double transmembrane 
domains. In such a system usually a very hydrophobic protein is used as the fusion 
partner like the ketosteroidisomerase (KSI) or Trp!LE leader peptide fusions. Since the 
final fusion protein is more hydrophobic, it will most likely accumulate as inclusion 
bodies and increase the final yield. Even though the insoluble fusion is a robust method, a 
potential problem is related to the cleavage of the fusion. Since the fusion protein is not 
soluble in most of the enzyme-compatible solutions, cyanogen bromide cleavage in 
guanidine chloride/0.1M HCl in most cases is employed[7]. This requires that no 
methionine should be present in the target sequence. Alternatively proteases can be used 
to cleave the fusion partner. The most important point of concern in this strategy is that 
for many membrane proteins to be soluble at useful concentrations they require more 
acidic or more basic pH levels, high or low salt levels, or the presence of detergents or 
chaotropes. It is therefore essential that the protease of choice retains substantial activity 
under these conditions. The most robust of the enzymes cited appear to be the SUMO 
proteases, the profinity enzyme, TEV protease and the C3 protease. We have used the C3 
protease, which retains activity in presence of detergents, to cleave the fusion partner.  
The affinity fusion tags like HIS, CBP, CYD (covalent yet dissociable NorpD peptide), 
Strep II, FLAG, HPC (heavy chain of protein C) peptide tags, and the GST and MBP are 
widely used as protein purification tags. 
 
 Fusion technology continues to expand with the introduction of new fusion 
partners, purification and detection tags, and cleavage reagents. Because every protein is 
unique, no single tag or cleavage method will answer every need. When considering 
which tag to use, key questions that should be asked are, whether our application tolerates 
retention of the tag or the presence of a few amino acids remaining at the cleavage site, 
requirement of expensive proteases, incomplete cleavage of the fusion protein and the 
requirement of additional steps of purification. Apart from the problems associated with 
the difficulties in expression and purification, NMR analysis is complicated by the large 
size of the GPCR /micellar complex and the poor chemical shift dispersion as well as the 
high frequency of occurrence of certain residues (such as Ala, Leu, Ile, Phe) in the 
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transmembrane region of the receptor. Therefore a critical need arises to look for other 
alternative approaches. According to Popot and Engelman the transmembrane domains 
can be thought of as independent folding units and can be studied separately[8]. It is 
therefore hypothesized that polypeptides or small proteins containing the amino acid 
sequences for turns or for transmembrane helices of membrane proteins built of helical 
bundles will exhibit the secondary structures in solution similar to that of the native 
protein. Use of peptides to determine secondary structure of membrane proteins is 
becoming widely accepted. A significant number of studies provided structural 
information on fragments corresponding to sequences of GPCR helices, loops and 
termini. E.g.:  Saccharomyces cerevisiae pheromone receptor[9], cannabinoid 
receptor[10], and Neurokinin-1 receptor[11]. Significant similarities between the 
structures of fragments of rhodopsin and the corresponding regions of the x-ray crystal 
structure of native rhodopsin  were observed[12].  
 
Furthermore, since the interactions of the lipid bilayer with membrane proteins 
are crucial for its solubility and stability, it is desirable to determine protein structures in 
a good membrane mimetic environment. Nuclear magnetic resonance (NMR) 
spectroscopy is very well suited for this goal, since it can be applied to molecules in all 
physical states, including liquid crystalline bilayers and micelles formed by the lipids that 
associate with membrane proteins. Solubilization and stabilization of membrane proteins 
using detergents constitute a bottleneck for the structural biology of membrane 
proteins[13, 14]. Detergent micelles provide such environments surrounding the 
hydrophobic domains of membrane protein and keeping them soluble in an aqueous 
environment, and thus are widely used for solubilization and purification of membrane 
proteins[15]. Generally, the suitable detergent or detergent mixture should solubilize the 
target protein most effective, keep it stable, and prevent its self-aggregation. However, 
due to individual differences between membrane proteins, the choice of detergent or 
detergent mixture for a particular protein cannot be predicted. Therefore, a systematic 
approach is required to select the optimal detergents to achieve solubilization and 
stabilization of each target protein.  
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A number of additional factors contribute to the quality of the NMR spectra 
obtained from peptides and proteins in micelles. Optimal salt concentration, pH, 
temperature and lipid concentrations much higher than the critical micelle concentration 
are essential for preparing samples that yield NMR spectra with sufficiently narrow line 
widths and the appropriate number of resonances.  
 
7.1 Materials and method 
The pLC01 plasmid which contains Trp!LE gene was obtained as a generous gift 
from Prof. Fred Naider (College of Staten Island, CUNY, NY 10314). All phospholipids 
were from Avanti Polar Lipids (www.avantilipids.com), octyl-glucopyranoside (OG) was 
from Fluka (www.sigmaaldrich.com), and deuterated sodium-dodecyl-sulfate (SDS) and 
dodecyl-phosphocholine (DPC) were from Cambridge Isotopes Laboratories 
(www.isotope.com). 
15
N-NH4Cl and D2O were obtained from Cambridge Isotopes 
Laboratories (www.isotope.com). C3 Protease expression plasmid was obtained from the 
EMBL. Oligonucleotide primers were synthesized by Microsynth GmbH (Balgach, 
Switzerland). 
 
7.1.1 Cloning and mutagenesis to generate double transmembrane 
constructs of human Y4 receptor into pLC01 vector  
           To generate a plasmid encoding the double transmembrane constructs TM4-TM5 
and TM6-TM7C, with and without fusion protein the corresponding DNA sequences 
were subcloned from wt cDNA of the Y4 receptor (University of Missouri-Rolla (UMR) 
cDNA Resource Center) by PCR. For non-fusion double transmembrane constructs, the 
primer sequence contain NdeI and BamHI restriction sites and the PCR product was 
digested with Nde1 and BamHI, the fragments were ligated with T4 DNA ligase into the 
pLC01 vector, which had also been digested with Nde1and BamHI to generate the double 
transmembrane constructs Y4 I2(147)TM4-E2-TM5-I3(259), Y4 I3(260)TM6-E3-TM7-
C without Trp!LE fusion protein.The target sequence pattern in pLCO1vector  for the 
non –fusion construct is as follows  
 TM4-TM5 : Nde1site–Histag-Y4 I2(147)TGWKPSISQAY-TM4-E2-TM5-I3(259)-stopcodon-BamH1site 
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 TM6-TM7-C(340): Nde1 site–Histag-Y4 I3(260)MKQVNV-TM6-E3-TM7-C(340)–stopcodon 
BamH1site  
 
To generate the Trp!LE fusion of the above mentioned double transmembrane 
constructs, in case of TM4-TM5 a Met residue was inserted at the N-terminus of the 
target sequence to remove the Trp!LE fusion by CNBr cleavage. In case of TM6-TM7C 
construct a C3 protease cleavage site is introduced since it contains internal methionine 
residues in the target sequence. The primer sequence contain HindIII and BamHI 
restriction sites and the PCR product was digested with HindIII and BamHI, the 
fragments were ligated with T4 DNA ligase into the pLC01 vector that contains the 
Trp!LE sequence, which had been digested with HindIII and BamHI. The generated 
plasmid encoded the Trp!LE leader sequence fused to the Y4-I2(147)TM4-E2-TM5-
I3(259) or Y4-I3(260)TM6-E3-TM7-C double transmembrane constructs.The sequence 
arrangement of both the constructs are represented as follows. 
Trp!LE-TM4-TM5: Nde1 site-Histag-Trp!LE-(CNBr Cleavage site -Met) Y4 I2(147)TGWKPSISQAY-
TM4-E2-TM5-I3(259)-stopcodon-BamH1site 
 Trp!LE TM6-TM7-C:  Nde1 site–Histag- Trp!LE-(C3 protease cleavage site -LEVLFQ/GP)-Y4 
I3(260)MKQVNV-TM6-E3-TM7-C(375)–stopcodon-BamH1site  
 
We wanted to test using the N-terminus of Y4 receptor as a fusion partner. To 
produce this fusion plasmid the pLC01 vector containing the gene I2(147)TM4-E2-TM5-
I3(259) without the Trp!LE fusion was used as a template for site-directed mutagenesis. 
The DNA sequence corresponding to the N-terminus of the Y4 receptor was amplified 
from the wt cDNA by PCR. This insert was used as an megaprimer to amplify the 
plasmid which already contains the gene for TM4-TM5 double transmembrane region to 
generate an fusion Y4N-TM4-TM5 by site directed mutagenesis based on the Stratagene 
QuikChange mutagenesis protocol (Stratagene, La Jolla, CA). The reaction mixture was 
subjected to digestion (80 units, at 37°C) of DpnI (NEB), which specifically cuts the 
methylated template DNA, and then transformed into DH5! competent cells 
(Invitrogen). The final plasmid pLC01generated, coded for Y4N-TM4-E2-TM5-I3(259). 
A slight difference exists in sequence between N-terminal fusion and Trp!LE fusion 
double TM constructs. In the N-terminal fusion construct the I2 loop residues (10 amino 
acids) are not included and immediately after the N-terminal domain fusion, the 4th 
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transmembrane sequence starts.The sequence arrangement of N-terminal fusion of TM4-
TM5 construct in pLC01 vector is as follows and for comparison Trp!LE –TM4-TM5 
sequence is also shown. 
N-TM4-TM5: HindII site-Histag- Y4 N(1-41)- (CNBr Cleavage site -Met) (158)TM4-E2-TM5-I3(259)-
stopcodon-BamH1site. 
Trp!LE-TM4-TM5: Nde1 site-Histag-Trp!LE-(CNBr Cleavage site -Met) Y4 I2(147)TGWKPSISQAY-
TM4-E2-TM5-I3(259)-stopcodon-BamH1site. 
 
The correctness of all the constructs was verified by DNA sequencing (Synergene 
Biotech, Switzerland). For the sake of simplicity the fusion proteins will be mentioned as 
N-TM4-TM5, Trp!LE-TM4-TM5 and Trp!LE-TM6-TM7-C, and the cleaved double 
transmembrane fragments as Y4-TM4-TM5 and Y4-TM6-TM7-C here afterwards.  
 
7.1.2 Protein expression and purification of the double transmembrane 
fragments 
The plasmid encoding the target protein was transformed into BL21-AI cells for 
expression, which due to their very low background expression levels were previously 
shown to result in higher expression levels compared to other strains[7]. A freshly 
transformed colony was used to inoculate 10 ml LB containing 100 mg/ ml ampicillin. 
This preculture was grown over night at 37°C and then used to inoculate 1L LB (for the 
unlabeled sample) or M9 (with 
15
NH4Cl and 
13
C glucose as sole nitrogen and carbon 
sources) media containing 100 mg/ml ampicillin and cultured at 37° C until the OD600 
reached 0.45–0.5. For induction of overexpression, the temperature was lowered to 20°C 
and 0.2% L-arabinose was added. Cells were harvested after 18-20 hrs and stored at -
20°C until further use. The cell pellet was resuspended in binding buffer (50 mM Tris–
HCl, and 500 mM NaCl, 5 mM "-mercaptoethanol, pH 8.0) and lysed by sonication. The 
resultant suspension was spun at 13,000 rpm for 30 min, the supernatant was discarded, 
and the solid pellet was resuspended at a ratio of 15 mL per liter of culture in binding 
buffer containing 6 M GdmCl and left to solubilize overnight at room temperature. After 
centrifugation (45 min at 19,000 rpm and 4°C) the supernatant was loaded into a 5 mL 
Hi-Trap chelating chromatography column (Amersham-Pharmacia Biotech), which had 
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been previously charged with 50 mM NiSO4 and equilibrated with binding buffer 
containing 6 M GdmCl. Impurities bound to the resin were removed by passage of 
enough buffer (30 mM imidazole, 50 mM Tris–HCl, 500 mM NaCl, and 6 M GdmCl, 
5 mM "-mercaptoethanol, pH 8.0) through the column until the A280nm remained 
constant as monitored with the detector of an FPLC apparatus. The fusion protein was 
finally eluted from the affinity column with 20 mL of elution buffer containing 
300 mM imidazole, 50 mM Tris–HCl, 500 mM NaCl, 6 M GdmCl, "-mercaptoethanol, 
pH 8.0. Fractions containing fusion protein were dialyzed against pure distilled water (3-
4 kDa) and the precipitate was recovered by centrifugation of the dialysate and 
lyophilized. The masses of the proteins were confirmed by MALDI–TOF MS. For Y4N-
TM4-TM5 (mass expected-18405.0 Da; mass obtained-18401.2 Da. If we consider the 4 
Cys in the oxidized form then the mass difference is 0.2 Da) and for Trp!LE-TM6-TM7-
C (mass expected -27076.4 Da; mass obtained -27069.9 Da. Again, if we consider 4 Cys 
in oxidized form then the mass difference is acceptable (2.5 Da). 
 
The lyophilized protein was then subjected to CNBr cleavage in case of the  
Trp!LE-TM4-TM5 construct and to a C3 enzymatic cleavage for the Trp!LE-TM6-
TM7-C construct (vide infra). The mixture was dialyzed (MWCO 3-8 kDa) against 
binding buffer containing 6M GdmCl for 4-5 hours and Ni-affinity chromatography 
under denaturing conditions was carried out to remove the His-tagged Trp!LE peptide 
and also the C3 protease. The protein sample was reduced with 100 mM DTT, 250 mM 
mercaptoethanol and the target proteins were finally purified by C4-RP-HPLC (Vydac, 
USA) by using a water/acetonitrile/0.1% TFA gradient. The final yield of the target 
protein was found to be 1- 2mg/L.! 
 
7.1.3 CNBr cleavage  
  The lyophilized protein was dissolved in 6M GdmCl/0.1M HCl to a final 
concentration of 10 mg/ml. 1.5 times weight excess of solid CNBr was added to the 
solution, the reaction mixture was flushed with nitrogen for 3 min, then wrapped with foil 
and the reaction mixture incubated in the dark for 20-24h at room temperature. The 
mixture was dialyzed (MWCO 3-8 kDa) against pure distilled water for 4-5 hours. The 
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utilization of chaotropic agents in the presence of diluted acids is the preferred cyanogen 
bromide cleavage medium of fusion proteins in order to maximize cleavage efficiency of 
hydrophobic sequences and to prevent deleterious degradation and structural 
modifications of the target peptides. The efficiency of the cleavage was  around 75-80%. 
All these procedures were conducted under a fume hood.  
 
7.1.4 Production of N-His6-3C protease 
The plasmid encoding the target protein N-His6-3C protease in a pET-24d (+) 
vector was transformed into BL21-DE3 cells for expression. A freshly transformed 
colony was used to inoculate 10 ml of LB containing required amount of 50 mg/ml 
kanamycin. This preculture was grown over night at 37°C and then used to inoculate 1L 
LB containing 1ml of 50mg/ml kanamycin culture until the OD600 is approx. 0.6. Then 
the culture was cooled on ice to 20°C. Over expression was induced by the addition of 
0.2 mM IPTG after which the culture was grown overnight at 20°C. Cells were harvested 
and the cell pellet from 1 L culture was resuspended in lysis buffer (50 mM Tris–HCl, 
and 200 mM NaCl, pH 8.0) and sonicated to lyse the cells. The supernatant of the cell 
lysate containing the recombinant
 
C3 protease protein tagged with 6x Histidine was 
applied to pre-equilibrated Ni-NTA resin
 
(Sigma). The protein-bound to Ni-NTA resin
 
was washed with chelating buffer (50 mM Tris–HCl, and 300 mM NaCl, 1 mM "-
mercaptoethanol, 10%glycerol, pH 8.0) containing 30 mM imidazole. The bound proteins
 
were eluted with chelating buffer containing 300 mM imidazole. The eluted protein was 
then dialysed against storage buffer (50 mM Tris–HCl, 150 mM NaCl, 1mM DTT and 
20% glycerol, pH 8.0). The yield was found to be 300mg/L of LB medium.  
 
7.1.5 Screening of cleavage conditions for Trp!LE-TM6-TM7-C by the 
C3 protease 
A mixture of the HRV-3C Protease and the target protein of 1:5(unit/µg) were 
added to 20mM Tris buffer containing 150mM NaCl and various concentrations of 
different detergents. (A concentration range of 0.5% and 1% was used for Triton-X-100, 
Tween-20, CHAPS, N-lauroyl sarcosine, N-lauroyldimethyl amine oxide (LDAO), and 
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0.01%, 0.05% and 1% for DPC and LPPG were used).  The reaction mixture was 
incubated at 4°C for 16 hrs and the extent of cleavage of the protein samples determine 
by SDS-PAGE analysis.  An undigested sample of the target protein was run as a control. 
 
7.1.6 NMR sample preparation 
Uniformly labeled [
15
N]-N-TM4-TM5,(fusion protein) [
15
N]-TM4-TM5 protein 
was dissolved in 200 "l 90% H2O/D2O containing 5% of respective detergents or 
phospholipids and 40mM DTT by thorough sonication for 30 min. 50µl of 0.2 mM 
phosphate buffer (pH 6.0) was added to give a final concentration of 40mM phosphate. 
The peptide/detergent mixtures were then transferred to a Shigemi NMR tube. Nitrogen-
proton heteronuclear single quantum correlation ([
15
N,
1
H]-HSQC) NMR spectra  were 
recorded on an AV-600 Bruker NMR spectrometer at 320 K. Chemical shifts of protons 
were calibrated according to the water line at 4.53ppm, from which the nitrogen chemical 
shifts were referenced indirectly using the conversions factors published on the BMRB 
database. The spectra were processed using the Bruker Topspin 2.0 software. 
 
7.2 Results and discussion  
7.2.1 Design and generation of double transmembrane constructs of 
human Y4 receptor into pLC01 vector  
Previously Dr.Chao Zou from our group has studied the double transmembrane 
fragment of the Y4 receptor (N-TM1-TM2) comprising the N-terminal domain, the first 
two transmembrane (TM) helices and the first extracellular loop followed by a (His)6 tag. 
Almost complete assignment of the backbone, including all TM residue resonances was 
obtained. We further wanted to validate the approach of using fragments of GPCRs as 
surrogates to probe receptor structure. We decided to generate double transmembrane 
fragments corresponding to the region TM4-TM5 and TM6-TM7C to determine their 
structure in membrane-mimicking environments (Figure 1). Due to their smaller size or 
due to their toxicity to the E.coli cells, direct expression was not possible. Therefore these 
transmembrane fragments were designed as Trp!LE fusion proteins and liberated from 
their fusion partner using cyanogen bromide cleavage or by C3 protease cleavage.  It is 
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generally assumed that a disulfide bond between extracellular loop (E- I and E- II) is 
formed in family-1 GPCRs. Since this would further complicate the synthesis and the 
analysis we abstained from making the double transmembrane fragments corresponding 
to the TM3-TM4 domains. Since the ligand binding site of Y4 receptor involves the N-
terminal part and the extracellular loops, it will be useful to study the interaction of 
ligands with TM4-TM5. Furthermore, TM6 of  GPCRs have been shown to be extremely 
important in signal transduction[16, 17]. !
 
7.2.2 The choice of the expression vector systems 
Critical factors governing efficient expression of any protein in E.coli include an 
adequate promoter in terms of strength, leakiness and inducibility, a low plasmid copy 
number if the target protein shows potential toxicity for the host bacteria, as well as a 
resistance marker that minimizes plasmid loss under strong counter selective pressure. 
Attention should also be given to good positioning and accessibility of translational 
initiators and to the presence of transcription terminators that insure mRNA stability and 
prevent promoter read-through that would compete with transcription. 
 
The pLC01 plasmid that is derived from pET vectors is one of the most powerful 
systems developed for the cloning and expression of recombinant proteins in E. coli. 
Target genes cloned in pET plasmids are under the control of the strong bacteriophage T7 
promoter, which contains the T7 RNA polymerase-binding site and the expression is 
facilitated by transferring the plasmid into an expression host containing a chromosomal 
copy of the T7 RNA polymerase gene under lacUV5 promoter (BL21DE3,C41DE3) or 
pBAD promoter control(BL21-AI strain). It is also possible to attenuate the expression 
level simply by lowering the concentration of inducer or by lowering the post induction 
temperature.  
 
The fusion contains the N-terminus leader peptide Trp!LE derived from the 
tryptophan operon. The advantage of the trp leader fusion sequence is that it helps to 
promote high levels of expression, which cause the fused polypeptide to form insoluble 
aggregates (inclusion bodies) in the cellular host, from which it can be solubilized and 
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purified. The Trp !LE sequence starts after the Nde I site with the first residue of the trp 
L gene and continues through codon of Ala-105. This codon is followed by a Hind III 
site, a met codon (TM4TM5) or a /LEVLFQ/GP C3 cleavage site (TM6TM7C) and the 
gene for corresponding for double transmembrane fragments of the Y4-receptor. The 
gene of interest was cloned between and Hind III and BamH I. The 6 methionines in the 
Trp!LE sequence were replaced with leucines to simplify the cyanogen-bromide 
cleavage reaction and the 2 cysteines were replaced with alanines[18]. For Y4-TM4-
TM5, the N-terminal domain of Y4-receptor was also used as a fusion protein. The 
advantage of using the N-terminal domain fusion is that owing to its small size (41 amino 
acids) direct characterization might be possible without the need to remove the fusion 
protein.  
 
 
Figure 2:  Scheme showing the two strategies used to produce double transmembrane fragments 
corresponding to the transmembrane regions of the Y4 receptor  
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In all the constructs a His–tag is present in the N-terminus of the fusion partner to 
facilitate purification by Ni-NTA affinity purification. In case of Y4 Trp!LE-TM6-TM7-
C construct following C3 protease cleavage two extra amino acids Gly and Pro are 
present along with the target sequence (Figure 2). In case of Y4Trp!LE -TM4-TM5 and 
Y4N-TM4-TM5 constructs no extra residues of the vector origin was left over in the 
target gene after the removal of the fusion protein. 
 
7.2.3 Selections of E.coli host strains 
Although expression in E.coli is often simple for soluble proteins, major obstacles 
are encountered in the expression of many heterologous proteins especially for the 
integral membrane proteins. Unfortunately, many of these proteins severely interfere with 
the physiology of E. coli. As a result, expression yields are dramatically diminished, and 
sometimes no expression is observed at all. Therefore, modified expression vectors, 
modified E. coli strains, and appropriate cultivation protocols are needed. Various host 
vector combination has to be tested to obtain optimum yields. 
 
A variety of E. coli strains designed to address many of these problems are 
commercially available. BL21(DE3) is the most widely used expression host. In E. coli 
strain BL21 (DE3), the gene encoding T7 RNAP is under the control of the poorly 
repressed lacUV5 promoter. This leads to leaky basal expression in these strains which 
may be problematic when the target protein is toxic to the bacteria. Silent mutations that 
accumulate over several generations can be selected for their ability to “immunize” E. 
coli against toxic genes. Miroux and Walker described the selection of two derivative 
strains called C41(DE3) and C43(DE3) that tolerated the expression of some toxic 
genes[19]. In strain C41(DE3), the basal expression levels were five times lower than 
those of a standard BL21(DE3). In addition, after induction, the target gene product was 
found to accumulate more slowly. T7 RNA Polymerase (T7 RNAP) is not only a highly 
selective enzyme but also a highly efficient enzyme. Indeed, small amounts of T7 RNAP 
are sufficient to direct high transcription levels from T7 promoters located on multicopy 
plasmids[20].  
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Using the PBAD promoter of the araBAD arabinose operon and the gene coding the 
positive and negative regulator of this promoter, araC, an induction-to-repression ratio of 
1200:1 was obtained[21]. This principle is used in vectors containing PBAD promoter to 
suppress the basal expression sufficiently. The benefits of the tightly regulated PBAD 
promoter and the efficient T7 expression system have been now combined in one E. coli 
strain, in which a chromosomal copy of the T7 RNAP was put under the control of the 
PBAD promoter. Because the T7 RNAP gene is inserted into the araB locus of the araBAD 
operon, expression of T7 RNA polymerase can be tightly regulated by the sugars L-
arabinose and glucose. This arabinose-induced host (BL21-AI, Invitrogen) has 4-fold 
lower basal expression levels than BL21(DE3)pLyS  and is especially useful to express 
genes that may be toxic to other BL21 strains where basal expression of T7 RNA 
polymerase is leakier.  
 
           
Figure 3: Selection of strain BL21-AI, BL21DE3, C41DE3 for expression of Trp!LE-Y4 TM4-
TM5. BI denotes ‘‘before induction’’ and 20 denotes ‘‘post induction growth temperature at 
20°C’’  
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To evaluate the variation of our target protein expression level in different 
bacterial hosts three different strains BL21(DE3), C41(DE3) and BL21-AI were 
screened. The expression for the Trp!LE-Y4 TM4-TM5 construct was tested for each 
strain at 20°C and the results were shown as an example in Figure 3. Considering the 
perfect control of leakage expression, and based on our previous successful experience 
for the construct Y4 N-TM1-TM2, BL21-AI was chosen as the more suitable host for 
large-scale expression; nevertheless the difference in yield in comparison to strains C41 
(DE3) is not very significant. 
 
7.2.4 Optimization of inducible expression and purification  
Our goal was to utilize the high-level expression power of E. coli to produce the 
double-transmembrane constructs as inclusion bodies. Inclusion bodies can be an 
advantage for purification because 1) they are easily isolated by centrifugation to yield 
highly concentrated and relatively pure protein, and 2) inclusion body formation protects 
the protein from proteolytic attack. In addition, toxic proteins may not inhibit cell growth 
when present in inclusion bodies. However, these inactive, insoluble aggregates must 
then be solubilized and refolded to obtain fully folded receptor protein. 
        
Figure 4:  Screening of E.coli strains BL21-AI, C41(DE3) and temperatures for expression of 
Y4-TM4-TM5 (non fusion construct). BI denotes ‘‘before induction’’, 37, 30, 20 denotes ‘‘post 
induction growth temperature at 37°C, 30°C, 20°C respectively. There was no over-expression 
under any of the conditions (expected molecular weight is around 13 kDa).  
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Our previous attempt to express N-TM1-TM2 of the Y4 receptor by direct 
expression leads to reasonable amounts of pure protein required for its structural 
characterization[22]. Based on the success of this strategy and also to avoid the 
chemical/enzymatic cleavage and minimize the steps in purification, first we tried direct 
expression of the double transmembrane segments, (TM4-TM5; TM6-TM7) of the Y4 
receptor without any fusion partner. We tested the three different host strains 
BL21(DE3), C41(DE3) and BL21-AI at different three temperatures 37°, 30° and 20°C 
with variable inducer concentrations. In none of these conditions we could see any over-
expression. The expression screening with two different E.coli strains at different 
temperature for Y4- TM4-TM5 (non-fusion) is presented in Figure 4.  
             
We therefore sought to utilize the fusion strategy to achieve better expression. We 
wanted to test using the N-terminus of Y4 receptor as a fusion partner as successfully 
done for the NY4-TM1-TM2 expression as a small fusion tag to favour the expression of 
double-transmembrane constructs. This fusion strategy takes advantage of the small size 
of the N-terminal domain, which may allow direct NMR analysis without the need of 
removing the fusion protein. In addition, the N-terminal domain was already assigned by 
our group[23] allowing to distinguish its resonances from those of the target protein. So 
to test this strategy an N-terminal domain fusion of TM4-TM5 was generated (Y4N-
TM4-E2-TM5). 
 
 Since our collaborating group of Fred Naider successfully expressed double 
transmembrane constructs from the Ste2p receptor as Trp!LE fusion proteins[7], we also 
cloned 2-TM constructs of TM4-TM5 and TM6-TM7 as Trp!LE fusions along with the 
N-terminal domain fusion constructs. A reasonable expression level of around 3-4 mg/L 
of the fusion proteins was obtained for both the TM4-TM5 constructs ( N-terminal 
domain fusion as well as Trp!LE  fusion) while a slightly higher yield of around 4-
5mg/L for the Trp!LE -TM6-TM7-C construct was achieved (Figure 5). 
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Figure 5:  Screening of temperature conditions for expression of Trp!LE Y4-TM4-TM5. UI 
denotes ‘‘uninduced’’, 37, 30, 20 denotes ‘‘post induction growth temperature at 37°C, 30°C, 
20°C respectively (left). The target protein N-TM4-TM5, Trp!LE TM4-TM5 and Trp!LE TM6-
TM7-C after Ni-NTA affinity purification (right). 
 
    As expression of GPCR fragments in E.coli is rarely trivial, modulating 
temperature, concentration of inducer or additives to the medium can significantly alter 
protein expression levels. It is well known that low temperatures will result in more 
protein expression, while higher temperature is detrimental because of the additional 
stress on the expression host. It is also known that proteolysis increases at higher 
temperatures. To configure the optimal temperature for over-expression, three different 
post induction growth temperatures (37°, 30° and 20°C) were tried (Figure 5). From the 
results of expression analysis it was found that post-induction growth at 20°C promoted 
the highest level of expression of the target protein. E.coli strains controlled by inducible 
promoters are also subjected to varying protein expression levels by altering 
concentrations of the inducing agent. As in our case we checked different amounts of 
arabinose with the BL21 AI strain, and different concentrations of IPTG for C41(DE3) 
and BL21(DE3). Finally, the use of M9 minimal medium supplemented with glucose 
(0.2–1%) instead of an LB rich medium can also improve expression of toxic genes, 
because glucose-mediated catabolite repression reduces the basal expression levels of T7 
RNAP in bacterial host strains. From small-scale expression screening of various growth 
parameters it was found that usage of BL21-AI host strain with 0.2% arabinose inducer 
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concentration and induction growth temperature at 20°C present the most suitable 
expression conditions for large scale target protein expression.  
 
The presence of contaminating lipids and low molecular weight proteins can 
introduce unwanted heterogeneity into the sample, broadening line widths or even 
introducing spurious resonances. Lipid–protein interactions may allow host cell lipids to 
remain bound to the protein throughout the Ni
2+
 affinity purification. In these cases 
further purification via RP-HPLC may be necessary to effectively remove the 
contaminants and improve sample homogeneity. We could previously demonstrate that 
removal of such lipids resulted in dramatically different solubility of the protein 
accompanied with much improved NMR spectra in case of the NY4-TM1-TM2 
construct[22]. Low levels of high molecular weight protein contaminants, while 
undesirable, may be tolerated if they do not interact with the protein of interest since the 
low concentration and long rotational correlation times of these proteins typically prevent 
them from being observed by NMR. 
 
7.2.5 Optmization of expression in deuterated growth medium  
 For structural studies of the membrane proteins, the concomitant increase in 
molecular weight as a consequence of micelle incorporation results in a dramatic 
decrease in spectral quality. In addition, slow conformational exchange processes lead to 
additional line- broadening. This has led to the frequently encountered experience that 
signals from the TM regions of membrane proteins remain invisible[24] . Thus 
deuteration is essential to yield spectra of sufficient quality. An small scale test 
expression was done to check for the overexpression of Trp#LE-TM4-TM5 fusion 
protein in deuterated medium. To allow expression in deuterated water, plasmid 
containing the target gene Trp#LE-TM4-TM5 transformed in BL21-AI cells were plated 
on a D2O LB agar plate and incubated at 37°C for 18-22 hrs and one colony was used to 
inoculate a LB preculture in 100% D2O containing 100 mg/ml ampicillin. The preculture 
was grown at 37°C overnight and was then used to inoculate 10 ml of 50% D2O M9 
containing 50 mg/ml ampicillin and incubated at 37°C (230 rpm) for 18-22 hrs. 2%of the 
inoculum was inoculated into 10 ml of 100% D2O M9 containing 50 mg/ml ampicillin. 
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After incubation at 37°C, overexpression was   induced when the OD600 had reached 0.45 
by adding 0.2% L-arabinose at 20°C, and cells were harvested after 18 h. By increasing 
the level of deuteration sequentially we were able to see the overexpression (Figure 6). 
 
                                  
Figure 6: Small scale expression of Trp!LE Y4-TM4-TM5 in fully deuterated M9 medium.  
UI denotes ‘‘uninduced’’ and AI denotes ‘‘after induction ’’ sample. 
 
7.2.6 Optimization of the cleavage of the fusion protein  
Once the protein is successfully expressed in a fusion system, it needs to be 
cleaved from the fusion protein. By incorporating a single methionine residue into the 
construct, the protein can be deliberated from the fusion protein using cyanogen bromide 
cleavage (Figure 7). An advantage to this is that the reaction is done under very acidic 
conditions, which is ideal for solubilizing these very hydrophobic transmembrane 
domains. But it requires that there are no internal methionines in the target sequence or 
that those can be removed without loss of structure/function by site-directed mutagenesis. 
In case of TM4TM5 there is no internal methionine in the sequence and we used this 
method to remove the Trp!LE and N-terminal domain fusion.   
 242 
        
Figure 7: Cyanogen bromide cleavage of Trp!LE-Y4 TM4-TM5 checked by SDS –PAGE 
electrophoresis (left). CNBr cleavage product subjected to C4 RP-HPLC purification, the peak at 
80% acetonitrile corresponds to the cleaved target protein Y4-TM4-TM5 (right). 
 
In TM6-TM7-C construct the C3 Protease cleavage site is introduced to facilitate 
the removal of Trp#L$ leader from the target protein. HRV 3C Protease is a recombinant 
form of the 3C protease from human rhinovirus type 14. A number of factors, including 
its small size (22 kDa), its robust activity at 4°C, high specific activity, activity in some 
detergent containing buffers and a His•Tag for its removal make HRV 3C protease an 
ideal choice for rapid cleavage of fusion proteins[25-27]. It recognizes the cleavage site: 
LEVLFQ/GP[26]. C3 protease was produced recombinantly in the BL21(DE3) strain and 
the yield was found to be 300mg/l of culture (Figure 8).  
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Figure 8: Expression of C3 precession protease in the BL21 (DE3) strain. BI denotes “before 
induction”, 6h denotes 6hrs after induction, ON overnight induction and P denotes pure C3 
protease protein after Ni-NTA affinity purification.  
 
Since the cleavage site is accessible to different extent in different proteins we 
needed to test several enzyme-to-target protein ratios, different detergents and incubation 
times to optimize the efficiency of cleavage. Especially in case of hydrophobic 
transmembrane constructs we had to find a suitable detergent buffer which solubilizes the 
protein as well as retains the C3 protease activity. A preliminary screening with several 
detergents like Triton-X-100, Tween-20, CHAPS, N-lauroyl sarcosine, N-
lauroyldimethyl amine oxide (LDAO), DPC and with phosopholipids like LPPG was 
done. We screened at 0.5% and 1% concentration for detergents and for DPC and LPPG 
0.05%, 0.1% and 1% were used.  The results of the detergent screening for optimizing 3C 
protease cleavage are summarized in the Table 1.  
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Detergent  Type CMC 
mM 
Removal by 
Dialysis  
Solubility 
of the protein  
Cleavage of the 
fusion protein   
Triton-X-100 Nonionic 0.24 No Very good No 
Tween -20 Nonionic 0.06 No Moderate Yes 
CHAPS Zwitterionic 8-10 Yes Moderate Yes 
LDAO Zwitterionic 2 Yes Moderate  Yes 
N-lauryl sarcosine Anionic ca 15 Yes  Very good No 
DPC Zwitterionic 1.5 No Moderate Yes 
 LPPG Zwitterionic 0.02–0.6 No Very good Yes 
 Table 1: Summary of results of the C3 protease cleavage of Trp!LE Y4 TM6-TM7-C in 
different detergent buffers (1% detergent is used for all reactions except for DPC and LPPG for 
which 0.05% is used) 
                                     
 
Figure 9:  Summary of results of the C3 protease cleavage of Trp!LE Y4 TM6-TM7-C in 
different detergent buffers (1% detergent is used for all buffer except for DPC and LPPG for 
which 0.05% is used) checked by SDS –PAGE gel electrophoresis 
 
Considering the three important factors like solubility, cleavage efficiency and 
dialysability, CHAPS or LDAO were found to be most suitable (Figure 9). An enzyme-
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to-target protein ratio (U/"g) of 1:5 was used for our cleavage reaction set up. 
Furthermore to optimize the cleavage efficiency and solubility of the target protein and to 
minimize the formation of higher molecular weight aggregates, varying concentrations of 
some buffer ingredients like NaCl and some buffer additives have to be tested. 
 
7.2.7 Detergent screening  
An ideal membrane mimetic for solution NMR will solubilize the integeral 
membrane protein (IMP) and allow for the acquisition of well-resolved spectra. 
Furthermore the protein should be stable enough to permit a series of multidimensional 
NMR experiments to be acquired on a single sample. Detergent micelles are the smallest 
membrane mimics that provide all of the interactions that integral membrane proteins 
require, prearranged in the appropriate order. It is not surprising that different detergents 
have such dramatic effects upon the spectra, as a number of complex interactions are 
involved. Thus selection of an appropriate detergent for NMR is a significant challenge. 
Furthermore the shape and dynamics of the detergent micelles can vary with pH and 
temperature thereby altering the environment surrounding the IMP. Spectra with broad 
line-widths and missing resonances are indicative of a micellar environment for which 
the protein is aggregated or has slow global motions resulting in poor spectral properties 
throughout the sample. Alternatively, the presence of more resonances than expected may 
indicate the presence of multiple conformations of the IMP or variations among the 
detergent micelles within the sample. 
 
 Since it is not currently possible to determine the best detergent a priori, a 
number of different detergent types including anionic (SDS and sarcosyl), long chain 
(LMPG and LPPG), medium chain (DPC), and short chain (DHPC) zwitterionic 
detergents should be screened to optimize NMR spectra. Detergent screens via analysis 
of a series of ([
15
N,
1
H]-HSQC) spectra are vital for selecting the appropriate detergent for 
each protein. The variation of resonance intensities within each spectrum can be a 
function of the detergent. These variations are likely the result of differing dynamics in 
spatially disparate regions of the protein or a result of sample heterogeneity. 
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Figure 10:  Plots of the two dimensional [
15
N,
1
H]-HSQC spectra of Y4-N-TM4-TM5. Spectra 
were recorded using 0.2 mM samples of the protein in 40mM phosphate buffer containing 40mM 
DTT at pH 6.0 in 5% LDAO(A); 5% OGP(B);  300mMDPC (C);  5% DHPC (D); 5%LMPG (E) ; 
5% LPPG (F) and  170mM SDS (G). All data were recorded at 47°C at 600 MHz proton 
frequency. All the spectra were recorded with protein samples of highest purity and homogeneity 
after RP-HLPC purification  
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For the N-TM4-TM5 construct, we measured a series of ([
15
N,
1
H]-HSQC) spectra 
in the following detergents: DPC (n-dodecylphosphocholine), DHPC (1,2-dihexanoyl-sn-
glycero-3-phosphocholine), LPPG (1-palmitoyl-2-hydroxy-sn-glycero-3-[phosphor-
RAC-(1-glycerol]), LMPG (1-myristoyl-2-hydroxy-sn-glycero-3-[phospho-RAC-(1-
glycerol)]), OGP ("-D octylglucopyranoside), SDS (sodium-dodecyl-sulfate) and LDAO. 
Though there is a drastic variation of the spectra in different detergents none of them 
resulted in spectra of sufficient quality to enable recording triple resonance experiments 
for the backbone assignment (Figure 10). The spectra measured in lysophospholipids 
(LPPG and LMPG) and SDS appears to be better dispersed compared to spectra 
measured in other detergents.    
 
We also tried some detergent mixtures (e.g. LPPG and SDS; LPPG and DPC) but 
unfortunately no improvement in the spectral quality was observed. Then we decided to 
remove the N-terminal fusion domain by CNBr cleavage. After the removal of N-
terminal domain fusion, the spectra measured with cleaved TM4-TM5 fragment shows 
peaks with broad line widths indicative of highly aggregated state of the protein. But the 
TM4-TM5 fragment cleaved from the Trp!LE peptide using CNBr to our surprise 
resulted in good quality spectra in LPPG and SDS micelles (Figure 11). This could be 
due to the slight difference in their sequence. In the N-terminal fusion construct, the I2 
loop residues (10 amino acids) are not included and immediately after the N-terminal 
domain fusion, the TM4-TM5 sequence starts. This sequence begins with Tyr which 
might lead to the pi-stacking interactions among the double TM fragments. Along with 
this, the highly hydrophobic nature of double TM and the formation of disulphide bonds 
among the transmembrane fragment might lead to a highly aggregated state of the 
protein. But the TM4-TM5 fragment generated from the Trp!LE fusion has residues 
from the I2 loop regions before the actual TM region begins. This might be helpful in 
minimizing the formation of aggregates. This might be one of the reason for the better 
resolved spectra for the double TM fragment I2(147)TM4-E2-TM5-I3(259)(cleaved from 
Trp!LE fusion) than the (158)TM4-E2-TM5-I3(259) (cleaved from N-terminal domain) 
which does not contain the I2 loop but  further sample optimization is needed to obtain 
well dispersed spectra. 
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Figure 11: Plots of the two dimensional [
15
N,
1
H]-HSQC spectra of Y4-TM4-TM5 purified after 
CNBr cleavage from Trp!LE-Y4-TM4-TM5. Spectra were recorded using 0.2 mM samples of 
the protein in 40mM phosphate buffer containing 40mM DTT at pH 6.0 in (A) 300mM DPC; (B) 
5% LMPG (C); 5% LPPG and (D) 170mM SDS. All data were recorded at 47°C at 600 MHz 
proton frequency. All the spectra were recorded with protein samples of highest purity and 
homogeneity after C4 RP-HLPC purification. 
 
It is common that a detergent performs very well under one set of conditions, yet 
poorly at a different pH or temperature. In case of the Y4-N-TM4-TM5 construct we 
have measured an series of [
15
N,
1
H]-HSQC spectra  at different pH ( pH5.0, 5.5, 6.0, 6.5, 
7.0 and 7.5)  in LPPG micelles (Figure 12). At slightly lower pH range (5.0 -6.0) spectra 
appears to be better. 
 
 249 
                    
Figure 12: Plots of the two dimensional [
15
N,
1
H]-HSQC spectra of  Y4-N-TM4-TM5. Spectra 
were recorded using 0.2 mM samples of the protein in 40mM phosphate buffer containing 40mM 
DTT in 5% LPPG at different pH such as (A) pH 5.0; (B) pH5.5; (C) pH 6.0; (D) pH 6.5; (E) pH 
7.0 and (F) pH 7.5   
 
7.2.8 Construction of larger transmembrane fragments of Y4 receptor  
 The double transmembrane fragments of Y4 receptor gave an moderate 
expression level in E.coli. We wanted to extend this methodology to express even larger 
fragments of Y4 –receptor. The first 3TM region of Y4-receptor (N-TM1-TM2-TM3) 
was cloned into pLC01 vector without Trp!LE fusion to check whether direct expression 
as in the case of N-TM1-TM2 is possible. Unfortunately this fragment didn’t give any 
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overexpression. Simultaneously another 3TM construct (Trp!LE-TM4-TM5-TM6), and 
4TM construct (Trp!LE-TM4-TM5-TM6-TM7-C) were cloned and both the constructs 
did not give any expression. In order to achieve good expression of these larger 
fragments currently we were trying other fusion partners like streptococcal GB1 domain, 
MBP, NusA tag that can be cleaved from the fusion protein by 3C protease.  
 
7.3 Conclusions 
Here we report on the biosynthetic production of double TM constructs from the 
human Y4 receptor in E.coli. After systematic screening of growth conditions, host 
strains and cleavage conditions a yield of 1-2 mg of target protein can be achieved from 1 
litre of culture. Because the amounts of double TM fragments were limited, the screening 
trials varied only the detergents while keeping other variables like protein, detergent 
concentration, temperature, pH and salt concentration constant. However for the N-TM4-
TM5 fusion protein in LPPG micelle which gave better spectra among all the detergents 
which are screened, we have done a pH screen to check whether it helps to get well 
resolved spectra. Though the spectral quality varies with different pH range it could not 
lead to good quality of spectra. For the isolated 2TM proteins once when we get 
reasonable spectra with some detergent or detergent mixtures, fine tuning can be done 
with varying salt concentration, pH and detergent concentration.  
!
While well-resolved ([
15
N,
1
H]-HSQC) spectra do not guarantee that a three 
dimensional structure can be determined, they may serve as highly sensitive monitors of 
purification and the entire sample preparation process and reflect the sample aggregation 
state. The 1.5 ppm dispersion of the amide proton chemical shifts is typical of native 
helical membrane proteins in micelles. Best chances for successful studies exists if more 
than 90% of all resonances are observed in a sufficient-quality ([
15
N,
1
H]-HSQC) 
spectrum. When this is not the case the amount of information available in later 
experiments will be severely compromised, limiting the possibility for successful 
assignments and structure determination. We are now in the process of fine tuning the 
detergent conditions to obtain a well dispersed ([
15
N,
1
H]-HSQC) spectra for the Y4 TM4-
TM5 fragment so as to proceed with triple resonance experiments to obtain the backbone 
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assignments. In case of the Y4 TM6-TM7-C construct CHAPS and LDAO are found to 
be the more suitable detergent for the C3 protease cleavage. However, optimization is 
still required for buffer ingredients. Once cleavage conditions are optimized we will 
proceed with the sample optimization for NMR measurements and hopefully proceed 
with assignments and structure calculations.  
 
The unique challenge in the study of membrane proteins lies in their inherent 
hydrophobicity and the difficulty to concentrate to levels high enough for most structural 
studies without aggregation. Sample optimization is demanding due to low yields in 
membrane protein production and the requirement of stable-isotope labeling. When the 
hydrophobic part of a transmembrane protein is too large or too small to match the 
hydrophobic bilayer thickness, the mismatch between the hydrophobic surface and the 
micelle dimensions may result in a perturbation of the protein structure to avoid 
hydration of the hydrophobic !-helices. The structural heterogeneity and potential 
exchange between the two populations of proteins provide a possible explanation for the 
observed NMR line broadening. Matching of the micelle dimensions to the protein’s 
hydrophobic surface avoids exchange processes that reduce the completeness of the 
NMR observations. Mixing detergents at different ratios might be a way to systematically 
change the size and shape of detergent micelles, which leads to the rational design of 
mixed micelles. The relationship between micelle size and thickness and membrane 
protein conformational homogeneity, plays an important role for NMR structure 
determination of transmembrane proteins. However, a correlation between the physical 
properties of the detergent micelle and the likelihood of obtaining a membrane protein 
structure is currently not well understood. Hence an extensive detergent screening has to 
be done to obtain well resolved spectra suitable for the structural studies.  
   
A major problem with the 2 TM approach is that the biological significance of the 
structures is difficult to prove. In order to take care of this problem we plan to add 
missing parts of the TM region as separate proteins to the sample. For some cases it could 
be shown to result in split receptors capable of signal transduction. For those split 
receptors assays to monitor their biological activity are available. The remaining part will 
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be added as a non-labelled protein, so that the 2-TM part under study is only visible in the 
NMR spectra. We are likely to observe changes in chemical shifts of 2 TM parts in 
presence and absence of the remainder of the receptor, but expect that the assignments 
can be adjusted. In addition to the structure of the 2TM segment in a biologically relevant 
context these experiments will also deliver information on the stability and assembly of 
the full-length receptor. 
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outings, birthday parties with egg masalas, numerous funny games and delicious dinner times with 
you all. Thanks a lot dear friends. Moments shared with you guys will always be cherished. I 
would also like to thank Prasanna`s mother and Kalpana`s father for their kindness and delicious 
food during the stressful period of  thesis writing.  In this time, I should definitely mention about 
two girls Jocia and Prasanna who played a major role in tuning my life in many aspects. We have 
been friends together in sunshine and in shade. Sometimes you put walls up not to keep people 
out, but to see who cares enough to break them down. These two friends are of that type. They are 
truly great friends hard to find, difficult to leave, and impossible to forget.  
 
I am indebted to my lovely mother, who gave me life, raised me, taught me and loves me 
no matter what happens. God could not be everywhere, so he created mothers. This is a real truth. 
All that I am or ever hope to be, I owe to my beautiful angel mother. I would like to thank my 
lovely father for showering countless blessings from heaven. Really I miss you a lot Accha.. A 
very big hug to my brother Mohan for his immense efforts to fulfill all my needs, for his endless 
patience and encouragement when it was most required. Anna, I am smiling because you are my 
brother. I am laughing because there is nothing you can do about it!. If I am given the chance to 
select the best brother in the world, It would be you only! I also want to thank my sister in law, her 
sweet kids Harish and Thusara, all my relatives, and my friends for their immense love and 
support. I would like to thank all my previous teachers for their valuable teachings and blessings. 
Finally I would like to thank God Almighty. “Faith is not knowing God can…it’s knowing that he 
will.” Thanks a lot Ganesha… 
